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This thesis hoped to inform the practice of future individual myopia management. All myopia risk 
factors across global ethnic regions must be considered, instead of relying on the most widely 
used averaged parameters, towards the development of growth model tools. There could be 
possible crucial cut points of near phoria development at specified age ranges, earlier and later 
in life, suggesting this myopia risk factor should be measured alongside other primary outcome 
parameters important for treatment efficacy. Other notable human lifespan findings included: 
emmetropic and female patients attended eye examinations more frequently; females exhibited 
higher levels of near phoria and myopia; myopes were more esophoric than emmetropes, 
progressive myopes were more esophoric than both myopes and emmetropes, and were less 
likely to increase in exophoria with age. The presumed design optimisation, regarding daily CE-
marked optical myopia control strategies, was based on the possible mechanism behind myopic 
retinal defocus (blur) and accommodative lag in myopia development and progression. Contact 
lens designs could have an inherent characteristic for their treatment effect in the temporal 
retina at 30° and J0 astigmatic component. Multifocal contact lenses for myopia control 
significantly impacted glare, but did not affect contrast sensivitiy differently than standard 
lenses, and would offer equally acceptable treatment compliance and qualifty of life 
expectations. Specialty instrumentation for measuring primary outcomes (refraction and axial 
length) should be used interchangeably for myopia control studies. This was confirmed between 
the gold standard biometers, IOLMaster 700 and IOLMaster 500, for the key parameters of axial 
length, anterior chamber depth and corneal topography, where discrepancies in white-to-white 
corneal diameter values, following MiSight and NaturalVue contact lens wear, were minimal and 
clinically irrelevant. Further novel discoveries proved myopia control contact lenses were viable 
non-invasive sampling vehicles for human dopamine detection. Thus, the thesis probed the 
viability of novelty applications of such “labelled” and/or gold standard medical devices and 
instrumentations towards treating individual myopic patients and highlighted that appropriate 
global myopia management and standardisation remain poor. 
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Chapter 1 Introduction 
Myopia has become a global public health issue (Vitale et al., 2008; Morgan et al., 2010; Holden 
et al. 2016). Uncorrected myopia is the most common visual condition encountered and has 
been described as an epidemic with its increasingly early onset and high progression rates 
worldwide (Bourne et al., 2013; Holden et al. 2016; Fricke et al., 2018). Myopia progression 
during childhood even at low levels increases the risk of sight-threatening ocular diseases in 
adult life, as a result of abnormal eye growth (Vongphanit et al., 2002; Younan et al., 2002; 
Wong et al., 2003; Saw et al., 2005; Flitcroft, 2012). Previous animal research has shown that 
ocular growth is associated with peripheral hyperopic defocus (Smith et al., 2007; Smith et al., 
2009a; Smith et al., 2012). Treatment modes such as specialty spectacles and soft contact 
lenses, orthokeratology or OK (corneal reshaping/refractive therapy or reverse geometry rigid 
gas-permeable contact lenses), and pharmaceuticals have been shown to control myopia 
progression in addition to correcting visual acuity (Walline et al., 2011; Smith & Walline, 2015; 
Gonzalez-Meijome et al., 2016). 
 
The scientific community has been developing various interventions to control myopia, including 
the general undercorrection of myopic refraction (Chung et al., 2002; Adler & Millodot, 2006; 
Vasudevan et al., 2014), multifocal spectacles (Gwiazda et al., 2003; Berntsen et al., 2012; 
Cheng et al., 2014), contact lenses; [multifocal soft contact lenses or MFSCLs (Anstice & 
Phillips, 2011; Sankaridurg et al., 2011; Walline et al., 2013), rigid gas-permeable (Khoo et al., 
1999; Katz et al., 2003; Walline et al., 2004), and orthokeratology (Kakita et al., 2011; Hiraoka et 
al., 2012; Swarbrick et al., 2015)], topical pharmaceuticals; [low-dose atropine of 0.5%, 0.1%, 
and 0.01% (Lee et al., 2006; Chia et al., 2012; Chia et al., 2014) and pirenzepine (Siatkowski et 
al., 2004; Tan et al., 2005; Siatkowski et al., 2008)], and lifestyle changes (Guggenheim et al., 
2012; Jones-Jordan et al., 2012; Lin et al., 2014), but a standardized clinical protocol only 
continues in development. Additionally, these strategies are mostly off-label treatments (not 
approved specifically for myopia control), and low dose atropine and pirenzepine in particular 
are not commercially available (Smith & Walline, 2015). Other techniques such as scleral 
reinforcement surgery (Hu et al., 2018) and cross-linking (Zhang et al., 2015) have postulated 
scleral strengthening and thickening, but lack human reproducibility/repeatability (Ward, 2013).  
 
Despite evidence-based research, management challenges persist due to cost (Flitcroft, 2012), 
safety (Liu & Xie, 2016), inadequate information (Santodomingo-Rubido et al., 2012), and 
outcome unpredictability (Wolffsohn et al., 2016), whilst myopia often continues to be wrongfully 
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treated with conventional remedies (undercorrection, single vision spectacles and contact 
lenses) only capable of correcting visual acuity. Rigid orthokeratology and soft multifocal contact 
lenses currently remain the most promising tools available to clinicians (Smith & Walline, 2015; 
Gonzalez-Meijome et al., 2016; Wolffsohn et al., 2016). However, studies have not directly 
investigated the myopia management efficacy of different MFSCL designs. The optimisation of 
all methods, including “labelled” and gold standard instrumentation techniques and clinical 
guidelines, must be challenged to aid the quest towards universal myopia management 
standardisation. Moreover, this thesis will also explore novel applications of these treatment 
strategies, such as predictive technology, and other avenues including MFSCLs acting as viable 
dopamine vehicles, which may possibly lead to improved individual patient care.          
 
1.1 Emmetropisation & Eye Growth Overview 
1.1.1 Paediatric Development   
Refractive error, or ametropia, reflects the mismatch between the power of the eye’s optical 
system (corneal and lens shape/size/position) and its length. Ametropia is mainly described by 
the following terms: myopia (nearsightedness); hyperopia (farsightedness); astigmatism (error 
from irregular corneal or lens curvature and anterior chamber development; changes as the 
corneal curvature increases horizontally with age and typically occurs in conjunction with 
myopia and hyperopia); and presbyopia (age-related vision impairment at near distance, due to 
the natural loss of accommodation-the crystalline lens’ elastic ability to adjust light focus at 
various distances). Mutti et al. (2005) noted that whilst eye growth may continue until puberty, 
the increase in corneal curvature occurs in the first few months, whilst lens power decreases 
during early childhood. The average newborn infant is hyperopic (Mutti et al., 2005) and 
astigmatic (Gwiazda et al., 1984) with a decline between six months and six years of age. This 
reduction in refractive error, or emmetropisation, during the first years of life is based on the 
eye’s ability to focus light and corresponding retinal image quality dictated by optical power 
(spherical and astigmatic defocus) and visual optics (higher-order monochromatic aberrations-
mainly positive spherical aberrations, coma, trefoil, and astigmatism) respectively (Troilo et al., 
2019). Emmetropisation is regulated via the balance of increase in axial length (AL) leading to 
myopia and radius increases in the cornea or crystalline lens causing hyperopia by decreasing 
the lens power (Wildsoet, 1997; Ip et al., 2008). Although the impact is much lower, 
emmetropisation is further influenced by higher-order aberrations affecting luminance and 
chromatic contrast, due to additional corneal and lens refractive index and thickness changes 
during infantile development with previous studies reporting approximately 20-50% more 
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aberrations exhibited by children than adults (Brunette et al., 2003; Wang & Candy, 2005); as 
well as astigmatism (Fulton et al., 1982; Gwiazda et al., 2000). Overall, refractive status 
depends on an infant’s visual experience within sensitive periods of development, which is 
determined by genetics and the environment (Mutti et al., 2002; Farbrother et al., 2004).  
 
The IMI (International Myopia Institute) – Report on Experimental Models of Emmetropization 
and Myopia white paper by Troilo et al. (2019), summarized in full the current understanding on 
emmetropisation, myopia development and treatments for its progression from research with 
experimental animal models. This compendium also attributed axial and refractive changes 
triggered by form-deprivation/optical defocus, optical image quality (higher-order monochromatic 
aberrations and astigmatism), lighting (luminance and chromatic contrast signals), as well as 
circadian rhythms to both genetic and environmental vision-dependent factors – regulated signal 
cascade pathways locally restricted to the retina and decreased exerted magnitude with 
eccentricity, without brain input. Moreover, ocular anatomic changes caused by independent 
visual regulation during experimentally induced refractive errors were particularly related to the 
posterior segment (scleral and vitreous chamber shape and size) and not the programmed 
growth changes in the anterior segment (corneal curvature, anterior chamber depth, 
accommodation with increased intraocular pressure) (Bailey et al., 2008; Pucker et al., 2013, 
2015). The report has further reviewed the literature surrounding the involved molecular 
mechanisms and significant drug interactions in eye growth and refractive error relative to 
defocus, as well as including the following notably identified biochemical compounds: 
neurotransmitter (retinal dopamine, vasoactive intestinal peptide), growth factor (retinoic acid, 
glucagon, insulin), and gene expression (nitric oxide, melanopsin) visual signals in the retina, 
retinal pigment epithelium, choroid, and sclera; all depicted by Figure 1.1 below (Troilo et al., 
2019). Choroidal thickness is especially considered a major determinant of ocular growth and 
emmetropisation potentially via accommodation (Guggenheim et al., 2011); whilst atropine is 
consistently accepted to be effective in myopia prevention possibly via muscarinic/non-
muscarinic mechanisms inhibiting smooth muscle contraction and resultant choroidal thinning, 
but not involving ciliary muscles or accommodation (Stone et al., 1991; Tigges et al., 1999; 
Barathi et al., 2009). 
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Figure 1.1:  Vision-dependent/retinal defocus feedback mechanisms and associated 
functional/structural ocular anatomical changes, regulating emmetropisation and 
eye growth during paediatric development, as adapted and copied from the IMI – 
Report on Experimental Models of Emmetropization and Myopia white paper 
(Troilo et al., 2019). 
 
Human (Rabin et al., 1981; Huo et al., 2012) and animal (Gottlieb et al., 1987; Norton & 
Siegwart, 1995) studies have suggested shared mechanisms in form-deprivation myopia such 
as increased axial elongation rate (especially increased vitreous chamber depth and elongation) 
with thinned fibrous sclera and choroid at normal intraocular pressure. Likewise, human axial 
elongation rate and choroidal thickness compensation for optically-imposed defocus in the 
retina (along with gene expression changes) was shown to be bidirectional, respective of the 
encoded lens sign (Read et al., 2010; Chakraborty et al., 2012, 2013; Wang et al., 2016). Zhu et 
al. (2005) had stated choroidal thinning by as much as ~50 µm is possible in just an hour. 
Increased eye growth due to defocus also causes retinal pigment epithelium enlargement from 
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blocked ionic fluid transport between the vitreous chamber and choroid, resulting in swelling and 
thinning respectively (Liang et al., 2014; Jonas et al., 2017a, 2017b). Historically, the choroid 
(van Alphen, 1986), but especially the sclera (Curtin et al., 1979), are both considered to dictate 
human eye size and shape. Scleral remodeling caused by myopia results from thinning via loss 
of its extracellular matrix mainly at the posterior pole (Norton & Rada, 1995; Gentle et al., 2003), 
coupled with increased extensibility/viscoelasticity or decreased stiffness due to higher fibrous 
tissue creep rate (Siegwart & Norton, 1999; Phillips et al., 2000) and cartilage growth (Grytz & 
Siegwart, 2015).   
1.1.2 Uncorrected Refractive Error Prevalence & Economic Burden    
Refractive error prevalence varies with age (the most important factor), sex, ethnicity and 
socioeconomic status. Uncorrected refractive error is the primary cause of visual impairment 
(visual acuity <6/18) with a reported estimate of 108 million in 2010 and the second leading 
cause of blindness (visual acuity <3/60) worldwide (Bourne et al., 2013). In 2007, the global 
burden of uncorrected refractive error was conservatively estimated to be $268.8 billion (Smith 
et al., 2009). This is a global public health issue due to its effect on individual visual 
performance and quality of life, as well as economic productivity loss regarding subsequent care 
and disability. Since levels of hyperopia are typically low, human clinical studies have not been 
implemented to investigate control strategies. In contrast, myopia is now considered an 
epidemic by the World Health Organization (WHO) and is the commonest refractive error 
among children and young adults (Morgan et al., 2010). 
 
1.2 Myopia  
1.2.1 Definition & Classification  
Due to the excessive classifications and associated terms of myopia in the existing literature, 
simpler and internationally agreed evidence-based standards are necessary. In their IMI – 
Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiological 
Studies white paper report, (Flitcroft et al., 2019) recommended the descriptive terminology to 
be consolidated into myopia, axial myopia, refractive myopia, secondary myopia, and 
pathological myopia; standardized quantitative myopia thresholds for children were proposed as 
pre-myopia (≤ +0.75 D and > -0.50 D), myopia (≤ -0.50 D), low myopia (≤ -0.50 D and > -6.00 
D), and high myopia (≤ -6.00 D). This comes after discovering significant myopia threshold 
variations among epidemiologic studies from conducted meta-analysis, reporting: 87.7% of 138 
studies used < -0.50 D or ≤ -0.50 D for myopia; 35.6% and 61% of 59 studies used < -5.00 D or 
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≤ -5.00 D and < -6.00 D or ≤ -6.00 D for high myopia respectively (Flitcroft et al., 2019). In order 
to prevent inconsistency, over-simplification, and misleading for true myopia study and 
management, Tables 1.1 & 1.2 below include this IMI committee’s recommended consensus on 
terms and definitions for global adaptation; based on myopia “optics, etiology (if known), 







































“A refractive error in which rays of light entering the eye parallel to 
the optic axis are brought to a focus in front of the retina when 
ocular accommodation is relaxed. This usually results from the 
eyeball being too long from front to back, but can be caused by an 
overly curved cornea and/or a lens with increased optical power. It 
also is called nearsightedness.” 
 
“A myopic refractive state primarily resulting from a greater than 
normal axial length.” 
 
 
“A myopic refractive state that can be attributed to changes in the 
structure or location of the image forming structures of the eye, i.e. 
the cornea and lens.” 
 
 
“A myopic refractive state for which a single, specific cause (e.g., 
drug, corneal disease or systemic clinical syndrome) can be 





“A condition in which the spherical equivalent refractive error of an 
eye is ≤ -0.50 D when ocular accommodation is relaxed.” 
 
“A condition in which the spherical equivalent refractive error of an 
eye is ≤ -0.50 and > -6.00 D when ocular accommodation is 
relaxed.” 
 
“A condition in which the spherical equivalent refractive error of an 
eye is ≤ -6.00 D when ocular accommodation is relaxed.” 
 
“A refractive state of an eye of ≤ +0.75 D and > -0.50 D in children 
where a combination of baseline refraction, age, and other 
quantifiable risk factors provide a sufficient likelihood of the future 
development of myopia to merit preventative interventions.” 
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Table 1.1:  The recommended consensus on qualitative and quantitative myopia terms and 
definitions for global adaptation, as adapted and quoted from the IMI – Defining 
and Classifying Myopia: A Proposed Set of Standards for Clinical and 















































“Excessive axial elongation associated with myopia that leads to 
structural changes in the posterior segment of the eye (including 
posterior staphyloma, myopic maculopathy, and high myopia-
associated optic neuropathy) and that can lead to loss of best-
corrected visual acuity.” 
 
“A vision-threatening condition occurring in people with myopia, 
usually high myopia that comprises diffuse or patchy macular 
atrophy with or without lacquer cracks, macular Bruch’s membrane 





“Category 0: no myopic retinal degenerative lesion.  
Category 1: tessellated fundus.  
Category 2: diffuse chorioretinal atrophy.  
Category 3: patchy chorioretinal atrophy.  
Category 4: macular atrophy.  
‘‘Plus’’ features (can be applied to any category): lacquer cracks, 
myopic choroidal neovascularization, and Fuchs spot.” 
 
 
“A person who has vision impairment and vision acuity that is not 
improved by pinhole, which cannot be attributed to other causes, 
and:  
• The direct ophthalmoscopy records a supplementary lens < -
5.00 D and shows changes such as ‘‘patchy atrophy’’ in the 
retina or, 







“A combination of macular retinoschisis, lamellar macula hole 
and/or foveal retinal detachment (FRD) in eyes with high myopic 
attributable to traction forces arising from adherent vitreous cortex, 
epiretinal membrane, internal limiting membrane, retinal vessels, 






and posterior staphyloma.” 
 
“Optic neuropathy characterized by a loss of neuroretinal rim and 
enlargement of the optic cup, occurring in eyes with high myopia 
eyes with a secondary macrodisc or peripapillary delta zone at a 
normal IOP.” 
Table 1.2:  The recommended consensus on myopia structural complications terms and 
definitions for global adaptation, as adapted and quoted from the IMI – Defining 
and Classifying Myopia: A Proposed Set of Standards for Clinical and 
Epidemiological Studies white paper report (Flitcroft et al., 2019). 
 
Moreover, the committee has also submitted these updated, as well as collectively agreed to be 
more accurate, myopia definitions to WHO’s International Classification of Disease (ICD). 
 
1.2.2 Developmental (relative peripheral refraction; eye growth; refractive ametropia; age; 
binocular vision) Risk Factors & Progression  
 
Animal studies have associated vision-dependent peripheral refraction (Smith et al., 2007, 2009; 
Zhu et al., 2013; Benavente-Perez et al., 2014), as well as vision-independent higher-order 
aberrations (Coletta et al., 2003; Garcia de la Cera et al., 2006; Ramamirtham et al., 2007; 
Coletta et al., 2010) and astigmatism (Kee et al., 2003; Kee, 2013; Chu & Kee 2015) with 
myopia development and progression, but these may not be principal causes in humans. 
Several human studies demonstrated myopes had higher higher-order aberrations (Collins et 
al., 1995; He et al., 2002; Paquin et al., 2002; Llorente et al., 2004); and peripheral hyperopia 
relative to the central refractive error, which was even maintained through five years regardless 
of the increasing eye elongation since the myopia onset (Mutti et al., 2007); whereas 
emmetropes and hyperopes had relative peripheral myopia (Chen et al., 2010; Ehsaei et al., 
2011; Sng et al., 2011). However, other human studies have particularly considered relative 
peripheral refraction (Lee & Cho, 2013; Atchison et al., 2015) and higher-order aberrations 
(Carkeet et al., 2002; Cheng et al., 2003) only as possible risk factors or consequences of 
myopia development and progression, instead of having a causal relationship.  
 
Myopia is caused by an increase in eye length or vitreous depth (axial ametropia, where every 
0.09-0.10 mm increase translates to 0.25 D in higher myopia), and/or corneal curvature and 
crystalline lens power (refractive ametropia); axial ametropia has the largest effect on refractive 
error as it may progress into the third decade of life (Hashemi et al., 2004). Since light is 
focused in front of the retina, distance vision is blurry, whilst close objects remain clear. 
Childhood myopia assumes onset around age eight and continues to develop during 
N.B.Boychev, PhD Thesis, Aston University 2021                                                                    23 
 
adolescence between ages 15-16 (Goss & Cox, 1985; Thorn et al., 2005), after which is termed 
as late-onset (McBrien & Millodot, 1987; Jiang, 1995). However, the Correction of Myopia 
Evaluation Trial (COMET) stated that although myopia stabilised at an average age of 15.6 ± 4 
years, 95% stabilised by age 24 (COMET, 2013). The age to end treatment may be currently 
unspecified, but the need for early intervention is certainly indicated; the prospective Northern 
Ireland Childhood Errors of Refraction (NICER) and multi-center Collaborative Longitudinal 
Evaluation of Ethnicity and Refractive Error (CLEERE) key studies showed younger children 6-
10 years of age experienced axial growth faster (Breslin et al., 2013) with notable increases 
three years pre- and five years post- onset, as well as reduced hyperopia four years pre-onset 
(Mutti et al., 2007), respectively. Emmetropic axial length may range between 22-24.5 mm, 
whilst ALs >25 mm are considered myopic (Tideman et al., 2016b). Furthermore, annual AL 
increases of 0.1 mm vs. 0.2-0.3 mm are thought as emmetropic and myopic respectively (Mutti 
et al., 2007). In one study on Hong Kong Chinese high myopes of age 12-18, an AL >26 mm 
was considered significant for developing peripheral retinal pathologies (Cheng et al., 2013). 
Zadnik et al. (2015) additionally stated children at age six are of particular risk to develop 
myopia if they have hyperopia <0.75 D. This is further supported by Morgan et al. (2010), who 
stated that hyperopia is the natural endpoint for refractive development, in order to reduce the 
risk of myopia progression in children. A child’s binocular vision state is another possible 
association with myopia. Studies have reported higher levels of esophoria or inward eye 
deviation and unstable/insufficient accommodative responses or higher accommodative lag 
(Gwiazda et al., 1995; Nakatsuka et al., 2005; Allen & O’Leary, 2006), higher accommodative 
convergence or AC/A ratio (Gwiazda et al., 1999; Gwiazda et al., 2005), as well as lower 
accommodative facility (Allen & O’Leary, 2006; Pandian et al., 2006) at near distances among 
nearsighted children and young adults compared to their emmetropic counterparts. These 
outcomes are thought to be involved in triggering eye growth by causing relative peripheral 
retinal blur; however, both lower (Rosenfield et al., 2002; Berntsen et al., 2012) and higher 
(Gwiazda et al., 2003; Allen & O’Leary, 2006) accommodative lags have been shown among 
myopic and emmetropic subjects. For instance, better efficacy was achieved in children having 
higher esophoria and accommodative lag in the five-year COMET randomised clinical trial by 
spectacles fitted with progressive addition lenses (PALs) (Gwiazda et al., 2004); lower 
accommodative lag of <1.01 D by the three-year randomised clinical trial regarding prismatic 
bifocal spectacles (Cheng et al., 2014); lower accommodative amplitude with orthokeratology 
(Zhu et al., 2014), at near. These studies, including randomized clinical trials, suggest that 
binocular vision aspects also do not consistently indicate a causal relationship with myopia, 
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whilst remain important when designing control strategies and selecting management options 
for patients.  
 
Myopia progression refers to the uncontrolled growth of the eye via axial length elongation, 
which results in a change of refractive error (in the minus dioptric direction) and retinal/scleral 
thinning (Saw et al., 2005). Moreover, various studies have stated an average rate of 
progression in Caucasians per year of 0.50 D (Fulk et al., 2000; Gwiazda et al., 2003; Walline et 
al., 2004, 2009), whereas an earlier study on Singaporean children by Saw et al. (2000) 
considered annual progression of >0.50 D to indicate a faster rate. Although myopia 
progression is a multifactorial problem remaining misunderstood, previous studies in individual 
children have recognized earlier onset as the primary factor to its faster rate, regardless of 
genetic and environmental risks (Price et al., 2013; Sankaridurg & Holden, 2014; Chua et al., 
2016); with higher baseline myopia (Hsu et al., 2017) and seasonal changes such as during 
winter possibly due to reduced time outdoors coupled with more time in school (Gwiazda et al., 
2014) also considered. A population cohort meta-analysis of 20 myopia control investigations 
confirmed a similar average annual rate of progression in Caucasian and Asian nearsighted 
children of 0.50-1.00 D, with greater rates among younger female Asians (Donovan et al., 
2012). Even at low and moderate levels of myopia, nearsighted people are more prone to 
cataracts (Wong et al., 2001; Younan et al., 2002; Flitcroft, 2012), glaucoma (Yoshida et al., 
2001; Wong et al., 2003; Flitcroft, 2012), macular degeneration, retinal detachments/holes/tears, 
choroidal/peripapillary atrophy, tilted disc, staphyloma, and reduced cone photoreceptor density, 
whilst high myopia (>5.00-6.00 D) may ultimately lead to blindness (Pierro et al., 1992; 
Vongphanit et al., 2002; Saw et al., 2005; Flitcroft, 2012; Chang et al., 2013; Smith & Walline, 
2015). The risks for developing these ocular conditions are comparable to those of smoking and 
hypertension to cardiovascular health (Flitcroft, 2012). Even children with high myopia aged ≤10 
years had retinal pathologies in a retrospective review (Bansal & Hubbard, 2010). These 
conditions further solidify myopia’s status as an epidemic, being a primary contributor to global 
visual impairment and blindness, as described in the popular review by Holden et al. (2016), as 
well as more recently in a key systemic review and meta-analysis by Fricke et al. (2018). 
Although some of the risk factors associated with myopia are lower juvenile hyperopia (Zadnik 
et al., 2015), peripheral refraction (Mutti et al., 2007; Downie & Lowe, 2013), and binocular 
vision (Mutti et al., 2006; Felipe-Marquez et al., 2015), the type of visual environment has been 
shown to specifically dictate its onset, progression and cessation (Aller, 2014). Diet also may be 
a possible contributor, where Lim et al. (2010) noted that healthy Asian children with diets 
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consisting of higher saturated fat and cholesterol, but lower fruit, vegetable, and whole grain 
intakes had longer axial lengths, whilst Trier et al. (2008) identified caffeine (oral 7-
methylxanthine or 7-MX is approved as myopia control medication in Denmark) to reduce axial 
length via a scleral mechanism over three years; however, the 10-year Blue Mountains Eye 
Study deemed nutritional evidence as inconclusive (Hong et al., 2014). Other studies have also 
drawn an association between increased eye growth and human circadian rhythms, due to low 
sleep quality (Ayaki et al., 2016; Jee et al., 2016; Abbott et al., 2018) and higher serum 
melatonin (Kearney et al., 2017), but such lifestyle research is still limited. Although the exact 
physiological effects are unknown, this further stems from animal research associating diurnal 
light cycles (Li et al., 2000) and ocular circadian rhythms (Nickla, 2013) with myopic eye growth 
and emmetropisation based on axial length, choroidal thickness, or intraocular pressure daily 
fluctuations (Nickla et al., 2002) and scleral proteoglycan synthesis rate (Nickla et al., 1999); 
form-deprivation/defocus-related anterior chamber depth and corneal curvature changes 
resulting from circadian rhythm systems’ response to light duration, intensity, and level (Norton 
& Siegwart, 2013; Ashby, 2016); as well as the circadian rhythms and hormone roles of the 
spectral composition of light, chromatic signals, and wavelength-dependent defocus in 
luminance contrast (with specific oscillations in axial length, choroidal thickness, and vitreous 
chamber depth) (Rucker, 2013).   
 
1.2.3 Genetic (family history; ethnicity) & Visual Environment (near work; time outdoors; 
education) Risk Factors & Progression  
 
Rose et al. (2002) had already attributed genetics to the magnitude of myopia, especially the 
ocular biometry heritability of corneal curvature and axial length (Meng et al., 2011), whilst 
environmental factors are deemed responsible for the sudden worldwide increase in myopia 
prevalence (Morgan & Rose, 2005; Morgan et al., 2012; Dolgin, 2015). The IMI – Myopia 
Genetics Report (Tedja et al., 2019) confirmed refractive error and myopia predisposition is due 
to both genetics and environmental risk factors (near work and outdoor exposure; specifically 
education holding most prominence), as well as a light-processing retina-to-sclera molecular 
mechanism for common myopia development. The summarized literature on genome-wide 
association studies (GWAS) by the Consortium for Refractive Error and Myopia (CREAM) and 
23andMe, as well as genome-environment-wide interaction studies (GEWIS) has identified 
nearly 200 genetic loci for refractive error (spherical equivalent), high myopia, or eye growth 
(corneal curvature and axial length), and nine loci for the association between high education 
and high myopia susceptibility respectively (Tedja et al., 2019). In particular, more than half of 
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the loci were discovered during this decade and the report estimated myopia heritability in the 
range of 60-80%. Two GWAS meta-analyses also have found numerous retinal and other ocular 
tissue gene expression changes from animal studies to overlap with human myopia quantitative 
trait loci (QTL) (Verhoeven et al., 2013; Riddell & Crewther, 2017). Although all retinal cells and 
layers are considered sites of gene expression, a candidate gene meta-analysis validated only 
the PAX6 gene (Chen et al., 2012) for ocular development to be associated with high myopia 
(Tang et al., 2014). A GWAS meta-analysis specifically linked vasoactive intestinal peptide 
receptor 2 (VIPR2) with high myopia among Chinese people (Yiu et al., 2013). Likewise, 
secondary syndromic myopias (myopia with systemic or ocular conditions, as well as mental 
retardation and connective tissue disorders) have been uniquely associated to single causal 
genes (Li & Zhang, 2017) and only two such genes, the collagen type II alpha 1 chain or 
COL2A1 (Mutti et al., 2007; Metlapally et al., 2009) and fibrilin 1 or FBN1 (Fan et al., 2016; 
Tedja et al., 2018), have been linked to common myopia (Tedja et al., 2019). Table 1.3 below 
outlines the currently 27 secondary syndromic myopias associated with ocular abnormalities. 
Moreover, a combined GWAS meta-analysis by CREAM and 23andMe emphasized the TGF-
beta pathway and specific gene sets (“abnormal photoreceptor inner segment morphology”, 
“thin retinal outer nuclear layer”, “detection of light stimulus”, “nonmotile primary cilium”, 
“abnormal anterior-eye segment morphology”) as key myopia drivers (Tedja et al., 2018). Other 
methods, such as myopia epigenetics research considering noncoding RNAs, particularly 
microRNAs (miRNAs), have the potential for both prevention and treatment of associated retinal 
pathology (Liang et al., 2011; Chen et al., 2012; Jiang et al., 2017).        
 
Achromatopsia; Aland Island eye disease; Anterior-segment dysgenesis; Bietti crystalline 
corneoretinal dystrophy; Blue cone monochromacy; Brittle cornea syndrome; Cataract; 
Colobomatous macrophthalmia with microcornea; Cone dystrophy; Cone rod dystrophy; 
Congenital microcoria; Congenital stationary night blindness; Ectopia lentis et pupillae; High 
myopia with cataract and vitreoretinal degeneration; Keratoconus; Leber congenital amaurosis; 
Microcornea, myopic chorioretinal atrophy, and telecanthus; Microspherophakia and/or 
megalocornea, with ectopia lentis and/or secondary glaucoma; Ocular albinism; Primary open 
angle glaucoma; Retinal cone dystrophy; Retinal dystrophy; Retinitis pigmentosa; Sveinsson 
chorioretinal atrophy; Vitreoretinopathy; Wagner vitreoretinopathy; Weill-Marchesani syndrome 
Table 1.3:  Listed are the 27 currently known Online Mendelian Inheritance in Man (OMIM) 
secondary syndromic myopias associated with ocular abnormalities, as adapted 
and recreated from the IMI – Myopia Genetics Report white paper (Tedja et al., 
2019). 
 
Both Hammond et al. (2001) and Lyhne et al. (2001) attributed the variability of refractive error 
to genetic over environmental factors, due to the wide array of candidate genes and loci (Ciner 
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et al., 2009; Wojciechowski et al., 2009; Schache et al., 2013). In this regard, past familial and 
twin studies have reported a widely variable myopic spherical equivalent heritability in the range 
of 10%-98% (Angi et al., 1993; Lyhne et al., 2001; Sanfilippo et al., 2010). Similar studies have 
highlighted the high heritability of ocular biometry (Klein et al., 2009; Kim et al., 2013), and 
Guggenheim et al. (2013) especially stated a 64% correlation between measures of corneal 
curvature and axial length. Also, a family history correlation between increased genetic 
predisposition for myopia and the number of myopic parents has been demonstrated (Saw et 
al., 2006), with various studies highlighting an increased heritability risk of ≥3x when both 
parents are myopic (Mutti et al., 2002; Farbrother et al., 2004; Jones-Jordan et al., 2014; Wu et 
al., 2015). Jones-Jordan et al. (2010) particularly stated the risk of becoming nearsighted is five 
to six times greater when both parents are nearsighted, especially for children between 6-14 
years of age. The study additionally noted that the children of nearsighted parents spent less 
time outside, whilst engaged more in near work activities compared to children of parents 
without a refractive error.  
 
The IMI – Risk Factors for Myopia report (Morgan et al., 2021) recently stated education and 
time outdoors to be the leading risk factors for school myopia; Table 1.4 below shows the 
complete summary of factors associated with myopia, as outlined in this white paper. Studies 
also have considered ethnicity (Voo et al., 1998; Kleinstein et al., 2003; Ip et al., 2007, 2008; 
Rudnicka et al., 2010) to be an important determinant, since myopia onset, as well as its 
progression rate and duration differ worldwide, where Asians in particular have been worse off 
relative to other groups (Donovan et al., 2012; Morgan et al., 2018). East Asian children in 
Australia between 11-15 years of age were eight times more susceptible to become nearsighted 
compared to Caucasian children in the same age group (Ip et al., 2008). Similar ethnic myopia 
prevalence differences were given by the Child Heart and Health Study in England (CHASE) for 
South Asian children in Britain relative to their Caucasian European counterparts (Rudnicka et 
al., 2010). Rose et al. (2008) found that the duration of near tasks has ethnic variations, where 
East Asian children spent 20% more time than their Caucasian counterparts, whilst children 
from myopic parents were longer engaged with reading and less outside overall. However, 
environmental factors such as reduced time outdoors and sunlight exposure, as well as 
increased engagement in near tasks (especially using portable devices and reading at close 
distances of <20 cm for >45 minutes) with reduced lighting are considered the primary risks for 
developing myopia regardless of ethnicity (Ip et al. 2008; Li et al., 2015). Moreover, Ip et al. 
(2008) emphasized prolonged and intensive near tasks among highly pressured educational 
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systems as a contributing factor towards childhood myopia, just as found among Asian nations 
exhibiting the highest prevalence (Dolgin, 2015; Rose et al., 2016). Studies have approximated 
double the myopia prevalence among those entering higher education relative to groups at the 
level of primary education (Morgan & Rose, 2013; Mirshahi et al., 2013; Ramessur et al., 2015). 
Gene-environment (GxE) interaction studies with Mendelian randomization (MR) of GWAS 
meta-analysed cohorts have confirmed the causal relationship between education and myopia, 
reporting effects of 0.27 D myopic shift per year of education (Mountjoy et al., 2018) and 
estimated 0.92 D for two years of education (Cuellar-Partida et al., 2016). Although Jones-
Jordan et al. (2012) did not report a strong correlation between near work and myopia onset or 
progression, other studies have shown increased time outdoors to prevent myopia onset 
(Guggenheim et al., 2012; Jones-Jordan et al., 2014; Lin et al., 2014), but that is not an effective 











Strong and causal 





Role of light (intensity, 
duration, spectrum) 
Nearwork 
















Cultural attitudes or genetics 
Genetics or myopiagenic 
environments 
Years of education 
Years of education 
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Miscellaneous factors 
Allergic conjunctivitis, hay 














Reading in dim light, under 
bed-clothes or in transport 
Posture in reading/writing 










Table 1.4:  Listed are the 7 risk factor categories associated with myopia, along with the 
currently accepted relationship of each specific factor and its confounding issues, 
as adapted and recreated from the IMI – Risk Factors for Myopia Report white 
paper (Morgan et al., 2021). 
 
Indeed, a more recent key meta-analysis and systemic review by Xiong et al. (2017) confirmed 
increased time outdoors to be effective in preventing myopia onset and slowing the myopic shift, 
but not in controlling progression. Various studies have recommended at least 8-15 hours of 
weekly outdoor time (Rose et al., 2008; Guggenheim et al., 2012; Jones-Jordan et al., 2012; He 
et al., 2015; Read et al., 2015). French et al. (2013) have suggested that the preventative 
mechanism of increased outdoor activity is related to reduced accommodative demand, bigger 
depth of focus, improved contrast, higher levels of Vitamin D (Mutti & Marks, 2011; Choi et al., 
2014; Tideman et al., 2016a) and retinal dopamine acting against form-deprivation myopia. 
However, only minimal myopia causality via MR has been attributed to Vitamin D concentration 
(Tedja et al., 2019). Other studies have inconclusively contemplated the brightness (Dharani et 
al., 2012; Read et al., 2014; Read et al., 2015; Hua et al., 2015), as well as the elevated 
ultraviolet radiation and short-wavelength (blue light of wavelength <400 nm) transmission (Torii 
et al., 2017; Williams et al., 2017) associated with outdoor light exposure.  
 
1.2.4 Worldwide Myopia Prevalence 
In a recent publication, Holden et al. (2016) approximated global myopia prevalence at 1.4 
billion people and 163 million with high myopia (≥6.00 D) in the year 2000; but predicted these 
values to reach nearly 5 (~50% of the world population) and 1 billion respectively by 2050, even 
from the overall current estimate of ~30%. Moreover, the same review showed that myopia 
distribution by 2050 will spread between ages 10-79, when previously compared to ages 10-39 
in 2000, implying that this increased global myopic population will also be older. Whilst myopia 
in the U.S. has increased from 25% to 42% in the past 30 years (Vitale et al., 2008), prevalence 
varies widely from 3% in Nepalese children (Garner et al., 1999) to 90% in Taiwanese university 
N.B.Boychev, PhD Thesis, Aston University 2021                                                                    30 
 
students (Want et al., 2009). The literature is inconclusive whether males or females exhibit 
higher myopia prevalence (Katz et al., 1997; Attebo et al., 1999; Junghans & Crewther, 2003), 
although some studies have suggested females to hold greater representation (Dandona et al., 
2002; Hashemi et al., 2004; Bar Dayan et al., 2005; He et al., 2007). However, the samples of 
these studies largely varied in age groups and ethnicities. Overall, myopia prevalence is highest 
among children of Asian ethnicities (Voo et al., 1998; Kleinstein et al., 2003; Ip et al., 2007, 
2008), followed by Hispanic, African-American, and Caucasian backgrounds (Voo et al., 1998; 
Kleinstein et al., 2003).     
 
1.2.5 Economic Burden of the Myopia Epidemic 
Myopia carries a heavy socioeconomic burden. The cost of correcting myopia in Singapore, only 
for ages between 12-17 has been estimated to be $37.5 million (Lim et al., 2009), while the 
approximate individual cost for adults of age ≥ 40 was $709 annually (Zheng et al., 2013). In the 
United States, an approximate annual cost between $3.9-7.2 billion was reported (Vitale et al., 
2006). 
 
1.2.6 Modes of Myopia Treatment 
From the currently implemented myopia control strategies, only multifocal soft contact lenses 
(MFSCLs), orthokeratology (OK), and topical pharmaceuticals are considered clinically 
significant (the ability to reduce myopia progression by approximately 50%); Figure 1.2 (Smith 
& Walline, 2015) and Table 1.5, below. Myopic undercorrection (Chung et al., 2002; Adler & 
Millodot, 2006), as well as conventional single vision spectacles or contact lenses increase its 
progression in nearsighted children between 0.50-1.00 D annually (Donovan et al., 2012). 
However, multifocal spectacles and those with progressive addition lenses (PALs) can produce 
an efficacy of 20-50% in some cohorts (Gwiazda et al., 2003; Cheng et al., 2014) and with 
minimal safety concerns. Orthokeratology efficacy has been reported in the range of 30-60% by 
various studies (Walline et al., 2009; Hiraoka et al., 2012; Santodomingo-Rubido et al., 2012), 
including the longitudinal randomised Retardation of Myopia in Orthokeratology (ROMIO) 
clinical trial (Cho & Cheung, 2012). Reported treatment efficacy for OK may vary with study 
location and subject ethnicity, unless a range of ethnicities were present (Jones et al., 2019). 
Similar efficacy of 30-50% or higher can be achieved by MFSCLs depending on the design 
(Anstice & Phillips, 2011; Sankaridurg et al., 2011; Lam et al., 2014; Aller et al., 2016; Cooper et 
al., 2018). The efficacy with atropine extends to 30-80% (Chua et al., 2006; Tong et al., 2009; 
Chia et al., 2012), but unlike OK (Santodomingo-Rubido et al., 2017) and MFSCLs (Walline et 
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al., 2013), atropine (Pineles et al., 2017) is contraindicated for long-term application exceeding 
two years. Children have not been deemed anymore prone to either OK (Bullimore et al., 2013; 
Liu & Xie, 2016) or MFSCL (Chalmers et al., 2011; Bullimore, 2017) complications than adults. 
However, it is important to highlight the effects of myopia control lenses on contrast sensitivity 
and the accommodation response. Recent notable works by Sanchez et al. (2018) and 
Przekoracka et al. (2020) have stressed the role of multifocal contact lens design in distinctly 
limiting visual performance by inflicting halos, reduced contrast sensitivity and visual acuity. 
Furthermore, Ruiz-Pomeda et al. (2018) and Cheng et al. (2019) suggested that the contact 
lens optical design may have a crucial role in myopic children by influencing the binocular and 
accommodative function in utilising positive spherical aberration. Novel use of combination 
therapy between optical and pharmaceutical treatments is also possible, but research in this 
area is still very limited (Verzhanskaya & Tarutta, 2017; Tan et al., 2020).  
 
 
Figure 1.2 The reported efficacy (%) of atropine, soft multifocal contact lenses, and 
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Table 1.5 The reported efficacy of atropine, soft multifocal contact lenses, and orthokeratology 
to reduce myopia by various controlled studies, after the review by Smith & Walline (2015). 
 
Due to persistent variability in efficacy and mechanism understanding of the current optical, 
pharmacological, environmental, and surgical treatment strategies, the committee on 
Interventions for Myopia Onset and Progression (Wildsoet et al., 2019) maintains that no 
therapy yet exists for all patients able to fully prevent, delay, or control myopia. This IMI white 
paper extensively summarizes the variable optical treatment efficacies as such: single vision 
spectacles (14%); bifocal and progressive addition spectacles (6-51%); off-label soft multifocal 
contact lenses (38%); and orthokeratology (30-55%). Also, studies have shown myopia 
progression to be clinically similar between full correction single vision spectacles and soft 
contact lenses (Horner et al., 1999; Fulk et al., 2003; Marsh-Tootle et al., 2009), whilst 
undercorrection in some randomized controlled trials (RCTs) either holds no significant clinical 
effect or further increases myopia progression (Chung et al., 2002; Koomson et al., 2016; Adler 
& Millodot, 2006). Although pharmacological control of myopia has consisted of atropine (non-
selective antimuscarinic antagonist), pirenzepine (M1-selective muscarinic antagonist), oral 7-
methylxanthine (adenosine antagonist), and topical timolol (non-selective beta-adrenergic 
antagonist), the report mentions only topical atropine has been widely used in both trials and 
practice with ranging myopia control efficacy of 60-80% for the 1% dose (Yen et al., 1989; Shih 
et al., 1999; Chua et al., 2006) and 42-58% for the lower 0.01% dose (Shih et al., 1999; Chia et 
al., 2014; Chia et al., 2016) resulting in reduced rebound and side-effects. Studies on 
environmental strategies have associated outdoor time efficacy with myopia prevention and not 
its control (Donovan et al., 2012; Gwiazda et al., 2014; Li et al., 2015); noted a missing 
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correlation between near work and outdoor time (Guggenheim et al., 2012; Lin et al., 2014; Li et 
al., 2015); and missing support for a causal relationship between lower serum vitamin D levels 
and myopia (Guggenheim et al., 2014; Cuellar-Partida et al., 2017). Moreover, the meta-
analysis by Sherwin et al. (2012) linked every extra hour spent outdoors per week with a 2% 
reduction in myopia development among children and adolescents. The committe has 
mentioned that the only surgical interventions for mypia control in the literature involve scleral 
reinforcement including posterior scleral reinforcement (PSR), injection-based scleral 
strengthening (SSI), and collage cross-linking scleral strengthening (CCL); where both clinical 
application and research has been limited to PSR and only in China, Eastern Europe, and 
Russia. 
Although complete understanding remains elusive, the potential mechanisms of these 
treatments consist of peripheral refraction, positive spherical aberration, and accommodation; 
whilst the extended efficacy, safety, and rebound effects in the current literature only spans up 
to five years. For instance, Berntsen et al. (2013) linked PAL efficacy with peripheral myopic 
defocus restricted to the superior retina, whilst Smith (2013) attributed the greater efficacy with 
OK and MFSCLs to their ability for induced simultaneous peripheral myopic defocus over all or 
most of the retina. The randomized clinical trial by Walline et al. (2004) on standard rigid gas-
permeable contact lenses reported only a temporary significantly reduced myopia progression, 
due to changes in corneal curvature, but no effect on axial elongation. Indeed, AL changes by 
contact lenses are well-correlated with myopia control, where many studies have mentioned 
mean efficacy of 41%, as well as corresponding increased average elongation over two-years of 
0.33 mm and 0.55 mm in the experimental and control groups respectively (Walline et al., 2009; 
Kakita et al., 2011; Cho & Cheung, 2012; Santodomingo-Rubido et al., 2012b; Charm & Cho, 
2013; Cheung & Cho, 2013; Walline et al., 2013; Lam et al., 2014; Back et al., 2017; Jones et 
al., 2019). There are various designs of orthokeratology lenses, all producing similar levels of 
myopia control, which are significantly more effective than traditional means (undercorrection, 
single vision spectacles and contact lenses). Centre distance progressive contact lenses are 
also effective and have started to emerge commercially (Kollbaum et al., 2013). Although visual 
acuity may be compromised depending on the design, the primary goal is controlling myopia 
progression. For instance, contact lens use particularly with preserved cleaning solutions and 
potential wear discomfort (Fonn, 2009; Chalmers, 2014; Mizoguchi et al., 2017), as well as 
topical atropine preserved with benzalkonium chloride toxic to the cornea (Baudouin et al., 
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2010; Datta et al., 2017), have been generally linked with dry eye disease, especially in younger 
groups (Mizoguchi et al., 2017; Wu et al., 2017).  
 
1.2.6.1 Spectacles 
Multifocal spectacles correct distance vision through the upper half portion of the lenses and 
were perceived to be able to slow myopia by relaxing accommodation via the bottom half (Mutti 
et al., 2006). Randomised clinical trials, including COMET 1 & 2 and the Study of Theories 
about Myopia Progression (STAMP), have incorporated bifocals and PALs with +1.50 or +2.00 
Adds (Hyman et al., 2001; Edwards et al., 2002; Gwiazda et al., 2003; Berntsen et al., 2010; 
Cheng et al., 2010; COMET 2, 2011), but new designs exerting relative peripheral defocus are 
being developed (Sankaridurg et al., 2010; Lam et al., 2017). Although a longitudinal 
randomised three-year clinical trial by Cheng et al. (2014) did report myopia control of 51% in 
Chinese-Canadian children of age 8-13, both large (Li et al., 2011; Cheng et al., 2014) and 
small (Sankaridurg et al., 2010; Hasebe et al., 2014) efficacy by multifocal spectacles has been 
reported. Various studies noted the ability of multifocal spectacles to control myopia in 
comparison to single vision lenses, especially in nearsighted children with faster progression, 
lower baseline myopia, binocular errors (near esophoria or high accommodative lag) and 
reduced reading distance, but the effect was generally not clinically significant and did not last 
for more than a year (Cheng et al., 2010; COMET 2, 2011; Berntsen et al., 2013; Smith & 
Walline, 2015). The randomised trial by Berntsen et al. (2012) also showed no rebound effect 
post-PAL treatment in children after one year of wear. However, Hasebe et al. (2005) have 
reported that nearsighted children wearing multifocal spectacles misuse the near zone within 
the lens profile by not fixating correctly and require regular frame adjustments. Overall, due to 
their unconvincing efficacy, as well as lack of wear compliance from reduced esthetics and 
useful field of view with visual distortion, spectacles for myopia management should be 
considered second-tier options for patients unideal to be fitted with contact lens treatments or 
those in remote geographical regions (Gifford et al., 2019; Jones et al., 2019).  
 
1.2.6.2 Soft Multifocal Contact Lenses 
Soft multifocal contact lenses that are normally used to correct presbyopia are also promising 
for myopia control (Anstice & Phillips, 2011; Sankaridurg et al., 2011; Berntsen & Kramer, 2013; 
Kang et al., 2013; Ticak & Walline, 2013; Walline et al., 2013; Fujikado et al., 2014; Lam et al., 
2014; Cheng et al., 2016; Gifford & Gifford, 2016; Sankaridurg, 2017). This treatment mode 
allows for flexible wear (Lam et al., 2014) and even better self-esteem among children relative 
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to spectacles (Rah et al., 2010). As with the different spectacle lens designs, although no 
rebound effect was found post-MFSCL treatment after one-two years of wear, Cheng et al. 
(2016) reported efficacy only during the initial six months. The two main designs of MFSCLs, 
usually utilised with a +2.00 to +2.50 D power Add, include: concentric dual-focus or bifocal with 
alternating distance plus power for refractive error correction and myopic defocus treatment; 
and aspheric progressive power or peripheral add having a central zone correcting distance 
refractive error with gradual increase in relative peripheral plus power for myopia defocus 
(Gifford et al., 2019). In 2011, Anstice & Phillips carried out a 20-month crossover study 
comparing a dual-focus center-distance concentric soft multifocal lens in one eye with a 
conventional single vision soft lens for distance correction in the other eye, which were 
exchanged after a 10-month interval. The researchers reported ≥30% reduction in myopia 
progression with the dual-focus lens. In a two-year study, Cheng et al. (2013) showed that the 
myopia control mechanism with aspheric soft multifocal contact lenses is based on inducing the 
most positive spherical aberration, whilst Anstice & Phillips (2011) did not report significant 
difference in visual acuity and contrast sensitivity using a concentric design. However, Kollbaum 
et al. (2013) found reduced visual performance (decreased acuity by one line) and contrast 
sensitivity when they compared a dual-focus center-distance multifocal (MiSight, CooperVision) 
and center-near bifocal (Proclear Multifocal, CooperVision) two-zone concentric soft designs 
with +2.00 D power Add to conventional spectacle-corrected performance in young adults age 
18-25, whilst no difference resulted when only the multifocal lenses were compared. In a two-
year study on myopic children of age 8-11 wearing aspheric center-distance soft multifocal 
lenses (Proclear Multifocal, CooperVision) with +2.00 D power Add, Walline et al. (2013) 
reported a maintained 50% and 29% reduction in myopic refraction and eye elongation 
respectively, when compared to a conventional single vision soft lens.  
 
The three-year Bifocal Lenses in Nearsighted Kids (BLINK) study (Walline et al., 2020) on 
approximately 300 children age 7-11, also the first randomised clinical trial comparing center-
distance multifocal soft lenses of +1.50 D and +2.50 D Adds, found that bifocal contact lenses, 
especially those of high-add, slowed myopia progression by 43% and reduce axial length by 
0.23 mm, when compared to standard single-vision contact lenses. Walline et al. (2017) earlier 
noted that even if myopia control is the primary concern, children must be able to tolerate lens 
wear. This comes after Lopes-Ferreira et al. (2011) earlier concluded only center-distance 
MFSCLs with +3.00 D and +4.00 D power Adds can induce significant relative peripheral 
myopic defocus, but Adds >2.50 D may not be visually acceptable by children (Bickle & Walline, 
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2013). A study by Sankaridurg et al. (2011), where Chinese children age 7-14 were fitted with 
an aspheric, peripheral progressive plus-powered (center-distance) soft contact lens (Lotrafilcon 
B, CIBA Vision) for one year, resulted in 34% and 33% reduction in myopic refraction and axial 
elongation respectively, when compared to the nearly two-fold reduced myopia control effectivity 
of the flat optical profile in spectacle lens wearers within the same age group. Although new 
developments are constantly made, the literature suggests that the current majority of contact 
lens designs for myopia control correct the distance refractive error within their central optical 
diameter, whilst control myopia progression by reducing the relative peripheral hyperopia 
(Gifford & Gifford, 2016). The study by Sankaridurg et al. (2011) showed that the use of 
conventional soft single vision contact lenses for myopia control is ineffective, since their optical 
profile only exerts relative peripheral hyperopia, instead of creating peripheral myopic defocus. 
Additionally, in their two-year randomised clinical trial among nearsighted Hong Kong Chinese 
children, Lam et al. (2014) proposed a positive correlation between Defocus Incorporated Soft 
Contact (DISC) lens wearing time and corresponding efficacy, suggesting a daily modality of ≥5 
hours. Studies have been inconclusive regarding the efficacy influence of inducing a relative 
peripheral myopia refraction profile with varying add powers and visual field treatment extent, as 
well as the impact on accommodation, all requiring further research (Smith, 2013; Walline et al., 
2017). To better understand such differences in retinal peripheral refraction with different lens 
designs and powers, recent studies have visualised the power profiles of the many used 
MFSCLs (Kim et al., 2017; Nti et al., 2021).  
 
1.2.6.3 Orthokeratology 
Orthokeratology has been implemented since the 1960s, but only in the last two decades has it 
generated significant attention (Mountford, 1997; Lui et al., 2000; Mountford, 2004). This is 
largely attributed to the worldwide increased prevalence of myopia (Vitale et al., 2008; Williams 
et al., 2015; Holden et al., 2016), coupled with improvements in lens materials, designs, and 
instrumentation (Coon, 1984; Wlodyga & Bryla, 1989; Mountford, 1997). Overnight OK is a 
temporary, reversible, and non-invasive treatment option that can provide natural daytime clear 
vision, without the need of a corrective appliance (Swarbrick, 2006; Walline et al., 2009; Cho & 
Cheung, 2012). Such a clinical option offers ground-breaking independence with subsequent 
quality of life improvements for many myopes, as well as ease for parental involvement and 
oversight (Lipson et al., 2005; Smith et al., 2009b; Santodomingo-Rubido et al., 2013). Although 
the exact mechanism of orthokeratology remains inconclusive, the literature suggests that the 
redistribution of epithelial cells increases the power of the mid-periphery to reduce eye 
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elongation (Alharbi & Swarbrick, 2003; Nieto-Bona et al., 2011a; Nieto-Bona et al., 2011b; Qian 
et al., 2013). These corneal changes of flattening and steepening represent the central and 
peripheral transition zones respectively, while the area of corneal flattening is referred to as the 
treatment zone (Mountford, 2004; Swarbrick, 2006; Lu et al., 2007). Studies have speculated 
that the treatment zone size of orthokeratology lenses is responsible for the treatment effect in 
myopia control (Owens et al., 2004; Lu et al., 2007; Gifford & Swarbrick, 2009), but existing 
research in this area is scarce.   
 
Orthokeratology is particularly effective in comparison to other optical myopia control strategies, 
due to its ability to treat moderate and high nearsightedness (3.00-6.00 D), as well as being less 
susceptible to eye movement and blinking than soft contact lens correction (Smith, 2013). 
Efficacy for correcting high myopia >6.00 D in conjunction with single vision spectacles has also 
been demonstrated over a two-year randomised study (Charm & Cho, 2013). The treatment 
zone is the site for corneal reshaping, where the cornea changes from prolate to a spherical 
shape (Mountford et al., 2004; Swarbrick, 2006; Chan et al., 2008). Success has been linked to 
the treatment zone size (Alharbi & Swarbrick, 2003) in relation to corneal epithelial thinning and 
refractive surgery concepts surrounding Munnerlyn’s formula, where the expected 
orthokeratology change in refractive error is based on corneal thickness or sagittal height 
changes (Swarbrick et al., 1998); higher myopia requires a wider treatment zone and deeper 
corneal flattening, which may increase the risk for corneal abrasion (Chan et al., 2008). 
Furthermore, higher myopic refractive error imposes an increased risk of lens decentration and 
corneal staining (Lu et al., 2007). Thus, the application of orthokeratology towards correcting 
myopia beyond 4.00 D is usually restricted to smaller optical treatment zones, in order to limit 
flattening into the corneal stromal tissue (Owens et al., 2004) and account for pupil size 
changes under dim illumination (Swarbrick et al., 1998). Optical zone diameters of four- and 
five-zone orthokeratology lenses typically range between 5.50-6.50 mm, with 6.00 mm being the 
most common; however, for corrections between 1.00-3.00 D and 3.50-6.00 D, it is possible to 
have a zone of 6.00-6.50 mm and 4.00-5.00 mm respectively (Mountford et al., 2004). 
Moreover, both studies by Owens et al. (2004) and Lu et al. (2007) found that longer 
orthokeratology lens wear (over four weeks) leads to an increasing treatment zone size, which 
has been associated with better visual acuity, increased optical aberrations, and improved 
subjective visual quality. A more recent study by Kang et al. (2013) investigated the effects on 
peripheral refraction, corneal topography, and aberrations and did not find significant differences 
after changing orthokeratology lens parameters (5.00 mm and 6.00 mm optic zone diameters) in 
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myopic (1.00 D to 4.00 D) young adults over a two-week period. Although statistically 
insignificant, the authors reported that the 6.00 mm orthokeratology lens seemingly achieved 
greater peripheral myopic defocus via steepening of the corneal midperiphery. Thus, the 
relationship between corneal reshaping, treatment zone sizes, optical aberrations, and quality of 
life measures warrants further research.  
 
Orthokeratology predominantly exists as an overnight modality based on many advantages: it 
eliminates adaptation problems associated with a blink reflex since lens movement and lid 
interaction are reduced in a closed eye, it lowers the risk of foreign bodies and corneal staining, 
offers a stable environment leading to a potentially higher compliance, and has higher overall 
efficacy (Mountford, 1997; Swarbrick, 2006; Cho et al., 2008). Also, the lenses never leave 
one’s home and parents may be involved with every aspect of their use in cases of children 
wearers (Santodomingo-Rubido et al., 2013). In addition to myopia control, overnight 
orthokeratology provides the same convenience and cosmetic appeal as laser surgery by 
providing quality unaided daytime vision, with the further advantages of being reversible, non-
invasive, and allowing patients to take a break from lens wear (Soni et al., 2004; Wu et al., 
2009; Chen et al., 2010). Orthokeratology can also be used to correct refractive error regression 
and restore corneal regularity due to complications arising from refractive surgeries (Ozkurt et 
al., 2012). Furthermore, dry eye prevalence in ages ≥40 was reported to be 54.3% (Shah & 
Jani, 2015), whilst tear evaporation has been found to be significantly higher in ages ≥45 
(Guillon & Maissa, 2010), especially in females, as the lipid layer in the tear film becomes 
thinner and less efficient with age. Dry eye symptoms experienced by presbyopic contact lens 
users can be avoided with overnight orthokeratology wear, since rigid lenses allow for less tear 
evaporation in a closed eye (Muntz et al., 2014).    
 
1.2.6.4 Pharmaceuticals 
The literature has shown that topical cycloplegic therapy (low-dose atropine of 0.01% or 
pirenzepine antimuscarinic drugs) most commonly applied to young children between ages 3-11 
is a highly effective myopia control strategy (Tan et al., 2005; Siatkowski et al., 2008; Tong et 
al., 2009; Chia et al., 2016). Cycloplegic drugs are already used to slow myopia progression in 
East Asia and success rates are between 32%-72% (Chia et al., 2014, 2016). However, 
atropine is not often clinically prescribed due to its side effects (temporary and reversible light- 
sensitivity, blurry vision at close distance, stinging/burning, and allergic conjunctivitis) via pupil 
dilation and lowered accommodation, whilst pirenzepine is not commercially available (Chua et 
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al., 2006; Tong et al., 2009; Chia et al., 2012; Smith & Walline, 2015). Unlike atropine, 
pirenzepine is a selective muscarinic receptor and may exert reduced side effects (Siatkowski et 
al., 2008). Tan et al. (2005) reported 50% (0.35 D) myopia reduction and deemed the 
application of 2% pirenzepine gel in Asian myopic children of age 6-12 over a one-year period 
as safe (one case of abdominal pain, two cases of treatment withdrawal due to accommodative 
relaxation and pupil dilation, and 8% withdrawal due to allergic reactions). In a two-year 
longitudinal study on the application of 2% pirenzepine gel among myopic children of age 8-12, 
Siatkowski et al. (2008) showed myopia control (myopia progression of 0.26 D and 0.58 D at 
years one and two respectively compared to the control group) and patient safety to be 
maintained. However, the use of pirenzepine is limited due to its unknown mechanism, initial 
age to commence application, treatment length, and long-term efficacy.  
 
Atropine is particularly a potent drug only available in 0.5% and 1% doses in the UK as ointment 
and drops. Other concentrations of ≤0.5% are not commercially available and unlicensed by the 
Medicines & Healthcare Products Regulatory Agency (MHRA). According to the Medicines Act 
1968, atropine is classified as a prescription only medicine (POM) available to UK practitioners 
with a minimum of additional supply training and is mainly used in hospital eye services (HES) 
for mydriasis or cycloplegia. In another two-year longitudinal study on myopic Asian children of 
age 6-12, Tong et al. (2009) showed that the cycloplegic effect of 1% atropine drops was 
reduced within six months and a lower myopia progression was observed in the following six 
months. Like the different orthokeratology lens designs, there is a rebound effect after atropine 
cessation, but long-term investigation on myopia control and post-treatment stabilisation with 
variable atropine concentrations also has not been performed yet. Debate continues regarding 
the optimum concentration necessary, in order to minimize the associated adverse reactions, 
whilst maintaining effectiveness and preventing rebound. The two-year longitudinal study on 
Asian myopic children of age 6-12 by Chia et al. (2012) demonstrated that lower atropine 
concentrations (0.5%, 0.1%, and 0.01%) had comparable efficacy and safety results. The 0.01% 
dose was especially shown to be the safest and with lower rebound effect (Chia et al., 2012; 
Loughman & Flitcroft, 2016), as well as reducing accommodative amplitude only by 2-3 D (Chia 
et al., 2016). The Atropine for the Treatment of Myopia (ATOM) studies (Chua et al., 2006; Chia 
et al., 2016) confirmed these outcomes, but over a five-year clinical trial. Although atropine’s 
action may be based on reduced accommodation and changes of the crystalline lens curvatures 
(Chua et al., 2006; Chia et al., 2014), or eye growth receptor interaction associated with 
circadian rhythms (Stone et al., 2013; Bullimore & Berntsen, 2018), the exact mechanism 
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remains unknown. One meta-analysis has also considered ethnicity, stipulating improved 
atropine efficacy in Asian children over their Caucasian counterparts (Li et al., 2014).    
 
1.2.7 The Problem with Myopia Treatment 
Although clinicians are aware of the available myopia control strategies, as well as the sufficient 
and accepted research evidence behind their efficacy and safety (Wolffsohn et al., 2016), the 
lack of global standardization in treatment protocol persists. In a review by Wolffsohn et al. 
(2016), important trends among current clinical practice regarding myopia control were noted: 
undercorrection continues to be employed as a control strategy particularly in India, Spain, 
Portugal, and South America despite its myopia inducing effects, pharmaceutical efficacy was 
reported to be underestimated, while the efficacy of increased outdoor activity was 
overestimated, and >68% of nearsighted children were still prescribed with single vision 
spectacles or contact lenses. In addition to clinical standardization, further clinical trials are still 
necessary to confirm the mechanism, efficacy, safety, predictability, and economic feasibility of 
these optical treatments, in order to gain clinical acceptance worldwide (Polse et al., 1983a and 
b; Santodomingo-Rubido et al., 2012).  
 
Myopia control treatments are mainly off-label/unlicensed prescriptions, and the relevant legal, 
regulatory, and professional stance is country-specific, varying worldwide. An exception is the 
recently approved European certification standard or CE marking for the MFSCLs dailies 
MiSight (CooperVision) and NaturalVue (Visioneering Technologies), which is also recognised 
in Canada, Australia/New Zealand, and sporadically in Asia. Increased practitioner training and 
patient education are additionally required to stagnate the myopia crisis. The IMI – Industry 
Guidelines and Ethical Considerations for Myopia Control Report (Jones et al., 2019) discussed 
extensively the ethical and regulatory responsibilities shared by stakeholders (governmental and 
regulatory bodies, manufacturers, academics, health and eye care practitioners, patients) 
regarding myopia control products, since these are mainly off-label/unlicensed treatments and 
devices directed at vulnerable patients. Off-label/unlicensed prescribing must be thoroughly 
understood, as listed reasons for and against off-label promotion, as well as permitted FDA 
sources of related use information in the United States may be found in the white paper report, 
as adapted from Ventola (2009). Its reported use by an early study was both common and 
frequent, for instance, accounting for about 21% of all prescriptions and possibly reaching 83% 
in some therapeutic specialties or patient populations in the United States (Radley et al., 2006).  
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The IMI – Clinical Management Guidelines Report (Gifford et al., 2019) has provided an 
evidence-based best practice framework to identify risk factors and environment interventions; 
lay terminology to discuss myopia, its risks and treatment options, including off-label strategies; 
standard procedure for baseline examination, as well as additional evaluation and exploratory 
tests; regulations for clinical advice and care; and advise for future research and clinician 
professional development. Further key conclusions from the white paper report include: a 
myopia range of at least 0.50-0.75 D is necessary before considering treatment; myopia 
correction is to be worn full time and undercorrection as a control strategy should be 
abandoned; near work should not be prevented, but coupled with time spent outdoors for the 
minimally recommended 8-15 hours/week; the efficacy and safety of treatments should be 
monitored on 6-month intervals.  
 
Futhermore, the IMI – Clinical Myopia Control Trials and Instrumentation Report (Wolffsohn et 
al., 2019) highlighted the following: clinical trials should span a minimum of three years (two 
years with treatment and the final year without treatment to assess possible rebound effects); a 
control group is mandatory; a standardised adverse event reporting system and dilated fundus 
examinations should be inplace; dysphotopsia should be investigated at baseline and 
throughout the study; classification of outcome measures is to consist of primary (refractive 
error or axial length), secondary (patient/guardian reported outcomes via a questionnaire and 
treatment compliance in real time), and exploratory (peripheral refraction, changes in 
accommodative lag and dynamics, ocular alignment, pupil size, outdoor activity and lighting 
levels, anterior and posterior segment anatomical changes particularly related to choroidal 
thickness, and scleral and corneal biomechanics) results.  
 
1.2.8 Developments in myopia assessment & prediction technology 
The global myopia epidemic has prompted the development of clinical models to predict and 
monitor its onset, progression, and control. Such predictive methods of assessment and 
technology have taken various forms from the use of growth models (Tideman et al., 2018; Diez 
et al., 2019; Jagadeesh et al., 2020), electronic medical record (EMR) systems into machine 
learning (Kaya et al., 2018; Lin et al., 2018; Xu et al., 2018; Yang et al., 2020), as well as mobile 
apps and devices (the Brien Holden Vision Institute [BHVI] Myopia Calculator; Plano; FitSight; 
Myopia Master; MYAH). Epidemiological research has identified many risk factors for childhood 
and adolescent myopia (Pan et al., 2012; Kim et al., 2013; Stambolian, 2013), but predictive 
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models have grouped these into optical, structural, genetic and environmental classifications. 
These categories have also assigned myopia-specific measurement parameters, such as 
uncorrected refractive error (including parental history), corneal curvature, crystalline lens 
power, accommodative lag, axial length (AL), age, ethnicity, sex, education and time spent with 
outdoor and near-vision tasks (He et al., 2015; Medina, 2015; Zadnik et al., 2015) towards the 
application of specialty devices. Furthermore, in the recent Singapore Cohort Study of the Risk 
Factors for Myopia (SCORM) among 674 children of age 7-10, Brennan et al. (2020) noted that 
although annual and subsequent annual progression were strongly correlated (1 D increase = 
0.35 D increase respectively), annual progression alone was a poor model for predicting long-
term myopia development. The authors concluded that practitioners must additionally consider 
past progression rates, if known, as well as the age of onset (especially early onset considered 
to be younger than age 12) and parental history, before commencing a myopia control 
treatment. Bullimore & Richdale (2020) added that multiple criteria for progression, investigated 
by standardised measurement methods, must be applied towards obtaining accurate myopia 
rate predictions.  
The present feasibility to predict true individual myopia progression rates is low (Hernandez et 
al., 2018). Thus, there is strong interest in non-invasive, predictive prevention and treatment 
strategies, particularly targeting at-risk potential high myopes, which will further equip 
policymakers, parents, and eye care professionals in successfully managing myopia. The scope 
corresponds to the proposed Package of Eye Care Interventions (PECI) and Integrated People-
Centred Eye Care (IPCEC) approaches, outlined in the latest World Health Organization report 
on vision (WHO, 2019), which should be considered by all involved in eye care. This is thought 
to be the first review of its kind on myopia predictive technology. 
1.2.8.1 Axial Length & Refractive Error 
Gordon & Donzis (1985) noted that AL and corneal diameter changes were the most significant 
factors in the first two years of life that determined human refractive development during 
childhood. Axial length measurement is long recommended as the gold standard in monitoring 
pediatric myopia progression (Meng et al., 2011), where ocular disease risk increases with each 
millimeter of elongation (Haarman et al., 2020), high myopia (≥6.00 D) has been linked with 
excessive AL (≥26 mm) (Tideman et al., 2016), and the associated higher risk of visual 
impairment evidenced by some of the latest randomised myopia control clinical trials 
(Chamberlain et al., 2019; Walline et al., 2020). However, the International Myopia Institute (IMI) 
has suggested the use of both AL and refractive error to predict myopia onset, due to their 
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variable correlation, particularly in early childhood, as well as the lack of global standardised AL 
criteria for individual patients (Gifford et al., 2019; Wolffsohn et al., 2019).  
A recent meta-analysis also highlighted significant ethnical differences in AL, where Asian 
children had 40% greater length than their Caucasian counterparts (Brennan et al., 2018) for the 
same refractive error. Brennan et al. (2020a) have additionally suggested the use of the 
Cumulative Absolute Reduction in Axial Elongation (CARE) factor for assessing myopia control 
efficacy, stating a maximum CARE of 0.44 mm (~1 D) over a period of 2-3 years for currently 
available treatments, as illustrated by Table 1.6. This is especially relevant, as Bullimore & 
Brennan (2019) previously analysed the data of 21,000 patients across five population-based 
studies, showing that a 1 D myopia increase and 0.44 mm reduction in axial length 
corresponded to a 67% increase and 40% decrease in myopic maculopathy, respectively. 
Further clinical research is needed to validate whether AL, refractive error, or their combination 
is the most reliable predictor for individual myopia progression rates within all population 
cohorts. 
 
Study Treatment CARE 
(mm) 
Study design details 
Time 
(y) 




et al. (2017) 
OK 0.44 6+ Opt N  14, 16  
Hiraoka et al. (2012) OK 0.42 5 Opt N  22, 21  
Leung & Brown (1999) Specs 0.41 1.5 US N  14, 32  
Chua et al. (2006) Atr 1.0% 0.40 2 US Y  166,190  
Zhu et al. (2014) OK 0.36 2 Opt N  65, 63  
Chen et al. (2013) OK 0.33 2 Opt N  35, 23  
Charm & Cho (2013) OK 0.32 2 Opt Y  12, 16  
Walline et al. (2009) OK 0.32 2 US N  28, 28  
Lam et al. (2019) Specs 0.31 2 Opt Y  79, 81  
Chamberlain et al. 
(2019) 
SMCLs 0.28 3 Opt Y  48, 51  
Cho et al. (2005) OK 0.28 2 US N  35, 35  
Cheng et al. (2014) Specs 0.28 3 US Y  46, 50  
Cho et al. (2012) OK 0.27 2 Opt Y  37, 41  
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Table 1.6  A summary of reported CARE for different myopia control strategies, across the 
literature, as adapted and recreated from Brennan et al. (2020a), where 
abbreviations are as follows: Devices (Opt – optical interferometric biometry; US - 
ultrasound); Rand. (whether the study was randomised); N = (T, C) indicating the 
sample size in treated and control groups.     
 
  
1.2.8.2 Models of Growth  
Research efforts have validated longitudinal population- and age- specific growth percentile 
charts referencing the visual development (refractive error and ocular biometry) of children and 
adolescents using large epidemiological cohorts, in order to estimate abnormally distributed 
clinical myopia relative to normative data. Early (Jones et al., 2005) and later (Rozema et al., 
2019) studies have also shown that myopia onset occurs at around a similar AL between future 
myopes and children who remained emmetropic, where boys and future myopes had a greater 
axial elongation rate than girls and persistent emmetropes, respectively. The study by Jones et 
al. (2005) tested 247 Californian myopic children of age 6-14 between 1989-2001 and produced 
differing myopic and persistent emmetropic growth curves for corneal power, axial length, as 
well as anterior and vitreous chamber depth. Furthermore, Rozema et al. (2019) added from 
their longitudinal SCORM data that future myopes had higher lenticular power loss than 
persistent emmetropes, before myopia onset. The Collaborative Longitudinal Evaluation of 
Ethnicity and Refractive Error (CLEERE) Study, which tested 1854 nonmyopic children, 
highlighted the relatively low sensitivity and specificity of first grade refractive error and the 
number of myopic parents alone for predicting myopia onset between grades two and eight, 
being 62.5% and 81.9%, respectively (Jones-Jordan et al., 2010). These results suggested that 
a multitude of myopia predictors must be combined to produce models with greater accuracy. 
Zadnik et al. (2015) also used CLEERE data, based on 4512 nonmyopic children from grades 
one to eight of diverse ethnicities between 1989 and 2010. The authors investigated 13 possible 
risk factors for their predictive ability of myopia onset and stated spherical equivalent refractive 
error as the best factor for estimation, particularly six years old children of <0.75 D. Zhang et al. 
(2011) validated a three-year predictive myopia model from two different population cohorts 
(236 and 1979 Chinese children from mixed urban-rural Xiamen and Singapore, respectively) by 
using measures of visual acuity, refractive error, biometry, height, and weight. The authors 
reported similar sensitivity and specificity to Jones-Jordan et al. (2010), but additionally 
mentioned that children of the Singaporean cohort had more myopia, longer mean axial length, 
and were taller and heavier.  
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Chen et al. (2016) compared the Guangzhou Refractive Error Study in Children (RESC) cross-
section data of 4218 children aged 5-15 and the Guangzhou Twin Eye Study (GTES) 
longitudinal data between 2006-2012 of 354 children, in order to validate reference centile 
refraction curves for predicting the high myopia onset and scaled severity that may be 
representative of the South Chinese school-aged urban population. The authors noted the 
efficacy of this age-specific tool and particularly the lower percentiles, where the 5th centile was 
the best overall diagnostic test (92.9% sensitivity; 97.9% specificity; 65% positive predictive 
value). Other studies have focused on AL growth. Tideman et al. (2018) provided normative eye 
growth values for myopia prevention and control, representative of European children; the study 
sample of 12,386, combined the AL and corneal curvature data from the Dutch Generation R 
and Rotterdam Study III (RS-III), and British Avon Longitudinal Study of Parents and Children 
(ALSPAC) studies, but was limited to only Dutch refractive error data. The authors reported AL 
growth predicted future myopia at a 50% rate. Diez et al. (2019) produced similar AL percentile 
growth curves from 12,554 Chinese children aged 6-15 and offered a comparison. The Chinese 
and European populations had similar percentiles for AL at age 6, but Chinese children showed 
higher percentile AL values at the ages of 9 and 15, and females always exhibited lower ALs 
than their male counterparts. More recently, Jagadeesh et al. (2020) analyzed the myopia-
associated structural changes from multiple optic disc and retinal features (ODRFs) on 2851 
Chinese children aged 6-9. The authors suggested such data may additionally be used in 
predicting myopia incidence and AL progression, having planned for an upcoming validation 
study of this model. 
 
1.2.8.3 Machine Learning & Artificial Intelligence  
Prognostic algorithms based on large-scale EMRs, or big data, and integration with cloud 
technology remain an untapped, but potentially may be the ultimate future clinical tool in 
medicine. As Obermeyer & Emanuel (2016) reported, the ability of such methods to compile 
seemingly infinite, complex volumes of clinical parameters and predictors is still based on 
correlation principles, which are prone to overestimate biased real-world data and still cannot 
provide knowledge of causation. The current research is promising, but independent clinical 
validation databases from unique population and time clusters are limited. Lin et al. (2018) 
combined the refraction data of Chinese school-aged children from EMRs spanning eight 
independent centres and two longitudinal population-based cohorts (>half a million ophthalmic 
records between 2005-2015), in order to validate a predictive random forest (RF) algorithm for 
high myopia in adulthood. By using the age of examination, spherical equivalent, and annual 
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progression rate predictors, the authors concluded that their model was clinically accurate in 
predicting high myopia over 10 years, which may be used as a targeted myopia progression 
monitoring and control intervention tool representative of Chinese school-aged populations. A 
more recent study by Yang et al. (2020) for instance, applied a Gradient Boosting Regression 
Tree (GBRT) machine learning method based on correlation analysis and found their predictive 
Support Vector Machine (SVM) model to be accurate. Other works have analysed 
Electrooculogram (EOG) data by various data mining techniques (Logistic Regression [LR]; 
Naive Bayes [NB]; RF; REP Tree [RT]) to categorise individual ametropia (Kaya et al., 2018), 
whilst Multiple Kernel Learning (MKL) frameworks have been utilised to predict ocular pathology 
(Xu et al., 2018). Thus, validated prospective models originating from the analysis and synthesis 
of longitudinal myopia progression datasets may hold the most promise towards solving the 
global myopia prediction problem.   
 
1.2.8.4 App & Device Tools  
Additional methods of predicting and tracking myopia progression exist. The Myopia Calculator 
by the BHVI combines patient history (age, ethnicity, refractive error) with the available 
evidence-based myopia control strategies to estimate an individual’s future myopia outlook 
using average data. The calculator is based on BHVI statistical datasets and the meta-analysis 
by Donovan et al. (2012) of myopia progression rates among urban Asian and European 
children corrected with single-vision spectacles from 20 studies, all spanning 1-3 years. Its 
effectiveness has been compared to the Northern Ireland Childhood Errors of Refraction 
(NICER) longitudinal data, where McCullough et al. (2016) evaluated the six-year refractive 
error change in UK Caucasian children and adolescents (aged 6-19) relative to an Australian 
cohort of European Caucasian children, as well as retrospective UK data of 50 years. Overall, 
the literature suggests accuracy of the BHVI calculator to improve with age (>12) and higher 
baseline refractive error, whereas myopia progression rates are prone to overestimation in 
younger Caucasian children; for instance, the BHVI Myopia Calculator overestimated myopia 
progression for groups aged 9-10 and 12-13 by 1 D and 0.75 D, respectively, than the NICER 
model. The Myappia Calculator, created by Thomas Aller in 2016, is another digital tool utilising 
peer-reviewed growth curves from large population cohorts, but also states it incorporates other 
myopia risk factors into its progression estimates aimed for a range of 10 years. The EndMyopia 
Calculator is one other, but different calculator, which has inputs for a patient’s current spherical 
prescription (D) and blur-distance or edge of blur (cm), in order to provide a true myopia value 
(D) result, according to the developers. This tool could eventually be used as an alternative 
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customisable monitoring option for parents and their children next to other recent smartphone 
application technologies, such as Plano of the Singapore National Eye Centre by Mo Dirani in 
2017, which tracks a child’s digital device habits and behaviour. The smartphone/smartwatch 
wearable FitSight tracker evaluating time spent outdoors patterns and associated levels of light 
illumination follows the same concept (Verkicharla et al., 2017). Although more validation is 
necessary, these options together could aid global myopia screening efforts by adding more 
longitudinal databases and consequentially enhance the ability to predict myopia.  
The combined advancement of the mentioned science and technology in this review has also 
allowed for the development of specialty instrumentation tailored to assessing and predicting 
myopia. These include the very new Myopia Master (2019) from OCULUS and MYAH (2020) by 
Topcon. OCULUS stated that the Myopia Master is the first device to apply the licensed 
predictive refractive error algorithms by the BHVI, alongside a documenting software for 
myopia-specific risk factors (ethnicity, number of nearsighted parents, time spent with outdoor 
and near-vision tasks) and measurement parameters (refraction, AL, keratometry); in order to 
compare an individual patient’s values to a large built-in age-related normative database, 
providing growth curves for refraction and AL. According to Topcon, MYAH assesses corneal 
topography coupled with aberration summary and support for specialty myopia contact lens 
fitting, dynamic pupillometry, AL by optical low coherence interferometry, myopia progression 
relative to treatment efficacy and provided initial baseline, as well as comprehensive dry eye 
analysis. Since these instruments are brand new, no peer-reviewed validation yet exists.   
 
1.2.8.5 Summary  
The predicting and tracking of myopia are multifactorial. Research involving large datasets of 
bespoke associated risk factors for individual patients across unique ethnic regions is still 
necessary to explain discrepancies in progression rates of similar cohorts. Moreover, these 
datasets must be perpetually updated to precisely reflect global epidemiological shifts. Axial 
length changes alone are insufficient to predict future myopia and should be considered 
alongside the other optical, structural, genetic, and environmental patterns discussed, in order 
to create true comparative emmetropic and myopic growth models. This may lead to greater 
specificity for predicting and tracking clinical myopia, as well as the efficacy of any 
correspondingly applied control treatments. Although various developments in these 
assessments exist, further validation is required to expand success outside of averaging the 
highly myopic and at-risk children. 
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Chapter 2 Global trends in myopia management attitudes and strategies in clinical    
practice – 2019 update  
2.1 Introduction 
Due to the uncontrolled global myopia growth, perpetual improvement in the evidence-based 
understanding of its vision risks and associated management remains essential. Holden et al. 
(2016) projected myopia to affect half of the world’s inhabitants by 2050 and its propensity to 
become the leading cause for irreversible blindness. Deeming it a public health concern 
worldwide, The International Myopia Institute (IMI) released white papers (available online: 
https://www.myopiainstitute.org/imi-white-papers.html) compounding the latest and complete 
knowledge surrounding myopia across seven expert committees, including: Myopia Control 
Reports Overview and Introduction (Wolffsohn et al., 2019); Defining and Classifying Myopia 
(Flitcroft et al., 2019); Experimental Models of Emmetropization and Myopia (Troilo et al., 2019); 
Myopia Genetics (Tedja et al., 2019); Interventions for Myopia Onset and Progression (Wildsoet 
et al., 2019); Clinical Myopia Control Trials and Instrumentation (Wolffsohn et al., 2019); 
Industry Guidelines and Ethical Considerations for Myopia Control (Jones et al., 2019); Clinical 
Myopia Management Guidelines (Gifford et al., 2019). This is a major milestone among many, 
as the field has always continued to expand and develop: the biennial International Myopia 
Conference, since 1964; the National Committee on Myopia, since 1990s; joint global myopia 
scientific meeting by the World Health Organization and the Brien Holden Vision Institute 
(2015); FDA interdisciplinary public workshop on myopia clinical trial design (2016).  
               
During the past two decades, research in the field of myopia has extrapolated, but global 
agreement of an optimum and standardized treatment guidance is still limited. Similarly, 
reported practitioner perception in the literature is scarce. A survey by Jung et al. (2011) noted 
that most Korean ophthalmologists preferred to prescribe full cycloplegic spectacle refraction for 
childhood myopia control, followed by orthokeratology and spectacle undercorrection, whilst 
atropine was mostly considered ineffective. An international perspective (Zloto et al., 2018), but 
also solely focused on the prescribing trends of pediatric ophthalmologists, reported: 57% of the 
total 940 respondents routinely engaged in myopia control, but a lack of consensus remained on 
when to initiate treatment; the main precursor for treatment was myopia progression of ≥ 1 
D/year; 70% prescribed eye drops of which atropine 0.01% accounted for 63.4%; 86% 
recommended increased time spent outdoors, whilst 60.2% and 63.9% advised less screen 
viewing and smartphone use respectively. From the survey conducted in 2015, Wolffsohn et al. 
(2016) reported that despite the high concern and activity over myopia progression and control 
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respectively, most eye care practitioners worldwide prescribed single vision spectacles and 
contact lenses. This paper provides an update of these attitudes and trends toward myopia 
management strategies in clinical practice four years later. 
 
2.2 Method 
A self-administrated, internet-based cross-sectional survey in Chinese, English, French, 
German, Italian, Portuguese, Russian and Spanish was distributed using software 
SurveyMonkey (Palo Alto, California, USA) through various professional bodies across the 
world to reach eye care professionals (optometrists, dispensing opticians, ophthalmologists and 
others) globally. The survey matched the 2015 version (Wolffsohn et al., 2016) comprising of 
nine questions relating to the self-reported clinical management behaviours of practitioners for 
progressive myopia and practitioner’s current opinions on myopia related clinical care including: 
• level of concern about the increasing frequency of paediatric myopia in their clinical practice 
(rated as ‘Not at all,’ to ‘extremely,’ on a 10 point scale) 
• perceived effectiveness, defined as the expected level of reduction in childhood myopia 
progression of a range of myopia control options (rated as a percentage from 0 to 100%) 
• how active they would consider their clinical practice in the area of myopia control (rated as 
‘Not at all,’ to ‘fully,’ on a 10 point scale) 
• frequency of prescribing different myopia correction options for progressive / young myopes 
during a typical month  
• minimum age a patient would need to be for them to consider myopia refractive correction 
options (assuming average handling skills and child/parent motivation) 
• minimum amount of myopia that would need to be present to consider myopia refractive 
correction options (specified in half dioptre steps) 
• minimum level of myopia progression that would prompt a practitioner to specifically adopt a 
myopia control approach (specified in quarter dioptre steps) 
• frequency of adopting single vision under-correction as a strategy to slow myopia 
progression (reported as ‘no,’ ‘sometimes,’ or ‘always’)? 
• if they had only ever fitted single vision spectacles/contact lenses for myopic patients, what 
had prevented them (multiple options could be selected) from prescribing alternative 
refractive correction methods; options consisted of: 
o They don’t believe that these are any more effective 
o The outcome is not predictable 
o Safety concerns 
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o Cost to the patient makes them uneconomical 
o Additional chair time required 
o Inadequate information / knowledge 
o Benefit / risk ratio 
o Other 
 
There was an option to add further comments to each of the questions and the topic as a whole. 
Voluntary participation in the survey, following an explanation of the research, was anonymous, 
however, respondents were asked to provide basic demographic information about themselves 
(highest qualification, years of being qualified and everyday working environment). The data 
was collected between October 2018 and April 2019. 
 
Statistical Analysis 
Statistical analysis was conducted with SPSS (v21 IBM, New York, USA). Only complete 
surveys were analysed. Median, mean and standard deviations were calculated for each 
question response, with the results grouped by continent (Asia, Australasia, Europe, North 
America and South America) and countries within a continent where response rate allowed (n ≥ 
30), with Kruskal-Wallis tests applied to determine statistical difference (taken as p < 0.05) 




The total number of 1,336 complete survey responses were received, with the distribution by 
continent being: Africa 13 (not included in further analysis), Asia 202, Australasia 79; Europe 
717; Middle East 5 (not included in further analysis), North America 147; and South America 
173. Country specific responses could be extracted from: 
• Europe: Germany (n=68), Italy (n = 102), Netherlands (n = 40) Portugal (n = 76), Russia 
(n=78), Spain (n = 173) and UK/EIRE (n = 78) 
• Asia: China (n = 37), Hong Kong (n = 59) and India (n = 30) 
• North America; Canada (n = 47) and USA (n = 90) 
Of the study participants, 72.5% (n=968) were optometrists, 19.6% (n = 262) were 
ophthalmologists, 6.7% (n = 90) were contact lens opticians and 1.2% (n = 16) were other types 
of eye care specialists. The principal working environment for 90.7% was in clinical practice (n = 
1,212), 5.1% worked in academia (n = 68), 2.1% worked within industry (n = 29) and 2.1% (n = 
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29) worked in other environments. However, all study participants were registered eye care 
practitioners. The median number of years qualified was the 11-20 category, with a normal 
distribution.   
 
Self-reported concern about the increasing frequency of paediatric myopia (Figure 2.1) 
Practitioners’ concern about the increasing frequency of paediatric myopia in their practices was 
highest (9.0 ± 1.6; p < 0.001) in Asia and lowest (7.6 ± 2.2; p < 0.001) in Australasia among the 
surveyed continents, with similar levels across Europe (8.0 ± 2.2; p < 0.001), North (7.9 ± 2.1; p 
< 0.001) and South America (8.5 ± 2.2; p < 0.001). In Asia, Chinese practitioners were more 
concerned (9.5 ± 1.2; p < 0.001) than those in Hong Kong (8.7 ± 1.4; p < 0.001) or India (8.9 ± 
1.3; p < 0.001). In Europe, practitioners from Russia (8.7 ± 1.9; p < 0.001), Portugal (8.7 ± 2.0; p 
< 0.001) and Spain (8.5 ± 1.9; p < 0.001) were most concerned, followed by Italy (7.8 ± 2.2; p < 
0.001) and the UK/EIRE (7.5 ± 2.5; p < 0.001), with lowest concern in the Netherlands (7.1 ± 
2.3; p < 0.001) and Germany (6.4 ± 2.3; p < 0.001). In North America, practitioners from the 
USA (8.1 ± 2.0; p < 0.001) were more concerned than their Canadian (7.5 ± 2.2; p < 0.001) 
neighbours. 
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Continental Location























Figure 2.1: Level of practitioner concern (rated from 0-10) regarding the perceived increasing 
frequency of paediatric myopia in their practice for practitioners located in 
different continents. N=1,336. Box = 1 SD, line = median and whiskers 95% 
confidence interval. 
 
Perceived effectiveness of myopia control options (Table 2.1) 
Overall, orthokeratology was perceived by practitioners to be the most effective method of 
myopia control, followed by pharmaceutical approaches and approved myopia control soft 
contact lenses. The least effective perceived methods were single vision distance under-
correction and single vision spectacles, as well as single vision soft contact lenses and 
refractive surgery options. These findings were largely consistent across all continents with 
some variations: practitioners from South America held the lowest relative consideration 
regarding the most effective perceived methods, whilst practitioners from Asia, Europe, and 
South America held the highest relative consideration for the least effective perceived methods 
(p < 0.001). Moreover, the single vision spectacles modality was considered the 7th least 
effective out of the 12 survey choices in South America (p < 0.001). Practitioners from Asia 
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considered bifocals and progressive addition (PALs) lenses to be relatively more effective for 
reducing childhood myopia progression compared with practitioners from all other continents (p 
< 0.001). Practitioners from Australasia and North America perceived single vision distance 
under-correction, single vision spectacles, rigid gas permeable (RGP) and single vision soft 
contact lenses, refractive surgery, and increased time outdoors as less effective than 
practitioners from other continents (p < 0.001).  
 
Within Asia, Chinese practitioners generally held the highest relative consideration for most 
myopia control options, whereas practitioners from Hong Kong held the least overall perceived 
effectiveness for most myopia control options (p < 0.001). Similar effectiveness among 
practitioners from China, Hong Kong, and India was perceived for multifocal and approved 
myopia control soft contact lenses, as well as orthokeratology and pharmaceutical modalities (p 
< 0.001). Within Europe, the Netherlands generally held the lowest relative consideration for 
most myopia control options, whereas practitioners from Portugal, Russia, and Spain held the 
highest overall perceived effectiveness for most myopia control options (p < 0.001). Spanish 
practitioners perceived approved myopia control soft contact lenses and orthokeratology as 
more effective than their European colleagues, while Portuguese practitioners did so regarding 
refractive surgery (p < 0.001). Russian practitioners perceived pharmaceutical methods as less 
effective than other European practitioners, while Italian practitioners and those from the 
UK/EIRE did so regarding increased time spent outdoors (p < 0.001).  Within North America, 
practitioners from the USA perceived rigid gas permeable (RGP) and multifocal soft contact 
lenses, as well as orthokeratology and pharmaceutical options as more effective than their 





























Under-correction 11.6 ± 21.6 -0.2 ± 6.6 6.9 ± 17.6 1.4 ± 4.6 14.9 ± 21.9 
Single Vision   17.6 ± 24.9 1.2 ± 3.8 13.4 ± 24.7 1.2 ± 3.7 21.3 ± 32.9 
Bifocals 33.0 ± 22.7 25.4 ± 17.4 19.4 ± 20.5 16.7 ± 15.1 16.0 ± 22.2 
Progressive 
Addition (PALs) 
















25.0 ± 27.8 8.4 ± 16.3 16.8 ± 24.1 6.8 ± 12.7 15.0 ± 25.1 
Single Vision Soft 18.1 ± 24.6 3.1 ± 10.3 13.1 ± 21.9 1.7 ± 4.5 16.3 ± 27.1 
Multifocal Soft 31.9 ± 23.6 35.7 ± 18.0 26.6 ± 22.5 31.4 ± 19.0 21.9 ± 26.6 
Approved Myopia 
Control Soft 
45.4 ± 24.0 45.6 ± 18.2 44.1 ± 24.4 42.9 ± 20.0 29.0 ± 29.4 
Orthokeratology 60.7 ± 21.9 52.5 ± 21.2 52.1 ± 24.7 48.3 ± 22.0 34.8 ± 31.1 
  Pharmaceutical 54.5 ± 23.6 52.1 ± 20.9 43.1 ± 26.9 45.6 ± 21.3 43.0 ± 29.8 
  Refractive Surgery 20.6 ± 33.0 7.7 ± 21.3 13.9 ± 25.6 8.1 ± 22.2 13.9 ± 24.8 
  Increased Time 
Outdoors  
43.6 ± 27.8 20.4 ± 20.5 37.1 ± 27.7 22.4 ± 20.1 40.2 ± 31.8 
Table 2.1: Perceived effectiveness (defined as the expected level of reduction in childhood 
myopia progression in percent) of myopia control options by practitioners in 
different continents. Data are expressed as mean ± S.D. 
 
Perceived level of clinical activity in the area of myopia control (Figure 2.2) 
Practitioners from Asia considered their clinical practice of myopia control to be the most active 
(7.7 ± 2.3; p < 0.001) among the surveyed continents, with similar levels for Australasia (7.3 ± 
2.5; p < 0.001) and Europe (7.0 ± 4.2; p < 0.001), and least by practitioners from North America 
(6.3 ± 2.9; p < 0.001) and South America (6.4 ± 3.2; p < 0.001). North American practitioners 
perceived themselves to be the least active in this area of practice (p < 0.001). Within Europe, 
practitioners from Russia (8.5 ± 9.8; p < 0.001) reported the highest perceived level of clinical 
activity in myopia control and the lowest was reported by those from the UK/EIRE (6.1 ± 3.5; p < 
0.001), with similar responses by Spain (7.0 ± 2.6; p < 0.001), Italy (7.0 ± 2.3; p < 0.001), 
Portugal (6.6 ± 2.5; p < 0.001), the Netherlands (6.6 ± 2.6; p < 0.001), and Germany (6.6 ± 3.0; 
p < 0.001). Within Asia, Indian practitioners (6.3 ± 2.6; p < 0.001) considered themselves 
relatively less active than their counterparts in China (8.4 ± 2.2; p < 0.001) or Hong Kong (8.1 ± 
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2.0; p < 0.001). Within North America, Canadian practitioners (5.7 ± 3.0; p < 0.001) considered 
themselves less active than those from the USA (6.6 ± 2.8; p < 0.001). 
Continental Location

































Figure 2.2: Perceived level of clinical activity in the area of myopia control for practitioners 
located in different continents. N=1,336. Box = 1 SD, line = median and whiskers 
95% confidence interval. 
 
Frequency of prescribing different myopia correction options for progressing / young myopes 
(Table 2.2) 
The majority of progressing / young myopes were being prescribed single vision (full correction) 
spectacles (39.3 ± 30.0%), followed by single vision soft contact lenses (12.3 ± 15.5%) and 
orthokeratology (12.0 ± 20.0%). The least frequently prescribed myopia correction option was 
refractive surgery (0.8 ± 4.1%), followed by rigid gas permeable (RGP) contact lenses (2.1 ± 
6.6%) and bifocal spectacles (2.4 ± 6.2%). Progressive addition (PALs) spectacles (8.8 ± 
14.5%), multifocal soft contact lenses (6.8 ± 13.9%), approved myopia control soft contact 
lenses (7.3 ± 13.0%), and pharmaceutical (8.2 ± 16.3%) options were prescribed at a similar 
frequency. These findings were largely consistent across all continents with some variations. 
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Practitioners from Asia indicated prescribing single vision (full correction) spectacles most 
frequently, whereas those from Australasia prescribed them least often (p < 0.001). Also, 
practitioners from Asia indicated prescribing bifocal spectacles most frequently for progressing / 
young myopes, whereas those from South America prescribed them least often (p < 0.001). 
Practitioners from Australasia, and to a lesser degree, practitioners from Asia, prescribed 
progressive addition (PALs) spectacles more frequently than those from other continents, while 
the option was prescribed least often by South America (p < 0.001). South American 
practitioners prescribed rigid gas permeable (RGP) contact lenses most frequently to these 
patients, while was done least often by their counterparts in Australasia (p < 0.001). 
Practitioners from North America and Australasia prescribed more single vision and multifocal 
soft contact lenses respectively, while Asian practitioners prescribed these options less often 
than other regions (p < 0.001). Approved myopia control soft contact lenses are being 
prescribed most in Australasia, Europe, and North America, while notably less in Asia and 
South America (p < 0.001). Practitioners from Australasia, and to a lesser degree, practitioners 
from Europe, prescribed orthokeratology more frequently than their counterparts, while the 
option was prescribed least frequently by South American practitioners (p < 0.001). South 
American practitioners indicated utilising pharmaceutical options notably most frequently for 
progressing / young myopes, while those from Asia and Europe did so the least (p < 0.001). 
South American practitioners also recommended refractive surgery more than other continents 
for these patients, but the prescribing frequency was still low (p < 0.001).  
 
Within Asia, practitioners from India prescribed single vision spectacles, rigid gas permeable 
(RGP), single vision, multifocal, and approved myopia control soft contact lenses, as well as 
pharmaceutical myopia correction options most frequently (p < 0.001). Chinese practitioners 
prescribed progressive addition (PALs) spectacles the most frequently and orthokeratology the 
least in comparison to Hong Kong and India (p < 0.001). Within Europe, practitioners from 
Russia and Spain prescribed single vision spectacles and soft contact lenses most frequently, 
whereas practitioners from the Netherlands prescribed these options the least (p < 0.001). 
Russian practitioners also prescribed bifocal and progressive addition (PALs) spectacles the 
most, whereas their colleagues from the Netherlands and Portugal did so the least (p < 0.001). 
German practitioners prescribed rigid gas permeable (RGP) and multifocal soft contact lenses 
most frequently, whereas those from the UK/EIRE and Portugal prescribed these options the 
least respectively (p < 0.001). Spanish practitioners demonstrated the highest frequency of 
prescribing approved myopia control soft contact lenses (p < 0.001). Orthokeratology was 
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prescribed the most in Italy and the Netherlands, and the least by Portuguese practitioners (p < 
0.001). Russian practitioners had the highest frequency of prescribing pharmaceutical and 
refractive surgery options (p < 0.001). Within North America, practitioners from the USA 
prescribed single vision spectacles and soft contact lenses more frequently than their Canadian 

















 Single Vision   
54.7 ± 31.9 18.8 ± 22.3 37.3 ± 29.3 36.5 ± 30.5 49.3 ± 35.8 
Bifocals 3.4 ± 7.7 2.8 ± 6.2 2.0 ± 7.5 2.6 ± 5.7 1.1 ± 4.0 
Progressive 
Addition (PALs) 
















1.8 ± 4.7 0.3 ± 1.1 2.9 ± 9.6 1.1 ± 9.1 4.5 ± 8.4 
Single Vision Soft 7.2 ± 13.0 9.6 ± 13.3 15.6 ± 17.3 16.6 ± 19.0 12.4 ± 14.8 
Multifocal Soft 1.7 ± 5.1 13.0 ± 18.5 5.5 ± 13.7 8.2 ± 15.5 5.6 ± 16.7 
Approved Myopia 
Control Soft 
3.6 ± 8.7 10.5 ± 14.9 10.5 ± 16.9 9.6 ± 16.4 2.2 ± 8.3 
Orthokeratology 11.5 ± 20.4 16.8 ± 22.0 15.9 ± 24.4 12.3 ± 19.4 3.3 ± 11.8 
  Pharmaceutical 4.1 ± 11.9 8.7 ± 11.7 4.7 ± 15.0 7.2 ± 12.1 16.3 ± 30.7 
  Refractive Surgery 0.9 ± 4.1 0.1 ± 0.6 1.0 ± 6.7 0.4 ± 2.9 1.7 ± 6.3 
Table 2.2: Frequency of prescribing myopia correction options for progressing / young 
myopes by practitioners in different continents for progressing / young myopes. 
Data are expressed as mean ± S.D. 
 
 
Minimum patient age that practitioners consider myopia correction options (Table 2.3) 
Overall, single vision spectacles were prescribed from the youngest age (6.8 ± 4.2 years), 
whereas rigid gas permeable (RGP) contact lenses were reserved for older children (13.3 ± 
5.3). Bifocal spectacles (8.9 ± 5.7), progressive addition (PALs) spectacles (8.9 ± 6.0), single 
vision soft contact lenses (9.0 ± 4.8), multifocal soft contact lenses (10.2 ± 4.9), specific myopia 
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control soft contact lenses (8.9 ± 4.0), orthokeratology (9.7 ± 4.8), and pharmaceutical (9.6 ± 
6.0) options were all prescribed for a similar minimum patient age range. Practitioners from all 
regions did not recommend refractive surgery to patients under 18 years of age (19.6 ± 1.6). 
Practitioners from Asia, Australasia, and North America were more conservative in their 
minimum fitting age of rigid gas permeable (RGP) contact lenses than European and South 
American practitioners (p < 0.001). Practitioners from Asia were most conservative in their 
minimum patient age for prescribing single vision, multifocal, and specific myopia control soft 
contact lenses (p < 0.001). South American practitioners tended to be least conservative 
towards most myopia correction options relative to their colleagues (p < 0.001).   
 
Within Asia, practitioners from Hong Kong were the most conservative in their minimum age for 
fitting rigid gas permeable (RGP), single vision and multifocal soft contact lenses, as well as 
pharmaceuticals (p < 0.001). Practitioners from India were the most conservative in fitting 
bifocal and progressive addition (PALs) spectacles, as well as orthokeratology (p < 0.001). 
Chinese practitioners were least conservative in prescribing bifocal spectacles, multifocal soft 
contact lenses, and pharmaceutical options (p < 0.001). Within Europe, practitioners from the 
Netherlands were the most conservative in their minimum age for fitting most of the myopia 
correction options, followed by the UK/EIRE, particularly for bifocal and progressive addition 
(PALs) spectacles, rigid gas permeable (RGP) contact lenses, as well as orthokeratology, 
pharmaceutical, and refractive surgery (p < 0.001). Within North America, Canadian 
practitioners were more conservative regarding bifocal spectacles and orthokeratology than 






























Single Vision   
7.0 ± 4.4 (1) 8.0 ± 6.0 6.0 ± 3.2 
(10) 
7.7 ± 5.9 5.5 ± 1.7 
(12) 
Bifocals 
10.4 ± 6.5 
(13) 
9.5 ± 6.9 9.0 ± 6.1 
(30) 




9.4 ± 4.9 (7) 7.6 ± 5.1 9.4 ± 5.7 
(27) 

















15.2 ± 5.6 
(8) 
15.4 ± 6.2 10.8 ± 4.8 
(28) 
14.2 ± 6.2 10.9 ± 3.9 
(45) 
Single Vision Soft 
13.2 ± 5.2 
(10) 
11.1 ± 5.8 9.0 ± 3.9 (9) 10.4 ± 5.3 10.2 ± 3.9 
(22) 
Multifocal Soft 
13.8 ± 5.9 
(16) 
9.9 ± 5.2 9.3 ± 4.5 
(26) 




10.8 ± 4.8 
(11) 
8.5 ± 3.9 7.8 ± 3.2 (4) 8.3 ± 3.9 9.2 ± 4.2 
(30) 
Orthokeratology 
9.8 ± 5.1 
(10) 
9.6 ± 5.0 9.3 ± 4.0 (8) 10.7 ± 6.1 9.1 ± 4.2 
(35) 
  Pharmaceutical 
13.0 ± 7.6 
(13) 
8.5 ± 5.8 10.6 ± 6.9 
(51) 
9.5 ± 6.5 6.5 ± 3.2 
(16) 
  Refractive Surgery 
19.9 ± 2.1 
(23) 
20.4 ± 1.2 19.3 ± 2.7 
(55) 
20.4 ± 1.2 18.2 ± 0.9 
(46) 
Table 2.3: Minimum patient age considered necessary by practitioners (from different 
continents who prescribed these options for different myopia correction options. 
Data are expressed as mean ± S.D years (% that would not prescribe this 
refractive modality). 
 
Minimum degree of myopia that needs to be present for practitioners to consider myopia control 
options (Table 2.4) 
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Overall, practitioners indicated that myopia would be corrected with single vision spectacles at 
the lowest degree of myopia (-0.82 ± 0.58 D), whereas it would be corrected with refractive 
surgery at the highest degree (-2.80 ± 1.72 D). All other myopia control options would be 
considered at approximately -1.50 D, except for rigid gas permeable (RGP) contact lenses that 
were considered at -2.50 D. Australasian and North American practitioners were willing to fit 
most modalities at a lower level of myopia than Asian, European or South American clinicians (p 
< 0.001). South American practitioners required a higher level of myopic refractive error before 
they would consider bifocal spectacles, multifocal soft contact lenses, and orthokeratology than 
all other regions (p < 0.001). Asian practitioners prescribed rigid gas permeable (RGP) and 
single vision soft contact lenses, as well as refractive surgery to children with higher degree of 
myopia than others (p < 0.001). However, North American practitioners considered rigid gas 
permeable (RGP) contact lenses at a lower level of myopia than in other continents (p < 0.001). 
Practitioners from Asia and South America recommended approved myopia control soft contact 
lenses and pharmaceutical options at higher levels of myopia (p < 0.001). 
 
Within Asia, Indian practitioners required a higher level of refractive error before they would 
consider bifocal and progressive addition (PALs) spectacles, as well as orthokeratology, 
pharmaceutical and refractive surgery options (p < 0.001) than practitioners from China or Hong 
Kong. Within Europe, Portuguese practitioners considered single vision, bifocal and progressive 
addition (PALs) spectacles, rigid gas permeable (RGP) and approved myopia control soft 
contact lenses, orthokeratology, pharmaceutical, and refractive surgery options for a higher 
myopia level than other countries in the continent (p < 0.001). Spanish practitioners also 
required a higher level of myopia for approved myopia control soft contact lenses and 
pharmaceuticals, as well as multifocal soft contact lenses (p < 0.001). Italian practitioners 
required high myopia levels when considering refractive surgery (p < 0.001). Practitioners from 
Russia required a higher level of myopia before utilising single vision soft contact lenses, but 
lower levels for pharmaceuticals relative to their European colleagues (p < 0.001). Practitioners 
from the UK/EIRE considered single vision, bifocal and progressive addition (PALs) spectacles, 
single vision, multifocal and approved myopia control soft contact lenses, and refractive surgery 
options for a lower myopia level than others in the continent (p < 0.001). German practitioners 
also required a lower level of myopia for single vision, bifocal and progressive addition (PALs) 
spectacles, as well as rigid gas permeable (RGP) and single vision soft contact lenses (p < 
0.001). The same was reported by practitioners from the Netherlands regarding single vision 
and bifocal spectacles, and rigid gas permeable (RGP) and single vision soft contact lenses (p < 
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0.001). The only difference across North America was that Canadian practitioners required a 
higher level of myopia before they would consider rigid gas permeable (RGP) contact lenses 

















 Single Vision   
-1.0 ± 0.9 -0.6 ± 0.2 -0.9 ± 0.7 -0.7 ± 0.4 -0.9 ± 0.7 
Bifocals -1.8 ± 1.4 -0.9 ± 0.4 -1.8 ± 1.3 -1.2 ± 1.0 -2.3 ± 1.7 
Progressive 
Addition (PALs) 
















-2.9 ± 2.0 -2.5 ± 2.1 -2.4 ± 2.0 -2.0 ± 1.6 -2.7 ± 2.1 
Single Vision Soft -1.8 ± 1.4 -1.0 ± 0.4 -1.3 ± 0.9 -1.0 ± 0.5 -1.5 ± 1.2 
Multifocal Soft -1.7 ± 1.2 -1.0 ± 0.4 -1.6 ± 1.3 -1.2 ± 0.7 -1.9 ± 1.6 
Approved Myopia 
Control Soft 
-1.8 ± 1.5 -1.0 ± 0.4 -1.5 ± 1.1 -1.2 ± 0.7 -1.9 ± 1.6 
Orthokeratology -1.7 ± 1.3 -1.3 ± 0.7 -1.6 ± 1.0 -1.3 ± 0.7 -2.1 ± 1.6 
  Pharmaceutical -1.9 ± 1.8 -1.2 ± 0.5 -1.5 ± 1.3 -1.3 ± 1.0 -1.9 ± 1.2 
  Refractive Surgery -3.8 ± 2.4 -2.2 ± 1.0 -3.3 ± 2.3 -2.0 ± 1.2 -2.7 ± 1.7 
Table 2.4: Minimum level of patient myopia (in dioptres) before myopia correction options 
would be considered by practitioners from different continents who prescribed 
these options. Data are expressed as mean ± S.D. 
 
Minimum annual amount of patient myopia progression that would prompt a practitioner to 
specifically adopted a myopia control approach (Figure 2.3) 
The minimum myopia progression rate that practitioners considered warranted a myopia control 
approach was 0.51 to 0.75 D/year for the majority of respondents (36.7%), with 82% indicating a 
level between 0.25 and 1.00 D/year. Practitioners from Australasia indicated they would adopt 
myopia control strategies for the lowest level of myopia progression, followed by Europe and 
North America (p < 0.001). Highest rates of progression were required in South America, 
followed by Asia (p < 0.001). Practitioners from Australasia, Europe, and North America 
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particularly indicated a range between 0.26 and 0.75 D/year of patient myopia progression that 
would prompt the adaptation of a myopia control approach. In comparison, the range increased 
to between 0.26 and 1.00 D/year for Asian practitioners and spread further between 0.26 and > 
1.00 D/year among South American practitioners (p < 0.001). Other factors influencing 
practitioners’ management decisions, as identified from the free text responses, included 
ethnicity (1 respondent), absolute degree of refractive error at the time (2 respondents), 
environmental factors/lifestyle (2 respondents), lighting exposure (2 respondents), parental 
decisions (2 respondents), ocular biometry (3 respondents), family history of myopia (6 
respondents), and age of myopia onset (10 respondents).  
Continent


























Figure 2.3: Minimum annual amount of patient myopia progression, in dioptres per year 
(D/year), that practitioners located in different continents considered to 
necessitate a myopia control approach. N=1,336  
 
Use of single-vision under-correction as a strategy to slow myopia progression (Figure 2.4) 
Overall, most practitioners did not consider single-vision distance under-correction to be an 
effective strategy for attenuating myopia progression (79.6%). South American practitioners 
used this strategy relatively more than all other regions (p < 0.001). Within Asia, Indian 
practitioners utilised under-correction more than those from China or Hong Kong (p < 0.001). 
Within Europe, practitioners from Portugal, Russia, and Spain indicated using under-correction 
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as a strategy to control myopia more than their counterparts (p < 0.001). Within North America, 
there was no difference in the use of under-correction between Canada and the USA (p < 
0.001).  
Continent























Figure 2.4: Use of single-vision distance under-correction as a strategy to slow myopia 
progression by practitioners located in different continents. N=1,336.  
 
Factors preventing the prescription of a myopia control approach (Figure 2.5) 
The most common reasons practitioners gave for not adopting myopia control strategies were: 
they were felt to be uneconomical (20.6%); they considered there to be inadequate information 
about the modalities (17.6%); they viewed the outcomes to be unpredictable (9.6%); concerns 
about safety (8.5%); they perceived them to be ineffective for reducing myopia progression 
(7.9%); the benefit to risk ratio was too low (7.0%); and additional chair time (3.1%). There was 
no significant difference in the distribution of these factors between or within continents (p > 
0.05). Free text comments identified other factors affecting the prescription of these strategies to 
relate to the relative availability of the myopia control treatments and the instrumentation 
necessary to prescribe them, and the need for consistent regulations and informational 
materials.  
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Benefit / risk ratio
 
Figure 2.5: Factors preventing practitioners located in different continents from prescribing a      
myopia control approach. N=1,336.  
 
2.4 Discussion 
This is the updated follow-up study to examine the self-reported attitudes and practices of eye 
care practitioners towards myopia control approaches across the globe. More than one 
thousand practitioners responded, principally spread over five continents. The exact response 
rate is not known, as maximum coverage was promoted by involving professional bodies whose 
members may not all be practicing eye care practitioners. However, it may be presumed that 
questionnaires are completed both by people cynical and enthusiastic to the issue being 
examined, balancing the average response. In addition, the recruitment approach across 
nations was the same, allowing cross-national comparisons. The majority of the respondents 
(92.1%) were again optometrists and ophthalmologists, reflecting those professions legally 
allowed to prescribe vision care correction and, in many regions, pharmaceuticals as well.  
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Once again, as one might expect from the high prevalence rates of myopia in Asia, Asian 
practitioners, especially those practicing in China, were more concerned about the increasing 
prevalence of paediatric myopia in their practices than clinicians in any of the other continents. 
A similar pattern existed in relation to how active they considered their clinical practice in the 
area of myopia control. Myopia prevalence is approximately 30% in 30-35 year olds in Spain 
(Montes-Mico et al., 2000) and may be increasing in Portugal (Jorge et al., 2007), but is as high 
as 58% in Italian university students, and as low as 23% in 12-13 year olds in the UK 
(McCullough et al., 2016) and 28% in Dutch school children (Hendricks et al., 2009); hence it is 
unclear why the former country’s practitioners are more concerned than the latter. The 
prevalence of myopia in the USA is around 42% in 12-54 year olds (Vitale et al., 2009). Despite 
their lower concern, the myopia occurrence is not documented in Canada; neither in Russia or 
Germany to warrant their higher and lower concern in Europe respectively. 
 
Overall, orthokeratology was again perceived by practitioners to be the most effective method of 
myopia control. However, in this survey update, eye care practitioners correctly perceived 
pharmaceutical approaches and approved myopia control soft contact lenses to be similarly 
effective, in accordance with the mentioned IMI white paper by Wildsoet et al. (2019). While 
single vision distance under-correction has been shown fairly conclusively to increase, rather 
than decrease, the rate of myopia progression in children (Chung et al., 2002; Adler et al., 
2006), there were still practitioners who consider the converse to be true; this was confirmed by 
a question later in the survey, with under-correction still practiced as a method of myopia control 
particularly by practitioners from South America, Portugal, Russia and Spain within Europe and 
India within Asia; however the reported use of undercorrection as a strategy for myopia control 
has decreased from the original survey (Wolffsohn et al., 2016). 
 
Despite the self-perceived activity of practitioners in the area of myopia control, still over half of 
progressing and/or young myopes were being prescribed single vision spectacles or contact 
lenses (52%), with continental and national differences in the adoption of refractive correction 
options known to reduce myopia progression. However, this is an improvement in comparison to 
the reported 68% from the original study four years ago (Wolffsohn et al., 2016). Approximately 
one third of practitioners not adopting myopia control approaches felt them to be uneconomical 
and/or that there was inadequate information about them; about another one third of 
respondents suggested that outcomes were unpredictable, the relative safety of these strategies 
was concerning, myopia control methods were ineffective and/or that the benefit to risk ratio 
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was too low; with some also mentioning the involved additional chair time. Further comments 
raised the issue of availability of some myopia control options, presumably of novel myopia 
control lenses, as current approaches are off-label, highlighting the need for regulatory oversight 
and guidance (Jones et al., 2019). Limited access to necessary instrumentation was also raised 
as a potential barrier, as more advanced contact lens fitting, such as orthokeratology, require 
the use of corneal topography (Gifford et al., 2019). Attempts to specifically manipulate 
peripheral retinal focus may also require instrumentation to rapidly and robustly assess 
peripheral retinal shape and/or refraction with myopia control ophthalmic medical devices 
(Wolffsohn et al., 2019). However, this strategy might not ‘translate’ well from animal studies to 
human trials (Mutti et al., 2011; Atchison et al., 2015). 
 
Spherical equivalent refractive error (measured under cycloplegia) is currently the single best 
predictive measure of juvenile myopia development, with children aged six years with less than 
+0.75D of hyperopia being at increased risk of developing myopia [108]. Most practitioners were 
again comfortable fitting single vision spectacles to myopic patients of this age, but in this 
update tended to wait until a child was older for single vision soft contact lenses and 
pharmaceuticals in addition to the more complex designs such as PALs, novel myopia control 
soft contact lenses and RGPs (including orthokeratology). Interestingly, one potential advantage 
of orthokeratology is that the parents or carer can manage lens application, removal and lens 
care, along with the lenses not having to leave the home, which can make this modality a 
popular option for parents or carers with younger myopic children. This is exemplified by Hong 
Kong, an early adopter of orthokeratology, where its use is considered at an earlier age than 
other countries in the region.  
 
Research suggests that lower levels of hypermetropia at a young age is a strong risk factor for 
myopia development, so it would seem that practitioners remain too conservative in waiting until 
mild-moderate levels of myopia (approximately -1.50 D for most interventions) are present 
before control approaches are considered (Mutti et al., 2011; Zadnik et al., 2015). However, this 
is an improvement in comparison to the reported -2.00 D minimum degree of myopia from the 
original study four years ago (Wolffsohn et al., 2016). Myopia progresses at much faster rates in 
children in comparison to teenagers, thus supporting the need for earlier intervention (Dong et 
al., 2013). There may be also a “window of opportunity” for myopia treatment according to the 
age of onset, rate of progression and myopia magnitude (Thorn et al., 2005). More research is 
needed on the relative benefits of myopia control strategies in adolescents and even young 
N.B.Boychev, PhD Thesis, Aston University 2021                                                                    67 
 
adults. Interestingly, Australasian and North American practitioners, but not those from Asia this 
time, considered most myopia control approaches at a lower level of myopia than other 
continents. This is evidence for the worldwide leap in success over recent years in the field, as 
demonstrated by the IMI and its white paper compendium (Wolffsohn et al., 2019). Chinese 
practitioners still considered prescribing pharmaceutical modalities at a younger age, and at a 
much lower level of myopia, compared with practitioners from other countries in the region. This 
may be due to different countries having different regulations and practitioners with different 
backgrounds (for example training, education and scope of practice), which can affect local 
practice, apart from the prevalence of myopia and need for correction or retardation. The rate of 
patient refractive progression that triggered practitioners to prescribe a myopia control approach 
generally mirrored the prevalence rate of myopia in each region; the higher the prevalence of 
myopia, usually the higher the level of myopia developed in individuals and the higher the risk of 
ocular pathology (Saw et al., 2005). Practitioners understandably also identified several other 
factors that, combined with the degree of myopic progression, influenced their decision to 
prescribe myopia control approaches; these included ethnicity, absolute degree of refractive 
error at the time, environmental factors/lifestyle, lighting exposure, parental decisions, ocular 
biometry, family history of myopia, and the age of myopia onset.  
 
2.5 Conclusion  
This updated global survey of current trends in eye care practitioner myopia management 
attitudes and strategies in clinical practice has identified that, despite growing evidence of the 
negative impact of even low levels of myopia on health economics, and moderate levels of 
practitioner concern and perceived activity (particularly where the prevalence of myopia is 
highest) uptake of appropriate techniques has improved, but remains generally poor. 
Furthermore, myopia control techniques are not being applied early enough in a child’s ocular 
development to elicit their optimum effect. Adequate education of practitioners is lacking, along 
with access to appropriately regulated myopia control ‘labelled’ products with efficacy and safety 
data. A guide, such as the IMI white papers, has been developed to inform practitioners of 
economically viable models of eye care, including the development of instrumentation to 
enhance management selection, which address the myopia epidemic to reduce the growing 
health burden.  
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Chapter 3 Clinical myopia-related near phoria magnitude and variability across the 
human lifespan among Canadians  
3.1 Introduction  
The recent review by Bullimore & Richdale (2020) suggested that the ability to decide when to 
implement myopia control treatment, but more importantly, to predict and prevent myopia 
progression cannot be based on a single factor; where, age, ethnicity, familial refractive history, 
as well as the measurement methods, separately influenced an individual patient’s 
management. The recent survey of paediatric ophthalmologists worldwide by Leshno et al. 
(2020) stated a progression rate of 1.10 D/year−1 in children, as the basis for treatment initiation. 
Notable publications pointed to baseline age as the primary criterion for myopia progression 
(Donovan et al., 2012) and axial elongation (Brennan et al., 2018), where ethnicity was a 
significant contributor, as both studies mentioned Asian children had 50% faster rates, 
respectively; specific axial elongation rates of 0.3 mm/year−1 (age 8) and 0.2 mm/year−1 (age 11) 
in White children, compared to 0.4 mm/year−1 (age 9) and 0.3 mm/year−1 (age 11) in Asian 
children were reported by Brennan et al. (2018). The effects of parental myopia history are 
scarcely documented and no recent literature exists: Saw et al. (2001) found rates of 
0.63 D/year−1 in children with myopic parents, compared to 0.42 D/year−1 in children without 
myopic parents, irrespective if one or both parents were myopic; whilst Kurtz et al. (2007) had 
rates of 0.78 D/year−1 and 0.55 D/year−1 among children with two myopic parents and with one 
or none, respectively. Despite these well-established mean rates, Hernandez et al. (2018) 
highlighted that past rates of averaged fast progression were able to aid in predicting future 
individual rates by only 2%. The effect of measurement methods on the clinical trial primary 
outcomes of refractive error and axial length must also be considered. Twelker & Mutti (2001) 
and Sankaridurg et al. (2017) reported that refractions without cycloplegia were more myopic in 
infants and children, respectively. Furthermore, studies have demonstrated that the cycloplegic 
drug of choice has an impact, where tropicamide led to higher myopic outcomes than 
cyclopentolate (Egashira et al., 1993; Mutti et al., 1994; Yazdani et al., 2018). Instrument 
myopia must also be accounted, as Moore & Berntsen (2014) noted an autorefraction 
repeatability of ~±0.21 D. Regarding axial length, Chakraborty et al. (2011) emphasised the 
importance of limiting diurnal variations, whilst Wolffsohn et al. (2019) have discussed in detail 
the ultrasound and optical biometry instrumentation techniques.  
The literature also differed on myopia progression across the human lifespan with reports of up 
to age 18 (Cooper et al., 2012); early 20s (Irving et al., 2009); 10% into late 30s (Fernandez-
Montero et al., 2015); 35% in ages 20-25, 20% in ages 25-30, 14% in ages 30-35, and 10% in 
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ages 35-40 (Buillmore et al., 2002); as well as that 40% of non-myopes becoming myopic by 
age 25 (National Research Council, 1989). Furthermore, Goss & Winkler (1983) showed myopia 
stabilised in females at ages 14.5-15.5 and males at ages 15-16.5, and Kurtz et al. (2007) later 
reported a similar mean age of 15.5, but this estimate was irrespective of parental myopia or 
sex differences. Regarding axial length, Hou et al. (2018) found the mean age of stabilisation to 
be at 16.5, slightly after refractive myopia. Bullimore & Richdale (2020) already summarised 
from these studies that axial length stabilisation was correlated with the patient’s sex and 
parental myopia history, but not ethnicity, whereas none of these factors were associated with 
myopia stabilisation. Longitudinal and population-based research has focused on prevalence 
distributions such as those outlined above, but studies investigating severity or magnitude 
changes over the human lifespan are limited; especially examinations of individual ocular 
changes with age (Strenk et al., 2006; Atchison et al., 2008; Richdale et al., 2013), refractive 
error (Atchison et al., 2004; Irving et al., 2019)), accommodation (Strenk et al., 2006; Richdale 
et al., 2013), and all three (Richdale et al., 2016); as well as those concerning binocular vision 
and near phoria (Palomo et al., 2006; Leat et al., 2013). Irving & Machan (2012) also previously 
noted distance phoria to trend towards orthophoria and remain stable over time. Furthermore, 
the Study of Progression of Adult Nearsightedness (SPAN) by Bullimore et al. (2006) stated that 
near work was the greatest risk factor for myopia progression and stabilisation in adults and 
teens, respectively. Previous research has also suggested a significant link of higher near 
esophoria among myopes (Gwiazda et al., 1995; Nakatsuka et al., 2005; Allen & O’Leary, 
2006); with variable prevalence rates in pre-presbyopic populations, due to differences in 
inclusion criteria: 10% (Hokoda, 1985); 15.5% (Porcar & Martinez-Palomera, 1997); 22% 
(Montes-Mico, 2001). In adult populations, Yekta et al. (1989) and Pickwell et al. (1991) found 
higher near exophoria up to age 65 and among those aged 40+, respectively. Leat et al. (2013) 
further showed the prevalence of binocular vision disorders was lower for all age groups 10 
years younger corresponding to the age groups 60-69, 70-79, and 80+, overall. Overall, Jones 
et al. (2005) compared various ocular component growth curves in refractive error groups 
among children and noted progression differences exist between emmetropes and myopes, but 
not relative to hyperopes.  
Thus, it remains unknown whether binocular vision errors are a component of myopia or directly 
cause its state. The literature above has investigated longitudinal population and individual 
changes, but not regarding near phoria, or the possible associated differences in sex and 
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among progressive myopes. This added investigation was intended to contribute further clues 
and aid to forming more appropriate myopia management guidelines. 
3.2 Methods  
Retrospective cross-sectional clinical data of 86 patient files were taken from the Waterloo Eye 
Study (WatES) database, consisting of 1400+ assessment dates and an average of 16 patient 
visits. The selected patients were drawn from a pool of 118 files, all seen between 1968 and 
2010 and for at least 27 years, having full and complete records for all measured parameters 
analysed in this study, and without a history of health conditions or treatments, whether medical 
or ocular in nature, as justified by the literature described below. This study focused on the 
following data: age, sex, and near phoria (measured by alternate cover test). The study was 
also approved by the University of Waterloo’s Office of Research Ethics and followed the 
Declaration of Helsinki. It is important to note the limitations of near phoria measures, as 
reported in the prospective, randomised study by Anstice et al. (2021). Specific to the alternate 
cover test data used in the present study, the authors noted that this method had the lowest 
variability for near heterophoria measures, indicating a stable accommodative response during 
clinical testing.   
Machan et al. (2011) previously confirmed the quality of the WatES database and that it was 
representative of Canadian patients. The database was used by Irving et al. (2011) and Irving & 
Machan (2012) in investigating the overall longitudinal prevalence changes of human refractive 
error and near vergence across the human lifespan, respectively, whilst Irving et al. (2019) and 
Leat et al. (2013) further applied those methodologies in examining the severity behind those 
parameters, respectively. These studies have also confirmed the similarity in systematic 
variations between longitudinal and cross-sectional clinical data. The current study followed 
these works by examining such changes in separate groups to explore individual differences in 
age (across the human lifespan), sex (males and females), and refraction (emmetropes, 
myopes and progressive myopes). Participants were defined by spherical equivalent refraction 
(SER; sum of sphere and ½ cylinder) as emmetropes (-0.50 D<SER<1.00 D), myopes (SER ≤-
0.50 D), and progressive myopes (rate of ≥-0.50 D (Parssinen et al., 2014; Afanasyeva, 2020)), 
all who remained in the respective groups, throughout the period.  
Statistical analyses (Microsoft Excel; Microsoft Corp.) from the right eye data included: means 
and standard deviations; ANOVA t-tests and Bonferroni post hoc tests (where P < 0.05 
represented statistical significance); regression mixed model linear functions, as well as 
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percentile (3rd, 50th, and 97th [Chen et al., 2016]) generated reference curves and charts over 
time for near phoria age distribution and direct group (sex and refraction) comparisons based on 
binned individual patients of the same parameters. Percentile growth curves and charts have 
been a recent application within the vision sciences used to predict the risk and severity of 
myopia and its development (Chen et al., 2016; Tideman et al., 2018; Diez et al., 2019). These 
studies have all highlighted the specific relevance of the 3rd, 50th, and 97th percentiles, where the 
3rd centile was particularly noteworthy for magnitude differences, the 50th centile was indicative 
of variation differences, and the 97th centile was best for representing changes between groups. 
3.3 Results  
The 70 analysed patients consisted of the following demographics: 43 women and 27 men 
(emmetropes [11 female and 10 male]; myopes [16 female and 11 male]; progressive myopes 
[16 female and 6 male]); mean age of 48.1 ± 18.0 years (range 2.7 to 91.3 years); mean SER of 
-1.19 ± 2.61 D, p<0.001 (Males -0.92 ± 2.53 D; Females -1.64 ± 2.38 D; p<0.001). The 
remaining 16 patients of the total 86 were hyperopes (13 females and 3 males), which were only 
accounted for to construct a complete near phoria (Figure 3.1) representations for the human 




Figure 3.1. Near phoria changes over the human lifespan, as a function of age for the right eye 
of 86 patients, where esophoric and exophoric deviations are represented by the (-) negative 
and (+) positive values on the y-axis. 
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The mean for near phoria (-3.00 ± 3.75; p<0.001) had statistical significance over the human 
lifespan in this population sample. There were statistically significant sex differences for mean 
near phoria (Males -2.53 ± 3.57; Females -3.28 ± 3.85; p=0.002), as well as within progressive 
myopes for near phoria (Males -1.54 ± 2.65; Females -3.46 ± 4.49; p=0.0007). Overall, females 
exhibited higher levels of near phoria and myopia. 
Percentile Growth Charts & Curves for Near Phoria 
Figures 3.2-3.4 and Table 3.1 show percentile (3rd, 50th, and 97th) generated reference curves 
and charts, respectively, over time for near phoria age (across the human lifespan) distribution, 
as well as associated sex differences; Figures 3.5-3.9 and Tables 3.2-3.5 provide the same for 
refraction (emmetropes, myopes and progressive myopes) group comparisons. 
 
Figure 3.2. Percentile near phoria curves over the human lifespan, where esophoric and 
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Figure 3.3. Percentile near phoria curves over the male human lifespan, where esophoric and 
exophoric deviations are represented by the (-) negative and (+) positive values on the y-axis. 
 
 
Figure 3.4. Percentile near phoria curves over the female human lifespan, where esophoric and 
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Age (Years) 3rd 50th 97th 
10 -5.5 -5.5 4.43 
15 -4.55 -1.5 -0.1 
20 -5 0 1.98 
25 -2.2 0 5.62 
30 -6.08 0 -1.03 
35 -9 1 4.16 
40 -6 0 0.4 
45 -0.63 0 -0.86 
50 -1.14 -1 -0.29 
55 6.02 0.5 3.39 
60 -5.52 0 -0.32 
65 -4 0 0 
70 -3 2 0 
75 -6.76 0 1.4 
Table 3.1. Percentile near phoria chart showing sex differences (female-male) over the human 
lifespan, where esophoric and exophoric deviations are represented by the (-) negative and (+) 
positive values. 
 
Percentile growth charts showed all three centiles were of different variation between the sexes. 
The female 3rd centile was more esophoric for all available age groups, spanning ages 10-79. 
The 50th centile was similar for both sexes, except where females were more esophoric for ages 
10-19 and 50-54. The 97th centile showed exophoric and esophoric changes, but differences 
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Figure 3.5. Percentile near phoria curves over the emmetrope human lifespan, where esophoric 




Figure 3.6. Percentile near phoria curves over the myope human lifespan, where esophoric and 
exophoric deviations are represented by the (-) negative and (+) positive values on the y-axis. 
 
 
Figure 3.7. Percentile near phoria curves over the progressive myope human lifespan, where 
esophoric and exophoric deviations are represented by the (-) negative and (+) positive values 
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Age (Years) 3rd 50th 97th 
10 0.3 2.5 10.79 
15 0.03 0.5 0.03 
20 -2.37 1.5 7.45 
25 -7.93 -0.5 0.09 
30 -0.09 -0.5 -5.55 
35 -0.12 -3 -2 
40 -4 -1 -0.06 
45 -6.1 -1 -3.04 
50 -1.33 0 -1.84 
55 -0.26 0 1.75 
60 -6.3 -1 -4.44 
65 -4 0 -2 
70 -4.28 -6 -0.02 
Table 3.2. Percentile near phoria chart showing refraction group differences (myope-
emmetrope) over the human lifespan, where esophoric and exophoric deviations are 
represented by the (-) negative and (+) positive values. 
 
All three centiles were of similar variation between myopes and emmetropes, but progressively 
differed with age commencement. The myope 3rd centile was more esophoric for all available 
age groups, spanning ages 20-74. The 50th centile was similar for both refraction groups, except 
where myopes were more esophoric from age 25. The 97th centile showed exophoric and 
esophoric changes, except where myopes were more esophoric from age 30.    
Age (Years) 3rd 50th 97th 
10 -6.07 -1 4.52 
15 -8.02 0.5 6.09 
20 -5.09 0.5 6.71 
25 -10.49 -1.5 5.19 
30 -7.85 -0.5 -0.57 
35 -9.45 -4 2.19 
40 -9.8 -1 -0.28 
45 0 -1 0.96 
50 0.15 0 -1.54 
55 4.24 -2 0.74 
Table 3.3. Percentile near phoria chart showing refraction group differences (progressive 
myope-emmetrope) over the human lifespan, where esophoric and exophoric deviations are 
represented by the (-) negative and (+) positive values. 
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All three centiles were of different variation between progressive myopes and emmetropes. The 
progressive myope 3rd centile was more esophoric for all available age groups, spanning ages 
10-44. The 50th centile was similar for both refraction groups, except where progressive myopes 
were more exophoric for ages 15-24 and 50-54. The 97th centile showed a reversed trend, 
compared to the other centiles.   
 
Age (Years) 3rd 50th 97th 
10 -6.37 -3.5 -3.79 
15 -8.05 0 6.68 
20 -2.72 -1 -2.26 
25 -2.56 -1 4.8 
30 -7.76 0 4.37 
35 -9.33 -1 4.28 
40 -5.8 0 -0.5 
45 6.1 0 0.46 
50 1.48 0 2.58 
55 4.5 -2 -5.75 
Table 3.4. Percentile near phoria chart showing refraction group differences (progressive 
myope-myope) over the human lifespan, where esophoric and exophoric deviations are 
represented by the (-) negative and (+) positive values. 
 
All three centiles were of different variation between progressive myopes and myopes. The 
progressive myope 3rd centile was more esophoric for all available age groups, spanning ages 
10-44. The 50th centile was similar for both refraction groups, except where progressive myopes 
were more esophoric for ages 10-14, 20-29, 35-39, and 55-59. The 97th centile showed 
exophoric and esophoric changes, but differences were more similar to the 50th centile.   
 
N.B.Boychev, PhD Thesis, Aston University 2021                                                                    78 
 
 
Figure 3.8. Percentile near phoria curves over the male progressive myope human lifespan, 
where esophoric and exophoric deviations are represented by the (-) negative and (+) positive 
values on the y-axis. 
 
 
Figure 3.9. Percentile near phoria curves over the female progressive myope human lifespan, 
where esophoric and exophoric deviations are represented by the (-) negative and (+) positive 
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Age (Years) 3rd 50th 97th 
10 -7.66 -6.5 1 
15 -4.82 -2 0.26 
20 -5 -0.5 1.31 
25 -10.55 -1 6.04 
30 -6.26 -1 1.15 
35 -9.15 -0.5 4.61 
40 -10.4 -2 3 
45 -9.77 -2.5 -0.94 
50 -1.28 -1 2.19 
Table 3.5. Percentile near phoria chart showing refraction group differences (female-male 
progressive myope) over the human lifespan, where esophoric and exophoric deviations are 
represented by the (-) negative and (+) positive values. 
 
The female progressive myope 3rd and 50th centiles were both more esophoric for all available 
age groups, spanning ages 10-54. The 97th centile showed a reversed trend, compared to the 
other centiles, except where female progressive myopes were more esophoric for ages 45-49.  
Clinical Patient Visits 
Investigation of patient visit (Figure 3.10) differences only across the emmetrope, myope, and 
progressive myope groups showed emmetropic and female patients were examined more 
frequently. 
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3.4 Discussion  
The mean for near phoria (-3.00 ± 3.75 Δ) over the human lifespan in this sample was similar to 
the results (mean near phoria of -2.03 ± 4.00 Δ analysed at the first visit, relative to that of -4.49 
± 4.56 Δ at the final visit) reported by Irving & Machan (2012) of the same larger population, 
both using the WatES database. This reliability was then applied towards additional individual 
patient analysis to investigate the age-dependent distribution of near phoria severity. However, 
no previous such study exists for further comparisons of the reported differences in sex, 
progressive myopes, as well as percentile growth charts and curves for near phoria spanning at 
least 27 years. 
Overall for the current study, emmetropic and female patients were examined more frequently; 
females and female progressive myopes exhibited higher levels of near phoria and myopia; 
myopes were more esophoric than emmetropes, progressive myopes were more esophoric than 
both myopes and emmetropes, and were less likely to increase in exophoria with age. These 
findings are important, since previous literature has reported on the constant and gradual 
increase of near exophoria with age in both pre-presbyopes and presbyopes, irrespective of a 
reading addition (Yekta et al., 1989; Hrynchak et al., 2011; Irving & Machan, 2012; Leat et al., 
2013).  
In this population sample, the 3rd centile was particularly noteworthy for differences in the near 
phoria magnitude, whereas the 50th centile was more indicative of the variation in near phoria 
onset, and the 97th centile was best for representing esophoric and exophoric changes among 
the sex and refraction groups, across the human lifespan. This agreed with Chen et al. (2016), 
who reported younger Chinese children with refractive centiles below lower percentiles, 
especially those below the 5th percentile having the highest predictive accuracy and age-related 
cut points, were expected to have high myopia later in life. In-between refractive group 
comparisons showed the most interesting changes. Myopes and emmetropes differed by 
esophoria onset, occurring earlier among myopes and 5 years later in each subsequent centile: 
ages 20-24 for the 3rd centile; 25-29 for the 50th, and 30-34 for the 97th. This is interesting 
relative to the study by Jones et al. (2005), who noted the growth differences between 
emmetropic and myopic eyes, whereas the respective investigated changes between these 
refraction groups remained similar at baseline. The present study also supported the notion of a 
short opportunistic interval for prediction and intervention prior myopia onset, as well as that 
myopes and emmetropes differed by growth. Moreover, the 3rd centile of the percentile growth 
curves in this study showed near phoria severity peaks occurred at the following: for the overall 
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sample population at ages 15-19, 25-29, 40-44, and 60-64, where this happened at 15-19, 25-
29, 45-49, 55-59 and 15-19, 25-29 for males and females, respectively; for emmetropes at ages 
45-49 and 55-59, for myopes at ages 25-29, 45-49, and 60-64, and for progressive myopes at 
ages 15-19, 25-29, and 40-44. The 50th centile from the percentile growth chart results included: 
relative to emmetropes, myopes were esophoric at ages 25-29, whilst progressive myopes were 
exophoric for ages 15-24 and 50-54; relative to myopes, progressive myopes were esophoric for 
ages 10-14, 20-29, and 55-59. Also relative to myopes, progressive myopes were esophoric for 
ages 10-14 and exophoric for ages 15-19 at the 97th centile of that percentile growth chart. 
These findings agreed with Rozema et al. (2019), noting the increased growth changes 
surrounding onset, followed by a gradual dip among progressive myopes. Likewise, the findings 
here supported the statement by Irving et al. (2019), who discovered the myopes in that 
population were the cause for the greater longitudinal refractive error variability and change over 
human life. The results suggested possible crucial cut points of near phoria development at the 
age ranges of 10-29 and 40-64, particularly 15-19, 25-29, and 40-49, earlier and later in life, 
respectively. This was emphasised by Diez et al. (2019), who suggested the age of 9 to be vital 
for Chinese children, after reporting that axial length centiles there, above the 50th percentile 
were expected to develop high myopia. Similar findings were observed by Tideman et al. (2018) 
in a European population. Thus, there may be a clinically manifesting myopia-related near 
phoria control target across the human lifespan, which was observed to be greater and occurred 
later in males and male progressive myopes.       
Although these findings reflected the age-, sex-, and refraction-specific near phoria distribution 
in Canadians, the study (known to be the first of its kind) intended to inform future research 
towards better understanding myopia prediction, its progression over human life, the way 
individuals might benefit from intervention, as well as suggesting that the near phoria risk factor 
should be measured alongside other primary outcome parameters important for treatment 
efficacy. This study may also be added towards the implementation of individual monitoring 
standards relative to a population, which would be beneficial for myopia assessment and 
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Chapter 4 Impact of blur from a dual focus and an extended depth of focus contact lens 
4.1 Introduction  
Since Holden et al. (2016) projected half of the world to become myopic by the year 2050, 
efforts towards myopia control and prevention have increased. In a meta-analysis of thirty 
randomized controlled trials (RCTs) with a minimum of one year treatment duration, Huang et 
al. (2016) noted that a range of interventions are effective against myopia progression in 
children relative to single vision spectacles or no intervention at all. However, due to persistent 
variability in efficacy and mechanism understanding of the current optical, pharmacological, 
environmental, and surgical myopia treatment strategies, the International Myopia Institute (IMI) 
committee on Interventions for Myopia Onset and Progression (Wildsoet et al., 2019) 
maintained that no therapy yet exists for all patients that is able to fully prevent, delay, or control 
myopia. Also, many myopia control treatments are currently off-label/unlicensed prescriptions, 
and the relevant legal, regulatory, and professional stance is country-specific, varying 
worldwide. An exception is the approved European certification standard or CE marking for the 
multifocal soft contact lenses MFSCLs MiSight (CooperVision), NaturalVue (Visioneering 
Technologies), and MYLO (Mark’ennovy in collaboration with the Brien Holden Vision Institute), 
of which only MiSight is additionally Food and Drug Administration (FDA)-approved and 
recognised in the US, Canada, Australia, New Zealand, Hong Kong, and Singapore for 
controlling myopia progression. MYLO is a monthly silicone hydrogel contact lens with extended 
depth of focus (EDOF) optics and higher water content, whilst MiSight and NaturalVue are both 
daily hydrogel lenses of similar water content, but MiSight has a dual focus optical design, 
whereas NaturalVue also incorporates EDOF. Since these options currently stand as the most 
accessible to eye care practitioners, it is of vital importance to understand the associated “real 
world” clinical applications.  
Wildsoet et al. (2019) outlined the variable optical treatment efficacies (reduction in myopia over 
time, compared to a simultaenous control group) such as: single vision spectacles (14%) [where 
the literature is adamant that any effect is unsustained and this treatment strategy is ultimately 
ineffective in slowing myopia]; bifocal and progressive addition spectacles (6-51%); MFSCLs 
(38%); and orthokeratology (30-55%). Despite these results, animal studies have consistently 
suggested that myopia developement and progression is driven by standard spherical optical 
treatments causing relative peripheral hyperopic defocus (Smith et al., 2007; Smith, 2010; 
Cooper et al., 2012). On the other hand, orthorokeratology options have been of concern 
regarding adverse effecs (Lang & Rah, 2004; Liu & Xie, 2016) and limitations for correcting low 
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and high myopia, as well as older patients (Fu et al., 2016; Want et al., 2017). A meta-analysis 
and systemic review by Bullimore (2017) on the safety of soft contact lenses in children, for 
example, asserted the risk of infiltrative complications was shown to be lower for ages 8-12 
relative to older groups, which also matches the typical commencement range for myopia 
control implementation. Thus, MFSCLs with centre-distance concentric ring or progressive 
power designs have been increasingly used as an attractive optical paediatric myopia 
intervention and are well accepted by both clinicians and their patients.  
Chamberlain et al. (2019) and Wildsoet et al. (2019) have recently summarised the majority of 
published MFSCLs trials, but without inclusion of the lone NaturalVue (Cooper et al., 2018) and 
MYLO (Sankaridurg et al., 2019) investigations, and only a few of these studies used country-
dependent commercially available lenses (Anstice & Phillips, 2011; Walline et al., 2011; Ruiz-
Pomeda et al., 2018; Chamberlain et al., 2019; Sankaridurg et al., 2019). NaturalVue also has a 
presently on-going clinical study performed by Thomas Aller and Visioneering Technologies, 
Inc. with an estimated completion by mid-2022. Wildsoet et al. (2019) highlighted that MFSCLs 
of concentric ring designs were more effective in slowing axial elongation. Furthermore, only 
Sankaridurg et al. (2011) and Fujikado et al. (2014) with MFSCLs, and Paune et al. (2015) with 
orthokeratology contact lenses, have examined the role of corrected peripheral refraction. The 
contact lenses in these studies have been termed concentric (Anstice & Phillips, 2011; Aller et 
al., 2016) or peripheral gradient (Sankaridurg et al., 2011; Fujikado et al., 2014; Paune et al., 
2015) lenses. The literature is definitive in that contact lenses are superior to spectacles in 
correcting peripheral refraction, as they move with the eye and are on the cornea. MFSCLs in 
particular have been shown to reduce myopia significantly more than progressive addition 
spectacles, due to their ablitity for exerting more extensive peripheral myopic defocus (Smith, 
2013).   
In addition to refractive error, axial length (AL), and relative peripheral defocus, there are other 
well established outcome measures from myopia control trials that should be adopted on the 
quest to solving the unanswered efficacy and mechanism questions (Wolffsohn et al., 2019). 
Early research has reported higher near accommodative lag and associated errors among 
myopes (Gwiazda et al., 1995; Nakatsuka et al., 2005; Allen & O’Leary, 2006), which are 
importantly linked to the induced retinal blur by MFSCLs (Anstice & Phillips, 2011; Paune et al., 
2016; Gong et al., 2017). The report by the IMI committee on Clinical Myopia Control Trials and 
Instrumentation (Wolffsohn et al., 2019) has stressed the examination of treatment compliance 
and qualifty of life impact by the effect of dysphotopsia and contrast sensitivity with myopia 
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control strategies. However, only single studies have reported some of these measures with 
0.01% atropine (Loughman & Flitcroft, 2016) and the MiSight and NaturalVue MFSCLs 
(Ghorbani-Mojarrad et al., 2021). MFSCLs, in particular, have previously been shown to 
significantly impact these measures in presbyopes, due to the alternating zones of optical 
powers (Rajagopalan et al., 2007; Kolbaum et al., 2012; García-Lazaro et al., 2015; Wahl et al., 
2018), but myopia control use is aimed at children and young adults.     
In order to address the above gaps in knowledge, this study evaluated the clinical impact 
(peripheral refractive defocus, accommodative lag, contrast sensitivity, and dysphotopsia) of the 
commercially available and CE-marked for myopia control MiSight and NaturalVue MFSCLs, 
compared with a standard single vision Proclear lens, after daily wear. This is considered the 
first such study, comparing these lenses and parameters, aimed at better understanding the 
possible mechanisms surrounding optical myopia control options, as well as how effectiveness 
may vary for individual patient or combine with other therapies. 
 
4.2 Methods  
4.2.1 Participants 
The study (single-centre, prospective, randomised, and double-masked) was conducted at the 
Aston University Ophthalmic Research Clinics, where 18 participants with myopia in good overall 
general and ocular health were recruited. This sample size was enough to obtain 80% statistical 
power for a significance level of α = 0.05 with a confidence level of 95%, based on an effect size of 
0.8 for the statistical analyses used in this study, published literature, and priori power analysis 
(G*Power 3.1, University of Dusseldorf). All participants gave informed written consent. All 
procedures followed the Declaration of Helsinki and the protocol was approved by the Aston 
University Research Ethics Committee.  
4.2.2 Contact Lenses 
Three different daily soft contact lenses (standard single vision Proclear® 1-Day [omafilcon A; 
hydrophilic; CooperVision, Inc.] for the control group, as well as specialty multifocal MiSight® 1-
Day [omafilcon A; hydrophilic, water content 60%; refractive index 1.40; center thickness of 0.08 
mm at -3.00 D; CooperVision, Inc.] and NaturalVue® 1-Day [etafilcon A; hydrophilic, water 
content 58%; refractive index 1.40; center thickness of 0.08 mm at -3.00 D; Visioneering 
Technologies, Inc.] designed for myopia control for the test groups) were compared. The optical 
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design technology of the MiSight and NaturalVue lenses has already been described in detail by 
Chamberlain et al. (2019) and Cooper et al. (2018), respectively.  
4.2.3 Study Design 
Eligible participants visited on alternating days and in the same week, in order to implement a test 
group washout period in between, and so that each participant can be fitted with all lenses. 
Participants were asked to attend for a morning visit (8:30 AM – 11:30 AM) and 8 hours later in the 
afternoon to allow for an adaptation period, mimic a typical work-day interval, and consistency in 
diurnal variation. The visits were each conducted by two separate investigators, where the first 
investigator fitted the randomised contact lenses via coded letter (A, B, C) assignment, known only 
by the principal investigator, whilst the second investigator performed the measurements. The 
participants were unaware as to which lens and in which eye they were fitted during the visit.   
During the morning visit, Investigator 1 provided a copy of the informed consent and participant 
information sheet; confirmed eligibility (age range 18-35; prescription range -0.75 D to -4.50 D with 
astigmatism ≤1 D; spectacle, contact lens, and myopia control intervention history; as well as no 
relevant contraindication; and medical and ocular health history, including medications); and 
performed autorefraction (3 measurements were taken from each eye, whilst the participant viewed 
a distant non-accommodative target [Grand Seiko WAM-5500; Grand Seiko Co., Hiroshima, 
Japan]), best-corrected distance visual acuity (logMAR letter chart), slit-lamp biomicroscopy 
anterior eye examination, and randomised contact lens fitting according to manufacturers’ criteria.  
In order to investigate differences in materials and designs, peripheral refractive defocus, 
accommodative lag, contrast sensitivity, and dysphotopsia were measured by also accounting 
for diurnal variations. 
During the afternoon visit, Investigator 2 measured the following:  
Accommodative Lag: 3 measurements were taken from each contact lens-corrected eye with the 
opposite eye being occluded and the lights turned off; the participant viewed a distant non-
accommodative target, followed by near readings at -3 D/33 cm and fixating the centre of a near 
Maltese cross target in free space attached to the mounted adjustable apparatus [Grand Seiko 
WAM-5500; Grand Seiko Co., Hiroshima, Japan].  
Contrast Sensitivity and Dysphotopsia (Glare): Contrast Sensitivity was measured with the 
Aston Contrast Sensitivity Near App and Dysphotopsia (disability glare) was measured with the 
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Aston Halometer and Tablet App; both monocularly from each contact lens-corrected eye and using 
an iPad4. The validation and repeatability completed previously on these techniques have been 
assessed by Kingsnorth et al. (2016) and Buckhurst et al. (2015; 2017), respectively, where the 
measurement protocol followed the recommendations in those studies. These tests were selected 
for their objectivity towards such normally subjective reported data.  
Contrast Sensitivity was measured at 40 cm, as participants traced the boundary of contrast grating 
detection using their finger on the touch screen (Figure 4.1). 
 
Figure 4.1. The Aston Contrast Sensitivity Near App, adopted from Kingsnorth et al. (2016). 
Dysphotopsia was measured at 2 m with the lights turned off. The Halometer is a light-emitting-
diode (LED) glare source centrally positioned on the iPad. The investigator manually moved 
randomised letters subtending 0.21° centrifugally from the LED in 0.05° steps in all 8 directions of 
gaze. Photopic scotoma size was measured, once participant responses were recorded at all 
orientations, where each letter response had to be correct in at least 2 out of 3 presentations 
(Figure 4.2).  
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Figure 4.2. The Aston Halometer and Tablet App, adopted from Buckhurst et al. (2015). 
Cyclo-Autorefraction: 3 measurements were taken from each eye with the opposite eye being 
occluded and the lights turned off; central (on-axis) refractive error was measured with the 
participant viewing a distant target 1 line larger than best VA; peripheral refraction was measured at 
30° in the horizontal meridian with the participant viewing a distant Maltese cross on a wall and the 
nasal/temporal sides randomised by head turning (Wolffsohn et al., 2019) [Grand Seiko WAM-
5500; Grand Seiko Co., Hiroshima, Japan]. 
Cycloplegia: complete details of the drops were provided along with official College of Optometrists 
leaflet; the British National Formulary (BNF) number, expiration date, and time of instillation were 
recorded [1% Tropicamide; 1 drop/eye; minimum 20-minute waiting period]. 
Visual acuity (logMAR letter scoring) and anterior eye health (slit-lamp biomicroscopy with 
fluorescein) were also examined, and the study concluded with a verbal debrief. Visual acuity 
(distance at 4 m [2000 Series Revised ETDRS Chart; Precision Vision] and near at 40 cm [Near 
Point Flip Charts; Precision Vision]) was assessed monocularly from each contact lens-corrected 
eye, until missing ≥3 letters on a line.    
4.2.4 Statistical Analyses 
The normality of the data distributions was confirmed using the Kolmogorov-Smirnov test 
(P>0.05). ANOVA t-tests and Bonferroni post hoc tests were carried out in Microsoft Excel for 
Office 365 ProPlus (Microsoft Corp.); values are means ± SD, where values denoted * were 
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considered significant (p<0.05). Statistical significance (P<0.05) between groups (contact lenses 
Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) is denoted *.  
An accommodative response ≥1.00 D was considered as lag of accommodation (Manny et al., 
2009), which was calculated as the average refraction difference between distance and near 
readings (Wolffsohn et al., 2019).  
Sphero-cylindrical refraction data was converted into power vector components M, J0, and J45 
using the standard formulas (Thibos et al., 1997) below: 
Spherical equivalent M = sphere + (cylinder/2) 
J0 = -(cyl/2) x cos(2xaxis) 
J45 = -(cyl/2) x sin(2xaxis) 
 
 
4.3 Results  
From the 18 subjects included in the study, the pool consisted of the following demographics: 15 
female and 3 male (12 British Asian and 6 white European); mean age of 22.8 years ± 4.1 
(range 18 to 35 years); mean spherical equivalent refraction (SER) of -2.4 ± 1.3 D (range -0.75 
to -4.50 D); there were no adverse events. 
4.3.1 Cyclo-Autorefraction 
Central and peripheral refractive error results measured by cyclo-Autorefraction are summarised 
in Table 4.1. Temporal (at 30° in the horizontal meridian) refraction for the J0 sphero-cylindrical 
power vector was found to be significant (p=0.019*), after 8 hours of contact lens wear. The 
result was followed by individual group comparisons in Table 4.2, where temporal peripheral 
defocus for the J0 vector exerted by the NaturalVue MFSCLs test group was significant 
(p=0.011*) relative to the Proclear single vision contact lens control group. This was not the 
case for the other MiSight MFSCLs test group, as well as there was no significant difference 
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  0.019611 * 










1.20 ± 2.83 
0.28 ± 0.74 




0.68 ± 2.46 
0.16 ± 0.95 




0.18 ± 2.57 
0.09 ± 0.80 






      0.32894 
Table 4.1. Central (on-axis) and peripheral (at 30° temporally and nasally in the horizontal 
meridian) cyclo-Autorefraction measured after 8 hours of contact lens wear; values are means ± 
SD, where values denoted * were considered significant (p<0.05). 
 
 J0 Temporal Refraction (D) 
Group A vs. Group B P 
Group A vs. Group C P 
Group B vs. Group C P 
0.064925 
  0.010582 * 
                             0.368238 
Table 4.2. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 
comparison of temporal (at 30° in the horizontal meridian) cyclo-Autorefraction for the J0 
sphero-cylindrical power vector, where * represented a significant (p<0.05) difference. 
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Figure 4.3. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 
comparison of temporal (at 30° in the horizontal meridian) cyclo-Autorefraction mean values for 
the J0 sphero-cylindrical power vector, where * represented a significant (p<0.05) difference. 
 
4.3.2 Accommodative Lag 
The type of contact lens had a significant (p=0.006*) effect on accommodative lag, after 8 hours 
of wear (Table 4.3). The result was followed by individual group comparisons in Table 4.4, 
where Accommodative Lag exerted by the NaturalVue MFSCLs test group was significant 
(p=0.002*) relative to the Proclear single vision contact lens control group. This was not the 
case for the other MiSight MFSCLs test group, as well as there was no significant difference 
between test groups. These contact lens group differences are further illustrated by Figure 4.4.    
 Proclear MiSight NaturalVue p 
Accommodative 
Lag (D) 
1.88 ± 0.65 1.39 ± 1.04 0.73 ± 1.28 0.006019 * 
Table 4.3. Accommodative Lag measured after 8 hours of contact lens wear; values are means 
± SD, where values denoted * were considered significant (p<0.05). 
 Accommodative Lag (D) 
Group A vs. Group B P 
Group A vs. Group C P 
Group B vs. Group C P 
0.102538   
  0.001833 * 
0.099409 
Table 4.4. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 
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Figure 4.4. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 
comparison of Accommodative Lag mean values, where * represented a significant (p<0.05) 
difference. 
 
4.3.3 Contrast Sensitivity 
Results for Contrast Sensitivity are summarised in Table 4.5. Although no significant differences 
were found, after 8 hours of contact lens wear, Figure 4.5 further illustrates the contact lens 
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 Proclear MiSight NaturalVue p 
CS at -1 
Frequency 
(cpd) 
0.06 -0.02 -0.003 0.66733 
 





















































































CS at 0.26 
Frequency 
(cpd) 
2.29 2.22 2.20 0.896381 
 
CS at 0.41 
Frequency 
(cpd) 
2.33 2.23 2.21 0.797075 
 
CS at 0.57 
Frequency 
(cpd) 
2.30 2.19 2.14 0.628749 
 
CS at 0.72 
Frequency 
(cpd) 
2.19 2.08 1.99 0.429189 
 
CS at 0.88 
Frequency 
(cpd) 
2.01 1.91 1.78 0.303972 
 
CS at 1.04 
Frequency 
(cpd) 
1.78 1.70 1.55 0.212765 
 
CS at 1.19 
Frequency 
(cpd) 




CS at 1.35 
Frequency 
(cpd) 
1.29 1.19 1.12 0.496834 
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Table 4.5. Contrast Sensitivity measured after 8 hours of contact lens wear; values are means, 
where values denoted * were considered significant (p<0.05). 
 
 
Figure 4.5. Contact lens comparison of Contrast Sensitivity across the sample population. 
 
4.3.4 Dysphotopsia (Glare) 
Results for Dysphotopsia (Glare) are summarised in Table 4.6. Glare at 0° and 225° was found 
to be significant (p=0.015901* and p=0.024147*, respectively), after 8 hours of contact lens 
wear. Figure 4.6 further illustrates the contact lens comparison of Glare across the sample 
population. The result was followed by individual group comparisons in Table 4.7 and Table 
4.8, representing Glare at 0° and 225°, respectively. Glare at 0° exerted by the NaturalVue 
MFSCLs test group was significant (p=0.015548*) relative to the Proclear single vision contact 
lens control group. This was not the case for the other MiSight MFSCLs test group, but there 
was a significant difference between test groups (p=0.02591*). Additionally, Glare at 225° 
exerted by both the NaturalVue and MiSight MFSCLs test groups was significant (p=0.007196* 
and p=0.016713*, respectively) relative to the Proclear single vision contact lens control group. 
There was no significant difference between test groups. These contact lens group differences 
are further illustrated by Figure 4.7 and Figure 4.8, representing Glare at 0° and 225°, 
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 Proclear MiSight NaturalVue p 
Radii (DOV°) at 
0° 
1.31 1.35 1.62   0.015901 * 
















































  0.024147 * 
 




















Table 4.6. Dysphotopsia (Glare) measured after 8 hours of contact lens wear; values are 
means, where values denoted * were considered significant (p<0.05). 
 
 
Figure 4.6. Contact lens comparison of Dysphotopsia (Glare) across the sample population. 
 
 Glare at 0° [Radii (DOV°)] 
Group A vs. Group B P 
Group A vs. Group C P 
Group B vs. Group C P 
0.691174  
  0.015548 * 
                             0.02591 * 
Table 4.7. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 
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Figure 4.7. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 
comparison of Dysphotopsia (Glare) at 0° mean values, where * represented a significant 
(p<0.05) difference. 
 
 Glare at 225° [Radii (DOV°)] 
Group A vs. Group B P 
Group A vs. Group C P 
Group B vs. Group C P 
  0.016713 *   
  0.007196 * 
0.565933 
Table 4.8. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 
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Figure 4.8. Contact lens group (Proclear [Group A], MiSight [Group B], NaturalVue [Group C]) 




The successful contact lens efficacy in slowing refractive myopia progression and axial 
elongation is well established, but the surrounding mechanisms and associated clinical impact 
remain inconclusive. Although Ghorbani-Mojarrad et al. (2021) recently assessed 
accommodative lag and contrast sensitivity based on patient experience, their analyses were 
exploratory and did not test a hypothesis. The present study is considered the first to 
additionally measure corrected peripheral defocus and dysphotopsia with the MiSight and 
NaturalVue MFSCLs (the only daily CE-marked myopia control options). This study is further 
unique in its used cohort (British Asian and European myopic adults) and control group 
(commercially available single vision contact lenses) for the comparisons, after 8 hours of  
contact lens wear. 
4.4.1 Peripheral Refraction 
Gifford et al. (2019) and Wolffsohn et al. (2019) have summarised the research surrounding 
peripheral refraction, concluding that its mechanism in myopia control and progression remains 
unknown, whilst clinically significant standardised criteria does not yet exist. However, studies 
have consistently showed that myopes have greater relative peripheral hyperopia, compared to 
emmetropes and hyperopes, and vice-versa for myopic relative peripheral refraction (Ehsaei et 
al., 2011; Sng et al., 2011; Lundstrom & Rosen, 2017). Based on the compiled findings for 
significant patterns in uncorrected relative peripheral refraction measurements across the 
literature, Wolffsohn et al. (2019) stated differences between 0.50-1.00 D in the 30° temporal 
visual field may be used as a reference. As mentioned above, only Sankaridurg et al. (2011) 
and Fujikado et al. (2014) have previously measured corrected peripheral defocus during 
MFSCLs wear, using single vision spectacle and contact lenses as controls, respectively. 
Moreover, the studies were performed on Chinese myopic children of ages 7-14 and Japanese 
myopic children of ages 10-16, respectively.    
Sankaridurg et al. (2011) measured peripheral refraction horizontally (both nasal and temporal 
directions) at 20°, 30°, and 40°, with and without correction, after 12 months. The authors 
reported no differences in relative hyperopia magnitude and/or eccentricity, without correction; 
expected increases with increased eccentricity, but particularly higher hyperopia magnitude 
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nasally for both spectacle and contact lens groups; however, spectacles lenses equally 
increased the relative peripheral hyperopia, whereas, contact lenses showed reductions, 
especially nasally, presumed to be a result of the nasal centering on the corneal geometric axis 
during wear. This study stated that increased relative peripheral hyperopia at 30° and 40° 
nasally, as well as 40° temporally were ultimately correlated with greater myopia progression. 
Fujikado et al. (2014) expanded the above findings in a randomised study with MFSCLs of 
nasally decentered optical design and lower add (0.50 D), after 12 and 24 months. However, no 
significant difference in reduced relative peripheral hyperopic blur between the naked eye and 
either contact lens type, regardless of eccentricity, was reported. In comparison to Sankaridurg 
et al. (2011), the authors attributed this discrepancy to that study’s use of higher addition (2.00 
D) MFSCLs, but concluded that the efficacy in AL reduction was similar, possibly due to the 
reduced near accommodation, which neither study investigated.     
Although interesting changes in central and peripheral (nasal and temporal) refractive blur were 
observed, where individual contact lens results supported indications by the literature, the 
present study also consistently found the temporal horizontal meridian at 30° for the J0 sphero-
cylindrical power vector to be of practical significance, particularly with the NaturalVue MFSCLs 
of EDOF optical design achieving the highest level of blur. No previous similar data exists for 
direct comparison, but Paune et al. (2015) did report a lack of significant correlations for the 
horizontal (J0) and oblique (J45) astigmatic components with multifocal orthokeratology contact 
lenses when tested on Caucasian myopic children of ages 9-16. A more recent study by Moore 
et al. (2018) investigated the effect of peripheral retinal defocus with four commercially available 
spherical soft contact lenses (Biofinity, Acuvue2, PureVision2, and Air Optix Night & Day) on 
myopic young adults at 20°, 30°, and 40°. The study stated that all lenses significantly reduced 
relative peripheral hyperopic defocus on the temporal retina when compared to the uncorrected 
eye, except PureVision2, but magnitudes differed with eccentricities: J0 was significant for the 
same three lenses at 40° temporally, as well as at 30° temporally and 40° nasally for Air Optix; 
J45 was significant only for Air Optix at 40° temporally. The authors noted that Air Optix was the 
only contact lens to decenter nasally, as well as that a more negative contact lens power overall 
(which is the opposite mechanism to spectacles [Lin et al., 2010]), and the optic zone size 
significantly accounted for differences between eccentricities; results confirmed to be similar to 
the summarised literature based on previous such studies. These insights further support the 
results in the current study, emphasising the essential importance of the optical design 
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characteristics in contact lenses, where: the treatment zones of the MiSight optic zone 
incorporate 2.00 D of defocus, whilst NaturalVue has a universal addition power up to 3.00 D.               
4.4.2 Accommodative Lag 
The significant results of reduced near accommodative lag, especially with the NaturalVue 
MFSCLs achieving the lowest level of lag, corresponded to the outcome in induced peripheral 
defocus. Although there are no previous data, but similar findings were reported in studies on 
myopic children evaluating changes in accommodative lag with MFSCLs (Paune et al., 2016; 
Gong et al., 2017); whereas, Anstice & Phillips (2011) and Berntsen et al. (2010) did not 
discover an impact on the accommodative lag with dual-focus soft contact lenses (which are of 
similar design to the MiSight lenses with 2.00 D treatment zones) and progressive addition 
lenses (2.00 D add), respectively. An early longitudinal study also stated a lack of significant link 
in childhood myopia progression with near accommodative lag (Weizhong et al., 2008). 
Moreover, Anstice & Phillips (2011) suggested the myopia control mechanism of the dual-focus 
contact lenses was based on sustained and simultaneous myopic defocus at both distance and 
near, where the lenses did not seem to be used as multifocal and relax accommodation, which 
can be attributed to the MiSight findings in the current study. The authors also noted this design 
with 2.00 D treatment zones and overall parameters may not be optimal. 
4.4.3 Visual Quality 
The effect on glare at 0° and 225° was significantly impacted by the contact lenses, especially 
for MiSight and NaturalVue achieving the highest level of glare at 225° and 0°, respectively. 
There were no significant differences in contrast sensitivity. Some studies in children have 
reported reduced contrast sensitivity with MFSCLs, particularly at the lower spatial frequencies 
(Paune et al., 2016; Gong et al., 2017; Sankaridurg et al., 2019), whilst others have not (Collins 
et al., 1989; Anstice & Phillips, 2011). The study by Wahl et al. (2018), which investigated 
contrast sensitivity (with and without glare) and disability glare influenced by centre-near and 
centre-distance MFSCLs with single vision spectacle and contact lenses as controls in myopic 
young adults, is the most similar to the present study for comparisons. The authors reported 
significant reductions in contrast sensitivity with the centre-distance MFSCLs, but only under the 
glare condition; disability glare was significant for all lenses and highest at low and medium 
contrast, but greatest for the centre-distance MFSCLs, whilst all other types had similar levels. 
Furthermore, van Den Berg et al. (2010) and Wahl et al. (2018) stated that visual acuity is not 
linked to glare, due to its minimal impact on contrast sensitivity relative to corrected blur with 
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MFSCLs. Gifford et al. (2013) and Loughman & Flitcroft (2016) also offered agreeable insights 
with overnight orthokeratology and 0.01% atropine, respectively. These findings support the 
observations in the current study and highlight the importance of including these visual 
performance parameters in myopia control research utilising various optical designs. 
 
4.5 Conclusion 
The presumed design optimisation, regarding the only daily CE-marked optical myopia control 
strategies, was based on the possible mechanism behind peripheral refraction and 
accommodative lag in myopia development and progression. MiSight and NaturalVue MFSCLs 
achieved myopic retinal defocus differently; MiSight reduced hyperopic blur by sustained and 
simultaneous myopic defocus, whilst reduced lag was not only associated with the treatment 
effect for NaturalVue in reducing hyperopic blur, but this novel EDOF lens design could have an 
inherent characteristic for doing so in the temporal retina at 30° and J0 astigmatic component, 
which potentially may also be used as a predictive factor for success. These findings may be 
extended to comparisons of all concentric and peripheral gradient contact lens types, 
suggesting that except for the possibility of a causal effect by these factors with NaturalVue, 
reduced hyperopic blur (temporally at 30° for the J0 sphero-cylindrical power vector) and 
accommodative lag appeared only to be byproducts of the optical design in other contact lenses 
influencing myopia progression. The optical design of multifocal contact lenses also directly 
influenced visual quality. Both myopia control strategies significantly impacted glare, but did not 
effect contrast sensivitiy differently than standard lenses, and would offer equally acceptable 
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Chapter 5 IOLMaster agreement evaluation in healthy adults, comparing ocular biometry 
measurements, after immediate soft contact lens wear for myopia control 
5.1 Introduction  
Optical biometry instrumentation is a critical tool for eye care practitioners in assessing 
keratometry (K), central corneal thickness (CCT), horizontal white-to-white (WTW) corneal 
diameter measurements, lens thickness (LT), anterior chamber depth (ACD), and axial length 
(AL); especially in relation to cataract and refractive surgery optical power planning (Rohrer et 
al., 2009; Akman et al., 2016; Young et al., 2018), glaucoma screening (Hashemi et al., 2005; 
Rosa et al., 2006; Dinc et al., 2010), specialty contact lens fitting and corneal shape analysis 
(Cho et al., 2002; Kamiya et al., 2014; Lloyd et al., 2014), and following myopia progression and 
control (Smith, 2013; Walline et al., 2017; Gifford et al., 2019). Although the IOLMaster 500’s 
(Carl Zeiss Meditec, Germany) partial coherence interferometry (PCI) technology has been 
established as the gold standard (Vogel et al., 2001), the newer swept-source optical coherence 
tomography (SS-OCT) approach, such as that used by the IOLMaster 700 (Carl Zeiss Meditec, 
Germany), has been shown to have many advantages, including faster analysis, the ability to 
measure CCT, LT, and both anterior and posterior structural curvatures, as well as higher 
accuracy performance with complicated patients (Tonn et al., 2014; Young et al., 2018; Haddad 
et al., 2020). Several studies have already reported on the excellent interchangeability, 
repeatability, and reproducibility of the IOLMaster 700 relative to the IOLMaster 500 in cataract 
patients (Srivannaboon et al., 2015; Akman et al., 2016; Kunert et al., 2016; Shammas et al., 
2016; Yoo et al., 2017; Lee & Kim, 2018; Bullimore et al., 2019; Moshirfar et al., 2019; Wang et 
al., 2019), but only one also included healthy children and adult groups (Huang et al., 2020).  
The report by the International Myopia Institute (IMI) committee on Clinical Myopia Control Trials 
and Instrumentation (Wolffsohn et al., 2019) provided best practice guidelines to assess myopia 
control intervention efficacy and mechanisms, as well as treatment and instrumentation 
development. Refractive error and axial length were classified as primary outcome measures. 
The literature has already established the strong correlation between increased axial length and 
myopia progression (Atchison et al., 2004; Saw et al., 2005; Richter et al., 2017), where diurnal 
variations (Stone et al., 2004; Read et al., 2008; Chakraborty et al., 2011), intraocular pressure 
(Leydolt et al., 2008; Read et al., 2011), and accommodation changes (Drexler et al, 1998; 
Read et al., 2010) must be accounted for during measurements. This is especially important, 
since a 0.1 mm change in axial length leads to a refractive change of ~0.3 D (Findl et al., 2003). 
In comparison to early axial biometry via ultrasound instrumentation limited to a resolution of 
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~0.30 D (Santodomingo-Rubido et al., 2002), accuracy of ~0.1 mm (Olsen, 1989), and 
repeatability of 95% limits of agreement (LoA) between 60.2 to 60.3 mm (Rudnicka et al., 1992; 
Chan et al., 2006; Hussin et al., 2006), current commercial optical biometers offer resolution of 
~0.03 D (Santodomingo-Rubido et al., 2002; Buckhurst et al., 2009), precision of ~0.01 mm 
(Drexler et al., 1998; Haigis et al., 2000; Santodomingo-Rubido et al., 2002), and repeatability of 
95% LoA of 60.04 mm (Chan et al., 2006; Hussin et al., 2006). Furthermore, some relevant 
exploratory measures indentified by this IMI white paper included anterior segment anatomical 
changes and biomechanics. Axial elongation is well correlated with a flatter corneal curvature 
(Chang et al., 2001; Fledelius & Goldschmidt, 2010; Park et al., 2010), whilst various studies 
have reported a deeper ACD in myopic populations (Hosny et al., 2000; Ucakhan et al., 2008; 
Park et al., 2010), as well as greater vitreous chamber volume (Orucoglu et al., 2015; Kasahara 
et al., 2017; Zong et al., 2017). Also, an association between axial elongation and weakened 
biomechanical properties of the posterior sclera (Saka et al., 2013) has been reported.  
Despite it being considered advantageous to be able to keep myopia control lenses in-situ, 
whilst performing measurements, in order to fully assess their demonstrated efficacy in exerting 
AL reduction (Walline et al., 2013; Lam et al., 2014; Chamberlain et al., 2019), studies by Lewis 
et al. 2008 (IOLMaster PCI; AL and K; undilated) and Ferrer-Blasco et al. 2019 (IOLMaster SS-
OCT; AL, CCT, ACD, and K; undilated) noted clinically significant changes with biometry 
through CLs compared to the naked eye. Hence CLs need to be removed to assess ocular 
biometry. The only study to examine the effect of prior soft CL wear on (undilated) ocular 
biometry (Goudie et al. 2018), immediately after removing contact lenses and then after 2, 4 and 
7 days of no contact lens use, concluding that any change in corneal shape did not significantly 
alter AL and K parameters. However, these were spherical lenses and lenses for myopia control 
have a more complex surface profile which could impact corneal topography and possibly axial 
length. Hence, this study investigated possible causes of these differences that may be 
attributed to the mentioned varying biometry technology, as well as the specialty optical dual 
focus and extended depth of focus designs (concentric ring design with alternating optical 
correction and treatment zones, simultaneously correcting the distance central myopia and 
exerting peripheral myopic defocus) of myopia control soft contact lenses (Ruiz-Pomeda et al., 
2018; Chamberlain et al., 2019).  
Thus, the clinical reliability of optical biometry instrumentation impacted by the post-wear of 
myopia control indicated soft contact lenses among healthy adults has not been previously 
investigated and warrants consideration towards improving myopia progression monitoring. The 
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purpose of this study was to evaluate the agreement between the IOLMaster 700 and 
IOLMaster 500 measurements in myopic eyes for axial length (AL), mean keratometry (Km), 
anterior chamber depth (ACD), and horizontal white-to-white (WTW) corneal diameter, after 
immediate MiSight and NaturalVue daily soft contact lens wear for myopia control, compared 
with a standard single vision Proclear lens. 
5.2 Methods  
5.2.1 Participants 
The study (single-centre, prospective, randomised, and double-masked) was conducted at the 
Aston University Ophthalmic Research Clinics, where 18 participants with myopia in good overall 
general and ocular health were recruited. This sample size was enough to obtain 80% statistical 
power for a significance level of α = 0.05 with a confidence level of 95%, based on an effect size of 
0.8 for the statistical analyses used in this study, published literature, and priori power analysis 
(G*Power 3.1, University of Dusseldorf). All participants gave informed written consent. All 
procedures followed the Declaration of Helsinki and the protocol was approved by the Aston 
University Research Ethics Committee.  
5.2.2 Study Lenses 
Two investigators compared the interchangeability between the IOLMaster 700 and IOLMaster 
500 for four measurement parameters (AL, Km, ACD, and WTW), after cycloplegia, and 
immediately following the removal of three different daily soft contact lenses (standard single 
vision Proclear® 1-Day [omafilcon A; hydrophilic; CooperVision, Inc.] for the control group, as 
well as MiSight® 1-Day [omafilcon A; hydrophilic, water content 60%; refractive index 1.40; 
CooperVision, Inc.; with center thickness of 0.08 mm at -3.00 D] and NaturalVue® 1-Day 
[etafilcon A; hydrophilic, water content 58%; refractive index 1.40; Visioneering Technologies, 
Inc.; with center thickness of 0.08 mm at -3.00 D] designed for myopia control for the test 
groups) via randomised coded letter (A, B, C) assignment (only the principal investigator had 
access to the lens assignments). 
5.2.3 Study Design 
Eligible participants visited twice on alternating days and in the same week, in order to implement a 
test group washout period in between, and so that each participant can be fitted with all three 
lenses. Participants were asked to attend for a morning visit (8:30 AM – 11:30 AM) and 8 hours 
later in the afternoon to allow for an adaptation period, mimic a typical work-day interval, and 
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consistency in diurnal variation. The two visits were each conducted by separate investigators, 
where the first investigator fitted the randomised contact lenses, whilst the second investigator 
performed the biometry measurements. The participants were unaware as to which lens and in 
which eye they were fitted during the visit.   
During the morning visit, Investigator 1 provided a copy of the informed consent and participant 
information sheet; confirmed eligibility (age range 18-35; prescription range -0.75 D to -4.50 D with 
astigmatism ≤ 1 D; spectacle, contact lens, and myopia control intervention history; as well as no 
relevant contraindication; and medical and ocular health history, including medications); and 
performed autorefraction (3 measurements were taken from each eye, whilst the participant viewed 
a distance non-accommodative target [Grand Seiko WAM-5500; Grand Seiko Co., Hiroshima, 
Japan]), best-corrected distance visual acuity (logMAR letter chart), slit-lamp biomicroscopy 
anterior eye examination, and randomised contact lens fitting. During the afternoon visit, 
Investigator 2 verified the distance visual acuity (logMAR letter chart); removed the contact lenses; 
applied cycloplegia (complete details of the drops were provided along with official College of 
Optometrists leaflet; the British National Formulary (BNF) number, expiration date, and time of 
instillation were recorded [1% Tropicamide; 1 drop/eye; minimum 20-minute waiting period]); 
performed cycloplegic-IOLMaster 500 (Carl Zeiss Meditec, Germany) and -IOLMaster 700 (Carl 
Zeiss Meditec, Germany) measurements for AL, Km, ACD, and WTW (>2.0 signal:noise or SNR), 
slit-lamp biomicroscopy anterior eye examination with fluorescein assessment; and concluded with 
a verbal debrief.  
5.2.4 Statistical Analyses 
The IOLMaster 700 and IOLMaster 500 agreement was evaluated by using Bland-Altman plots, 
where analyses were made with two tailed t tests (AL, Km, ACD, and WTW values with p<0.05 
were considered statistically significant) and 95% limits of agreement (LoA) as the mean 
difference ± 1.96 SD (narrow LoA was indicative of strong instrument interchangeability) in 
Microsoft Excel for Office 365 ProPlus (Microsoft Corp.). A Bland-Altman difference plot is a 
routinely used, standardised method of agreement analyses between quantitative 
measurements through the application of LoA. The normality of the data distributions was 
confirmed using the Kolmogorov-Smirnov test (P>0.05), enabling parametric statistical 
analyses. 
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5.3 Results  
From the 18 subjects included in the study, the pool consisted of the following demographics: 15 
women and 3 men (12 British Asian and 6 white European); mean age of 22.8 years ± 4.1 
(range 18 to 35 years); mean spherical equivalent refraction (SER) of -2.4 ± 1.3 D (range -0.75 
to -4.50 D); there were no adverse events. 
5.3.1 Agreement 
The mean difference and standard deviation, two tailed t test for the differences and their 
significance, and 95% confidence interval of lower and upper LoA based on ± 1.96 SD between 
the IOLMaster 700 and IOLMaster 500 for 4 parameters (AL = axial length; Km = mean 
keratometry; ACD = anterior chamber depth; WTW = horizontal [white-to-white] corneal 
diameter) are represented by Tables 5.1-5.3 for a post-wear Proclear, MiSight, and NaturalVue 
lens. The mean difference ± SD WTW (mm) values taken by the newer IOLMaster 700 were 
statistically significant and had wide 95% LoA, when measured from the post-wear MiSight (-
0.21 ± 0.23; -0.66. 0.24) and NaturalVue (-0.19 ± 0.41; -1.00. 0.62) daily soft contact lenses for 
myopia control test groups, compared with the IOLMaster 500 and post-wear standard single 
vision Proclear (-0.07 ± 0.49; -1.02. 0.89) lens control group. Bland-Altman plots (Figures 5.1-
5.12) implied good comparison agreement for all other parameters between the two instruments 
(where those mean differences were not significantly different from zero and with narrow 95% 
confidence interval of limits of agreement) and may be used interchangeably. This study 
evaluated clinical / “real world” correlations and comparisons of agreement via t tests, p values, 
95% LoA, and Bland-Altman plots, instead of assessing repeatability and reproducibility.  
Parameter Mean Difference ± 
SD 
P Value* 95% LoA 
AL (mm) -0.004 ± 0.06 .25 -0.13. 0.12 
Km (mm) -0.01 ± 0.02 .78 -0.05. 0.03 
ACD (mm) -0.07 ± 0.05 0.13 -0.17. 0.03 
WTW (mm) -0.07 ± 0.49 0.12 -1.02. 0.89 
Table 5.1. The reported post-wear Proclear lens mean difference and standard deviation, two 
tailed t test for the differences and their significance, and 95% confidence interval of lower and 
upper limits of agreement based on ± 1.96 SD between the IOLMaster 500 and IOLMaster 700; 
AL = axial length; Km = mean keratometry; ACD = anterior chamber depth; WTW = horizontal 
(white-to-white) corneal diameter. 
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Figure 5.1. Bland-Altman plots for axial length comparison between the IOLMaster 500 and 
IOLMaster 700 with the post-wear Proclear lens. The mean difference is designated by the solid 
line. The 95% confidence interval of the upper and lower limits of agreement based on ± 1.96 
SD are designated by the dotted lines.  
 
 
Figure 5.2. Bland-Altman plots for mean keratometry comparison between the IOLMaster 500 
and IOLMaster 700 with the post-wear Proclear lens. The mean difference is designated by the 
solid line. The 95% confidence interval of the upper and lower limits of agreement based on ± 
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Figure 5.3. Bland-Altman plots for anterior chamber depth comparison between the IOLMaster 
500 and IOLMaster 700 with the post-wear Proclear lens. The mean difference is designated by 
the solid line. The 95% confidence interval of the upper and lower limits of agreement based on 
± 1.96 SD are designated by the dotted lines.  
 
 
Figure 5.4. Bland-Altman plots for the horizontal (white-to-white) corneal diameter comparison 
between the IOLMaster 500 and IOL Master700 with the post-wear Proclear lens. The mean 
difference is designated by the solid line. The 95% confidence interval of the upper and lower 
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Parameter Mean Difference ± 
SD 
P Value 95% LoA 
AL (mm) -0.002 ± 0.02 .58 -0.05. 0.04 
Km (mm) -0.01 ± 0.02 .77 -0.05. 0.03 
ACD (mm) -0.07 ± 0.07 0.33 -0.2. 0.07 
WTW (mm) -0.21 ± 0.23 0.02* -0.66. 0.24 
Table 6.2. The reported post-wear MiSight lens mean difference and standard deviation, two 
tailed t test for the differences and their significance, and 95% confidence interval of lower and 
upper limits of agreement based on ± 1.96 SD between the IOLMaster 500 and IOLMaster 700; 
AL = axial length; Km = mean keratometry; ACD = anterior chamber depth; WTW = horizontal 
(white-to-white) corneal diameter; * = p<0.05. 
 
 
Figure 5.5. Bland-Altman plots for axial length comparison between the IOLMaster 500 and 
IOLMaster 700 with the post-wear MiSight lens. The mean difference is designated by the solid 
line. The 95% confidence interval of the upper and lower limits of agreement based on ± 1.96 
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Figure 5.6. Bland-Altman plots for mean keratometry comparison between the IOLMaster 500 
and IOLMaster 700 with the post-wear MiSight lens. The mean difference is designated by the 
solid line. The 95% confidence interval of the upper and lower limits of agreement based on ± 
1.96 SD are designated by the dotted lines.  
 
 
Figure 5.7. Bland-Altman plots for anterior chamber depth comparison between the IOLMaster 
500 and IOLMaster 700 with the post-wear MiSight lens. The mean difference is designated by 
the solid line. The 95% confidence interval of the upper and lower limits of agreement based on 
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Figure 5.8. Bland-Altman plots for the horizontal (white-to-white) corneal diameter comparison 
between the IOLMaster 500 and IOLMaster 700 with the post-wear MiSight lens. The mean 
difference is designated by the solid line. The 95% confidence interval of the upper and lower 
limits of agreement based on ± 1.96 SD are designated by the dotted lines.  
 
Parameter Mean Difference ± 
SD 
P Value 95% LoA 
AL (mm) 0.004 ± 0.01 .09 -0.02. 0.02 
Km (mm) -0.02 ± 0.01 .39 -0.05. 0.01 
ACD (mm) -0.04 ± 0.06 0.06 -0.16. 0.08 
WTW (mm) -0.19 ± 0.41 0.01* -1.00. 0.62 
Table 5.3. The reported post-wear NaturalVue lens mean difference and standard deviation, 
two tailed t test for the differences and their significance, and 95% confidence interval of lower 
and upper limits of agreement based on ± 1.96 SD between the IOLMaster 500 and IOLMaster 
700; AL = axial length; Km = mean keratometry; ACD = anterior chamber depth; WTW = 
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Figure 5.9. Bland-Altman plots for axial length comparison between the IOLMaster 500 and 
IOLMaster 700 with the post-wear NaturalVue lens. The mean difference is designated by the 
solid line. The 95% confidence interval of the upper and lower limits of agreement based on ± 
1.96 SD are designated by the dotted lines.  
 
 
Figure 5.10. Bland-Altman plots for mean keratometry comparison between the IOLMaster 500 
and IOLMaster 700 with the post-wear NaturalVue lens. The mean difference is designated by 
the solid line. The 95% confidence interval of the upper and lower limits of agreement based on 
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Figure 5.11. Bland-Altman plots for anterior chamber depth comparison between the IOLMaster 
500 and IOLMaster 700 with the post-wear NaturalVue lens. The mean difference is designated 
by the solid line. The 95% confidence interval of the upper and lower limits of agreement based 
on ± 1.96 SD are designated by the dotted lines.  
 
 
Figure 5.12. Bland-Altman plots for the horizontal (white-to-white) corneal diameter comparison 
between the IOLMaster 500 and IOLMaster 700 with the post-wear NaturalVue lens. The mean 
difference is designated by the solid line. The 95% confidence interval of the upper and lower 
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5.4 Discussion  
This study evaluated the agreement between the IOLMaster 700 and IOLMaster 500 
measurements in myopic eyes for axial length (AL), mean keratometry (Km), anterior chamber 
depth (ACD), and horizontal white-to-white (WTW) corneal diameter, after cycloplegia, 
immediately following the removal of three different daily soft contact lenses; standard single 
vision Proclear® 1-Day, as well as MiSight® 1-Day and NaturalVue® 1-Day designed for 
myopia control. This is considered the first study to investigate optical biometer instrument 
validation impacted by the post-wear of myopia control indicated soft contact lenses and 
specifically focused on the relative parameters.  
The mean difference ± SD WTW (mm) values taken by the IOLMaster 700 with its SS-OCT 
technology were statistically significant and had wide 95% LoA, when measured from the post-
wear MiSight (-0.21 ± 0.23; -0.66. 0.24) and NaturalVue (-0.19 ± 0.41; -1.00. 0.62) contact 
lenses, compared with the IOLMaster 500 and post-wear standard Proclear lens (-0.07 ± 0.49; -
1.02. 0.89). However, the discrepancy in WTW values between the IOLMaster 700 and 
IOLMaster 500 with the post-wear MiSight and NaturalVue contact lenses alone were minimal 
and clinically irrelevant, implying agreement. Bland-Altman plots suggested good comparison 
agreement for all other parameters (AL, Km, ACD) between the two instruments, across all 
post-wear contact lenses used, and may be used interchangeably. These WTW differences may 
be attributed to the overall varying technology in measurement, as previously suggested by Cho 
et al. (2018) in their comparison of the IOLMaster 700 with the Galilei G4 from cataract eyes, or 
the PCI with the Tomey OA-2000 using SS-OCT in healthy adults (Huang et al., 2017; Hua et 
al., 2018) and the AL-Scan in cataract eyes (Huang et al., 2014), stating the impact of grey-
scale image processing discrepancies and limbus detection sensitivity by any imposed darkness 
(device / eyelash / nose shadow), as possible causes. In addition to cataract patients, the only 
other evaluation of confirmed biometric measurement reliability with the IOLMaster 700 using 
SS-OCT, relative to the IOLMaster 500, as well as also including healthy adults and the WTW 
parameter is by Huang et al. (2020). The authors consistently noted excellent repeatability and 
reproducibility between the two devices for all parameters (AL, Km, ACD) in all three groups, 
besides WTW values among cataract patients (corneal arcus was reported to result in dimmer 
central boundaries).   
Lewis et al. (2008) previously validated the IOLMaster’s PCI repeatability and reliability for AL 
and Km in healthy myopic eyes fitted with soft contact lenses of -0.50 D (cast-molded 
SofLens38 [polymacon; hydrophilic, water content 38%; refractive index 1.43; Bausch & Lomb; 
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with center thickness of 0.035 mm] and the soft-molded Acuvue2 [etafilcon A; hydrophilic, water 
content 58%; refractive index 1.40; Johnson & Johnson; with center thickness of 0.119 mm]), 
relative to the naked eye. The study was interested in the possible coupling of soft contact 
lenses (as ideal optical interfaces) with PCI biometry in patients with corneal irregularities, 
inadequate fixation, and severe cataracts, before and after cataract surgery and Descemet’s 
stripping with endothelial keratoplasty (DSEK), which otherwise leads to unpredictable 
measurements. The authors noted the corresponding increased AL measures, as well as 
associated change in precorneal tear layer and central corneal thicknesses (which were 
correlated with the K differences), with the contact lens manufacturing method, thickness and 
higher water-content attributes. A different and more recent study by Goudie et al. (2018) 
investigated the effect of the specific cessation duration of soft contact lenses on IOLMaster 
biometry, concluding that any change in corneal shape did not significantly alter AL and K 
parameters. The only evaluation of confirmed biometric measurement reliability with the 
IOLMaster 700 using SS-OCT on eyes with soft contact lenses (hilafilcon B; hydrophilic, water 
content 59%; refractive index 1.40) was by Ferrer-Blasco et al. (2019), performed only on eight 
subjects with healthy eyes. This study was interested in the interaction of soft contact lenses 
with OCT biometry measurements, as a prelude to the use of specialty therapeutic (ocular drug 
delivery) or bandage (corneal epithelial healing) contact lenses, when not removed for 
assessments. Although there was no reported LT difference between soft contact lens wear and 
the naked eye (where contact lenses of varying optical powers may impose specific 
accommodation requirements in eyes without cycloplegia and possibly result in LT differences), 
increased changes in AL, CCT, ACD, and K were statistically significant, which the authors 
attributed to the individual contact lens thickness and optical design discrepancies, as described 
earlier by Lewis et al. (2008). This study is of particular interest regarding any future biometry 
evaluation with myopia control indicated soft contact lenses in-situ and assessing the possible 
impact on the crystalline lens, considering MiSight and NaturalVue are of similar material, water 
content, and refractive index.    
Previous studies involving IOLMaster validation have noted the following: a significantly flatter 
Km from the RK-F1 AutoRef-Keratometer in children of age 6 (Huynh et al., 2006) and the 
Lenstar OLCR assessed on cataract eyes (Chen et al., 2011) relative to the IOLMaster; 
interchangeable agreement in K and ACD values between the Lenstar OLCR, IOLMaster, and 
an A-scan ultrasonographer (Salouti et al., 2011); high repeatability, reproducibility, and 
agreement for corneal power from a comprehensive assessment of 8 devices (Wang et al., 
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2012), as well as when comparing the Keratograph 4, Pentacam HR, and IOLMaster (Mao et 
al., 2013), and the OphthaTOP, Pentacam HR, and IOLMaster (Huang et al., 2015) in normal 
eyes, without clinically significant differences. Mehravaran et al. (2014) compared the 
keratometry repeatability and agreement of the previous gold standard manual Javal 
keratometer with the IOLMaster, Pentacam, Topcon, and EyeSys instruments, stating that the 
IOLMaster had the best repeatability for minimum and maximum keratometry measurements. 
Other studies have further noted the IOLMaster’s accuracy and reliability for IOL power 
calculation in regular cataract patients (Olsen, 2007; Hsieh & Wang, 2012), as well as those 
also having high myopia (Roessler et al., 2012), although difficulty with abnormal eyes has been 
previously reported (Freeman & Pesudovs, 2005; McAlinden et al., 2015). Moreover, a 
comprehensive literature review by Dominguez-Vicent et al. (2016), specified device 
interchangeability for measuring ACD and WTW in healthy eyes among the following: A-scan 
ultrasound, Orbscan and Orbscan II, Pentacam and Pentacam HR, Galilei, Visante OCT, 
IOLMaster, and Lenstar LS 900.   
Regarding studies specifically investigating the interchangeability, repeatability, and 
reproducibility of the IOLMaster 700 and IOLMaster 500, Akman et al. (2016) did so by 
comparing AL, ACD, K, and failure rate measurements on cataract eyes, reporting excellent 
agreement, but significantly higher acquisition rate via the IOLMaster 700’s SS-OCT technology; 
which was able to overcome the IOLMaster 500’s PCI limitations, particularly in groups with 
advanced cataracts. In a prospective, multi-centre study on elderly patients undergoing cataract 
surgery, Kunert et al. (2016) noted a high repeatability between the IOLMaster 700 and 
IOLMaster 500 for AL, ACD, and spherical equivalent (SE), and for CCT and LT with the 
Lenstar OLCR. Cho et al. (2018) evaluated the agreement in cataract eyes between the 
IOLMaster 700 and IOLMaster 500, A-scan for AL; and Galilei G4, A-scan for ACD; and Galilei 
G4 for WTW; and Galilei G4, manual keratometer, automated refractor for Km. The study also 
concluded a higher acquisition rate over the IOLMaster 500, as well as outstanding agreement 
for AL and Km; for ACD between the IOLMaster 700 and Galilei G4, but poor correlation for the 
A-scan with either instrument; and no interchangeability with the Galilei G4 for WTW. However, 
Yang et al. (2017) found a longer AL from the IOLMaster 700 compared to the IOLMaster 500 in 
myopic eyes, emphasising its greater precision in patients with posterior staphyloma of good 
fixation status. The overall literature comparing the IOLMaster 700 and IOLMaster 500 is 
limited, particularly outside of cataract populations, but these authors suggested AL 
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discrepancies may be due to fixation loss, which is not necessarily evaluated by the IOLMaster 
500.     
Therefore, this study’s firstly comparative evaluation also confirmed good clinical agreement 
between the IOLMaster 700 and IOLMaster 500 for AL, Km, ACD, and WTW measured on the 
myopic eyes of healthy adults, following daily soft contact lens (standard and specialty for 
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Chapter 6 Are soft contact lenses a viable source for human dopamine levels 
measurement using the ELISA dopamine kit? 
6.1 Introduction  
Myopia has been well established as a worldwide epidemic and high myopia (≥6 D or axial 
length ≥26 mm) is one of the leading causes of global blindness (Holden et al., 2016). Although 
optical myopia may be corrected by optical and surgical interventions, high myopia still is not 
completely preventable or treatable (Bosch-Morell et al., 2015). The International Myopia 
Institute (IMI) – Myopia Genetics Report (Tedja et al., 2019) confirmed refractive error and 
myopia predisposition is due to both genetics and environmental risk factors (near work and 
outdoor exposure; specifically education holding most prominence), as well as a light-
processing retina-to-sclera molecular mechanism for common myopia development. A key 
meta-analysis and systemic review by Xiong et al. (2017), also noted increased time outdoors to 
be effective in preventing myopia onset and slowing the myopic shift, but not in controlling 
progression. French et al. (2013) previously suggested that the preventative mechanism of 
increased outdoor activity is related to reduced accommodative demand, bigger depth of focus, 
improved contrast, higher levels of Vitamin D (Mutti & Marks, 2011; Choi et al., 2014; Tideman 
et al., 2016a) and retinal dopamine acting against form-deprivation myopia. However, the 
mechanisms behind these protective effects remain unresolved, which may be vital to slowing 
childhood myopia progression and lead to more proficient clinical management.   
The dopamine (DA) retinal neurotransmitter is part of the signalling cascade that regulates eye 
growth (Feldkaemper & Schaeffel, 2013), where its increased levels during the day and with 
higher light intensity have been shown to inhibit axial elongation upon emmetropisation 
(Nebbioso et al., 2014), and has been recognised to be critical for light adaptation and 
preventing myopia (Teves et al., 2014). Although human DA levels could be measured from 
biological fluids such as blood plasma, cerebrospinal fluid (CSF) and urine (Suominen et al., 
2013), tear fluid sample extraction through the commonly used Schirmer strips and capillary 
tubes (Dumortier & Chaumeil, 2004; Shetty et al., 2016; Shetty et al., 2017) has been preferred 
for its non-invasive nature (Sharma et al., 2019). This is especially beneficial to longitudinal 
studies with pediatric patients, where compliance is of paramount importance. However, 
comparative investigation of the non-invasive Schirmer strip and capillary tube sampling 
techniques for human tear fluid has been mixed. Capillary tube collection was perceived as less 
invasive, since Schirmer strips have been reported to induce irritation and further reflex tear 
secretion (Choy et al., 2001), as well as damage conjunctival cells (van Setten et al., 1990), 
which may all affect the true tear concentrations. On the other hand, the Schirmer strip 
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technique was reported to be quick, simple, and precise (Small et al., 2000), whilst the capillary 
tube extraction was more aggressive and irritable, posing a higher injury risk. More recently, 
Posa et al. (2012) concluded that the difference of tears from Schirmer strips containing higher 
protein composition was minimal, and although both methods were efficient and suitable for 
non-invasive human tear fluid analysis, Schirmer strips were quicker, simpler, and perceived as 
having a more pleasant sensation by patients.         
 
The proteins found in human tear fluid have long been identified as non-invasive biomarkers for 
numerous conditions (Hagan et al., 2016), including cancers (Evans et al., 2001) and diabetes 
(Herber et al., 2001), as well as eye-specific pathologies (blepharitis [Koo et al., 2005]; allergic 
conjunctivitis [Li et al., 2010]; keratoconus [Acera et al., 2011]; and pterygium [Zhou et al., 2009] 
among others). Likewise, abnormal DA levels have been linked to Parkinson’s (Dirkx et al., 
2017); Alzheimer’s (Yates et al., 1979); schizophrenia (Brisch et al., 2014); epilepsy (Starr, 
1996); and various ocular diseases (myopia [Feldkaemper & Schaeffel, 2013]; glaucoma 
[Bucolo et al., 2018]; and dry eye [Lemon & Shah, 2013]. Research on DA detection from 
human tears is scarce (Van Haeringen, 1981; Trope & Rumley, 1984; Sharma et al., 2019) and 
only that by Sharma et al. (2019) has evaluated the use of the direct competitive 
chemiluminescent enzyme-linked immunosorbent assay (ELISA; [Cloud Clone Corp, TX, USA]) 
dopamine kit, as an alternative quantification method. Soft multifocal contact lenses have been 
successful to reduce myopia and axial length progression in children and young adults via 
peripheral defocus (Walline et al., 2013; Lam et al., 2014; Chamberlain et al., 2019). Willcox 
(2019) summarised the literature showing the many tear film proteins adsorbing on contact 
lenses, which varied with the material (Saville et al., 2010; Babaei et al., 2011; Brown et al., 
2013), patient (Omali et al., 2013), modality (Willcox et al., 2002), as well as whether a 
disinfectant was used or if there were other proteins (Chao et al., 2019). Moreover, Willcox 
(2019) noted that besides fibronectin, phospholipids, secretory immunoglobulin A, and 
cholesterol, tear film biochemistry was not affected by contact lens wear.    
 
Thus, the purpose of this study was to (1) assess the viability of daily soft contact lenses 
(MiSight and NaturalVue for myopia control, as well as a standard single vision Proclear lens) to 
be used as a non-invasive vehicle for DA measurements in human tears and (2) optimise the 
ELISA-based dopamine kit methodology for ex vivo lenses and future applications, since the 
effect of other tear components on the DA assay has yet to be determined. This exploratory/pilot 
study is considered the first of its kind – investigating the potential for an additional non-
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invasive, efficient, and reliable tool to monitor local DA status, which may become an integral 
early diagnostic clinical component in the fight against myopia. 
 
6.2 Methods  
6.2.1 Participants 
This exploratory/pilot study (single-centre, prospective, randomised, and double-masked) was 
conducted at the Aston University Ophthalmic Research Clinics, where 18 participants with 
myopia in good overall general and ocular health were recruited. This sample size was enough 
to obtain 80% statistical power for a significance level of α = 0.05 with a confidence level of 95%, 
based on an effect size of 0.8 for the statistical analyses used in this study, published literature, 
and priori power analysis (G*Power 3.1, University of Dusseldorf). All participants gave informed 
written consent. All procedures followed the Declaration of Helsinki and the protocol was 
approved by the Aston University Research Ethics Committee.  
 
6.2.2 Study Lenses 
The three different daily soft contact lenses used in this study were: standard single vision 
Proclear® 1-Day (CooperVision, Inc.), as well as MiSight® 1-Day (CooperVision, Inc.) and 
NaturalVue® 1-Day (Visioneering Technologies, Inc.) designed for myopia control. These 
lenses were randomised via coded letter (A, B, C) assignment (only the principal investigator 
had access to the lens assignments). Equal unworn number of these lenses were used as the 
control sample group.  
6.2.3 Study Design 
Eligible participants were asked to attend for a morning visit (8:30 AM – 11:30 AM) and 8 hours 
later in the afternoon to allow for an adaptation period, mimic a typical work-day interval, and 
consistency in diurnal variation. The first investigator fitted the randomised contact lenses in the 
morning and removed these 8 hours later. The lenses were then stored in random order, in a 
beaker that was either dry, or instilled with a saline solution just fully covering the lens. The 
beakers were sealed, labelled, and transferred to the Biomaterials Research Unit (BRU) within 
48 hours for tear sample analysis by a second investigator; the fluid envelop and ocular species 
associated with each lens on removal allows analysis of tear proteins and lipids, without tear 
fluid stimulation. The participants were unaware as to which lens and in which eye they were 
fitted during the visit.   
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6.2.4 Measurement of tear dopamine 
Total dopamine levels in the tear fluid from the lenses were quantified using a direct competitive 
chemiluminescent enzyme-linked immunosorbent assay (ELISA) dopamine kit.  
The methodology sequence was: (1) lens removed from eye; (2) tear fluid (envelop) extracted into 
phosphate-buffered saline (PBS) solution in a sterile 1.5 ml microcentrifuge tube at 4°C for 1.5 
hours; (3) the tear extract in saline was quantified using an ELISA dopamine kit (ENZO Life 
Sciences) where positive results were shown as blue colouration (each plate has 96 wells, where 
the first 16 are used to create the standard curve); (4) plate read in spectrometer (SpectraMax 2; 
Molecular Devices Corp., CA, USA), where each sample was run in duplicate with each well read 9 
times; (5) averaged absorbance values for the samples converted to concentrations using the 
standard curve (This study used 3 plates in total).   
6.2.5 Statistical Analyses  
The data was reported as means and standard deviations, or as median with the corresponding 
range. P<0.05 was considered of statistical significance. 
 
6.3 Results 
From the 18 subjects included in the study, the pool consisted of the following demographics: 15 
women and 3 men (12 British Asian and 6 white European); mean age of 22.8 years ± 4.1 
(range 18 to 35 years); mean spherical equivalent refraction (SER) of -2.4 ± 1.3 D (range -0.75 
to -4.50 D); there were no adverse events.  
6.3.1 Tear dopamine levels 
The tear DA level (Table 6.1) extracted from Plate 1 was 354.1 ± 49.3 pg/ml (mean ± SEM) with 
a value range of 268.9 and 484.8 pg/ml (median, 333.3 pg/ml). In comparison, this was lower 
than Plates 2 & 3 with a DA level of 485.8 ± 44.6 pg/ml (mean ± SEM), and a value range of 415 
and 569.1 pg/ml (median, 477 pg/ml). Thus, Table 6.1 showed the collection variation between 
the three plates, prior continued standardisation, where collections for Plates 2 & 3 were better 
controlled, despite being comparative to previous studies using Schirmer strips and capillary 
tubes.    
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Plates 2 & 3) Schirmer Capillary 
Mean 354.1 485.8 279 470.4 
Min 268.9 415 152 254.7 
Max 484.8 569.1 519.1 845.0 
Median 333.3 477 273.2 428.4 
SD ± 49.3 ± 44.6 ± 14.8 ± 37.6 
Table 6.1. Comparison of tear DA levels (pg/ml), as well as comparative Schirmer strip and 
capillary tube values from Sharma et al. (2019). 
 
Table 6.2 showed the differences between the daily soft contact lenses used in the current 
study, reflecting the results obtained only from the standardised set (Plates 2 & 3). Proclear DA 
was 491.5 ± 48.1 pg/ml (mean ± SEM) with a value range of 415 and 569.2 pg/ml (median, 
479.2 pg/ml); MiSight DA was 482.5 ± 47.2 pg/ml (mean ± SEM) with a value range of 415.2 
and 547.4 pg/ml (median, 470.2 pg/ml); NaturalVue DA was 488.5 ± 42.9 pg/ml (mean ± SEM) 
with a value range of 405.5 and 556.9 pg/ml (median, 486.4 pg/ml). Thus, similar DA levels 
were obtained, irrespective of the contact lens type, suggesting lens material was not a factor.  
    
 Proclear MiSight NaturalVue 
Mean 491.5 482.5 488.5 
Min 415 415.2 405.5 
Max 569.2 547.4 556.9 
Median 479.2 470.2 486.4 
SD ± 48.1 ± 47.2 ± 42.9 
Table 6.2. Comparison of tear DA levels (pg/ml) between the different contact lenses extracted 
from Plates 2 & 3. 
 
6.4 Discussion  
 
Although the DA values were within the range reported by the only other recent study (Sharma 
et al., 2019) with human tears DA values using ELISA, the recovery rate from the Schirmer 
strips was less, emphasising one of the indications for contact lenses being used as a probe to 
remove the tear envelope. Sharma et al. (2019) further noted that the tear DA level from both 
Schirmer strips and capillary tubes was significantly higher relative to plasma fluids, specifically 
stated as 3.9 ± 0.84 (mean ± SEM) and 6.2 ± 0.85 (mean ± SEM) fold higher respectively. 
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Additionally, the authors showed 80% of the subjects had >1.2 fold higher tear DA levels from 
the capillary tubes, relative to the Schirmer strips.   
 
DA measured from plasma and urine has been originally implemented by high-performance 
liquid chromatography (HPLC) with fluorescence (Peaston & Weinkove, 2004; Tsunoda, 2006; 
Pussard et al., 2009). A study by Nichkova et al. (2013) on the validation of a competitive ELISA 
for urinary DA samples did report high specificity, good precision, reliability and efficiency for the 
analysis and monitoring of a pathological DA system such as Parkinson’s disease, which was 
well-correlated to liquid chromatography tandem mass spectrometry (LC-MS/MS; the more 
recently preferred method [Kushnir et al., 2002; de Jong et al., 2011; Moriarty et al., 2011]). 
Although immunoassays have been considered being more efficient than LC-MS/MS, research 
has reported on associated drawbacks when applied to biological fluids, such as an oxidising 
tendency, specific antibody requirement, and low physiological concentrations (Peaston & 
Weinkove, 2004; Kim et al., 2008, 2010). Furthermore, You et al. (2015) compared the 
quantification of human tear lactoferrin between ELISA and multiple reaction monitoring (MRM) 
mass spectrometry in prostate cancer patients, noting that despite tear fluid analysis being 
limited by the small available tear volumes of ≤10 µl, the amounts of lactoferrin were 
comparable to the published literature. A previous study examining the tear film in patients with 
keratoconus with a capillary tube and specific ELISAs concluded that the differences in tear 
proteomics had no correlation with age, gender, or contact lens wear (Balasubramanian et al., 
2012).   
 
Therefore, data from this exploratory/pilot study informed the following: (1) daily soft contact 
lenses proved to be viable non-invasive tear envelope sampling vehicles for human DA 
detection; (2) lens type was not a factor, as the detected DA levels were well correlated for all 
contact lenses used in this study; (3) ELISA successfully detected DA; (4) values were similar to 
those reported previously from tears obtained with Schirmer’s strips and capillary tubes, but 
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Chapter 7 Conclusions 
 
This thesis explored novelty utilization methods of some of the latest myopia control strategies 
available with a scope on assessing and managing the individual short-sighted patient.  
 
Despite the negative worldwide myopia outlook, as well as the notable escalation of practitioner 
concern and treatment activity, the global trends survey showed that appropriate management 
and standardisation remain poor. Moreover, treatment is not implemented early enough, whilst 
practitioner education and access to regulated myopia control options are still inadequate. The 
following research chapters probed the viability of such “labelled” and/or gold standard medical 
device and instrumentation options towards their application in individual patient treatment.  
 
For instance, percentile growth curves and charts demonstrated that there may be a clinically 
manifesting myopia-related near phoria control target across the human lifespan, including 
possible associated differences in sex and within progressive myopes. This study intended to 
better understand myopia prediction and its progression by suggesting that the near phoria risk 
factor should be measured alongside other primary outcome parameters important for individual 
treatment efficacy.  
 
In studying the only daily CE-marked optical myopia control strategies, it was evident that 
MiSight and NaturalVue MFSCLs achieved myopic retinal defocus differently. These findings 
may be extended to comparisons of all concentric and peripheral gradient contact lens types, 
suggesting that except for the possibility of a causal effect by these factors with NaturalVue, 
reduced hyperopic blur and accommodative lag appeared only to be byproducts of the optical 
design in other contact lenses influencing myopia progression. The optical design of multifocal 
contact lenses also directly influenced visual quality and although glare was significantly 
impacted, contrast sensitivity, treatment compliance and quality of life expectations were 
undeterred.   
 
The evaluation of the agreement between the gold standard optical biometers investigated the 
impact by the post-wear of myopia control indicated soft contact lenses, after cycloplegia. 
Findings reported good interchangeability for all other parameters (AL, Km, ACD) between the 
two instruments, where WTW differences were attributed to the overall varying technology in 
measurement, as well as the impact of grey-scale image processing discrepancies and limbus 
detection sensitivity by any imposed darkness. The overall literature comparing the IOLMaster 
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700 and IOLMaster 500 is limited in myopic populations. Thus, this study should be of particular 
interest regarding any future biometry evaluation with myopia control indicated soft contact 
lenses in-situ and assessing the possible impact on the crystalline lens. 
 
The exploratory/pilot study informed that daily soft contact lenses are viable non-invasive tear 
envelope sampling vehicles for human DA detection. This suggested that practitioners may 
have an additional tool to monitor local DA status, which may become an integral early 
diagnostic clinical component in the fight against myopia.  
 
This thesis intended to contribute to the growing innovative developments in the field of myopia. 
The IMI white papers should be used in conjunction by all professionals interested in this topic. 
The global myopia problem is not going anywhere and such efforts at dissecting the individual 
utility potential by each control strategy must be pursued.  
 
7.1 Limitations & Future Direction 
 
 
7.1.2 Global trends in myopia management attitudes and strategies in clinical practice – 2019 
update  
Future similar studies should note the many strengths (cheap, practical, quick, simple, scalable, 
standardised, anonymous, valid, reliable) and limitations (room for dishonesty, allows user 
interpretation, accessibility constraints, response fatigue) of online questionnaires, as a 
methodology.  
 
7.1.3 Clinical myopia-related near phoria magnitude and variability across the human lifespan 
among Canadians  
Like Chen et al. (2016), the attributes in this exploratory study were specific to the examined 
cross-sectional WatES database. Future efforts should implement equal sample sizes for all 
groups; ethnicity and prevalence levels towards international validation and translation; data for 
ages before 10; further centiles (2nd, 5th, 10th, 25th, 75th, 90th, 95th, and 98th); receiver 
operating characteristic (ROC) analysis for model validation by including sensitivity and 
specificity, as well as positive predictive value (PPV) diagnostic testing of the near phoria 
percentile curves. Additional consideration of risk factors such as optical biometry (Jones et al., 
2005; Tideman et al., 2018; Diez et al., 2019; Rozema et al., 2019), near work activity (Rose et 
al., 2008; French et al., 2013), genetics (parental myopic history [Negrel et al., 2000; Baird et al. 
2010]) and environmental (Rose et al., 2008; Morgan et al., 2018) into the model is also 
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warranted. It would be of value to make future comparisons to the myopic SER reversal in the 
late 20s reported by various studies (Irving et al., 2019).  
7.1.4 Impact of blur from a dual focus and an extended depth of focus contact lens 
Limitations from this study, regarding the measure of peripheral refraction and accommodative 
lag stem from the cohort (young adults and not children) and the use of the Grand Seiko WAM-
5500, which is affected by the contact lens optical design. Future studies should consider the 
following: other lens designs and of different powers; peripheral defocus effects in other retinal 
locations; disability glare and dysphotopsia under further conditions; varying contact lens wear 
periods to understand the natural time course of such parameter changes; richer demographics 
for a better balance between the sexes, ethnicities, age groups, and eyes of varying complexity 
and severity; inclusion of subjects with binocular vision ailments; adding fixation status, ocular 
alignment, or lens decentration as stand-alone parameters; the implementation of a multi-
centre, longitudinal clinical trial.      
7.1.5 IOLMaster agreement evaluation in healthy adults, comparing ocular biometry 
measurements, after immediate soft contact lens wear for myopia control 
Sources of analysis variability consisted of the following: the timing of post-lens wear 
measurements was not standardised and future studies should measure exactly the time 
between lens removal and parameter measurement. 
Future instrument validation studies on the IOLMaster 700 may consider the following: a follow-
up study with peripheral off-axis measurements and the plausible inquiry into the effect of 
varying contact lens cessation periods; study the comparison with myopia control soft contact 
lenses in-situ to assess the possible impact on off-axis measurements, crystalline lens, or post-
lens tear film and associated refractive index changes of similar and different contact lens 
materials; investigate the repeatability and reproducibility for other specialty contact lenses such 
as orthokeratology and sclerals, considering appropriate timespans across the set of visits; 
implement different optical powers and richer demographics to incorporate a better balance 
between the sexes, as well as additional ethnicities, age groups, and eyes of varying complexity 
and severity; inclusion of lens status, but especially fixation status as a stand-alone parameter; 
astigmatism and vector analysis relative to toric IOL; the implementation of a multi-centre trial. 
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7.1.6 Are soft contact lenses a viable source for human dopamine levels measurement using 
the ELISA dopamine kit?  
Sources of analysis variability consisted of the following: some data was incomplete, since 
lenses stored in saline solution were in variable volumes and too large for the detection limit, 
hence, dry lens collection is recommended; although stored at the same temperature (-80°C 
degrees), the storage time interval between lens collection and analysis was longer for plate 1 
than plates 2 and 3, therefore, lenses should be placed directly into the extraction (where 
volume of 300 µl is recommended) microtube of an ELISA plate to reduce degradation.  
 
Future studies should explore the following: whether there is a significant drop in dopamine if 
contact lenses were to be worn only for a shorter daytime period and/or in the evening/overnight 
to note any diurnal variations; the application of a microcuvette to enable direct use of a 300 µl 
dopamine extract and other ocular biomarkers via ELISA, without following ex vivo lens 
extraction and possibly make the analysis more sensitive to lower dopamine levels; collect tear 
fluid using Schirmer’s strips and capillary tubes on the same visit for alternative sampling 
technique control comparison; include a richer patient demographic and larger cohort, in order 
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1. Background and Rationale 
Myopia, and its increasing global prevalence, has been described as a global epidemic; 
a condition which brings significant socio-economic burden and can lead to sight-
threatening ocular complications.1 While the highest prevalence of myopia is found in 
East Asian populations, research from the UK demonstrates that myopia constitutes a 
significant burden in our population; with nearly 20% of white teenagers and 40% of 
South Asian teenagers being myopic.2,3 There is an increasing body of evidence to 
suggest that myopia is influenced by environmental factors. Research points to the 
protective effects of spending time outdoors,4,5 more specifically that it could prevent the 
onset of myopia however the exact mechanism is currently unclear. Evidence for the role 
of time outdoors as being protective for myopia progression is equivocal. Studies on 
animals have suggested that manipulating peripheral defocus through an optical means 
while simultaneously providing correct axial focus can either discourage or encourage 
axial growth to effectively treat myopia or hyperopia respectively6. Recent research has 
established that progression of myopia and axial growth can be significantly reduced in 
children and adolescents through the use of bifocal, dual focus, extended depth of focus 
or multifocal contact lenses7-10. The dual focus and extended depth of focus lenses while 
correcting the distance central myopia impose simultaneous myopic defocus. This 
intervention relies on active accommodation and the myopia control studies show that 
children accommodate normally with multifocal contact lenses. Some children in myopia 
control intervention studies show minimal further progression in their myopia whereas 
others show greater progression of myopia.10 Understanding the mechanisms underlying 
development and progression of myopia is paramount to establishing greater efficacy in 
myopia control interventions. 
 
The proposed study would explore how blur impacts on ocular parameters and in 
particular how the eye responds to the simultaneous defocus (blur) it receives from a 
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2. Study Objective and Design 
 
2.1 Study Objective 
 
• To explore how the ocular parameters in particular the ciliary muscle and choroid 
respond when subject to simultaneous blur 
 
2.2 Study Design 
 
Everyone who is able to take part in the study will visit the research centre over a period of 3 
within a two week period. Two visits per day for 3 consecutive days. The 2 visits per day is to 
allow fitting of the contact lenses in the morning and allow an adaption period before 
measurements are taken in the afternoon. The participants will be randomised to which lens 
they wear on which day. 
Lens conditions: 
1) Single vision Proclear daily disposable (DD) contact lens 
2) MiSight DD contact lens 
3) NaturalVue DD contact lens 
 
The measurement procedures are described below.  
At the first visit to the research centre, we will: 
• assess spectacle and contact lens wearing history and any history of previous myopia 
control interventions 
• assess suitablility to participate in the study by measuring refractive error with an 
autorefractor (WAM Grand Seiko. This instrument is used in a number of research studies eg ref 
#556).  
 
At each visit to the research centre, we will: 
• measure visual acuity using a logMAR letter chart. Additionally VA will also be measured 
using a black and white grating chart both with the participant looking straight ahead and with 
them looking at 40 degrees to fixation. This is to assess impact of peripheral blur from the 
contact lens on vision. 
• measure the shape of the anterior part of the eye and it’s components (lens, anterior 
chamber and ciliary muscle). This is done using an ocular coherence tomographer (Zeiss Cirrus 
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5000/ Zeiss Visante). The participant is required to place your chin on a rest and look at a 
target. 
• the thickness of the retina and choroid will also be made using the ocular coherence 
tomographer.  
• measure the length of the eye. This is done using the IOLMaster 500 (Zeiss). It has been 
used in previous studies ref (#556 #551). The participant places their chin on the machine’s chin 
rest and looks at a spot of light straight ahead and the machine will take several quick 
measurements of the eye length. Nothing touches the eye. 
• Assess lag of accommodation – focussing ability at near to a specific distance of 33cm, 
this will be assessed with the autorefractor. 
 
At the final visit we will also: 
• measure refractive error under cycloplegia using tropicamide 1% with an autorefractor to 
allow accurate assessment.   
Eye drop information: Tropicamide 1.0% 
The eye drops used in the study are used to make the pupils larger than normal allowing the 
investigator to view the inside of the eye more easily and to reduce focusing at near. The drops 
take about 15 to 30 minutes to work and around 6 hours to wear off, off (in some cases up to 24 
hours.) It is very unlikely, but should you experience any unusual symptoms such as severe 
pain and/ or blood shot around the eye and cloudy vision during this period please contact Dr 
Nicola Logan (n.s.logan@aston.ac.uk 0121 204 4128) and/ or your optometrist/ GP as you may 
be experiencing an adverse reaction to the drops. 
 
An adaptation period will be allowed between each set of measurements to allow for any 
change in lighting level and for change in fixation distance. 
Refractive error will be assessed using the Grand Seiko WAM 500 open-field autorefractor. This 
is a non-contact instrument and involves the participant placing his chin on a chinrest and 
forehead against a forehead rest. Five measurements will be taken from each eye when the 
participant is viewing a distance non-accommodative target. 
The measurements will take a maximum of 45 minutes to complete including time for adapting 
to the different conditions. We allow 20 minutes for initial fitting of the contact lens in the 
morning and 1 hour for the afternoon session. 
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3. Selection and Withdrawal of Participants 
 
3.1 Inclusion Criteria 
• Able to wear contact lenses 
• Participants aged 18-30 years 
• Myopia range -0.75D to -5.00D 
• Astigmatism 1D or less 
 
3.2 Exclusion Criteria 
• Amblyopia 
• History of ocular surgery or myopia control intervention 
• Use of medications known to impact on growth 
 
3.3 Withdrawal of Participants 
 
Participants will be withdrawn from the study in the following circumstances: 
• If there are not able to have tropicamide instilled into their eyes 
• any serious side effects related to contact lens wear 
• If the investigator determines that it is not in the best interest of the participant to 
continue in the study 
 
3.4 Expected Duration of Study 
 
The study is expected to last one year from July 2019 to July 2020.  
 
 
4. Study Procedures 
• Informed consent 
• Visual acuity using logMAR chart at distance and using grating acuity centrally and 
peripherally 
• Lag of accommodation using autorefractor 
• Axial length measures using a biometer 
• Ciliary body and crystalline lens assessment using optical coherence tomography 
• Choroidal thickness measures using OCT 
• Cycloplegia using tropicamide 
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• Refraction undertaken objectively with autorefractor 
• Verbal debrief at the end of the study. 
 
5. Assessment of Safety 
 
5.1 Participant Safety 
Potential hazards in this study relate to those associated with contact lens wear but are no 
greater than with normal use. All participants will be experienced contact lens wearers and 
aware of risks with contact lens wear. The researchers are experienced optometrists (one 
researcher, Daniel Lea, is a student optometrist who will work under supervision) who are 
trained to recognise and manage any complications arising from contact lens wear and will 
closely monitor subjects throughout the study.  
 
Dilation drops are used routinely during the course of optometric practice. All eyes will be 
checked appropriately prior to instillation of tropicamide. 
 
The instruments used within this study are standard ophthalmic instruments. The risks in this 
study are considered to be minimal and no greater than those associated with normal contact 
lens wear or the use of dilation drops in routine practice. A number of measures have been 
taken to minimise risks: 
 
• Participants will be monitored closely throughout the study  
• Eyes will be checked prior to instillation of tropicamide and pre and post contact lens 
wear. 
 
Participants will be instructed during the consent process that they are free to withdraw at any 
stage of the study. Leaving the study part way through will not have detrimental consequences. 
 
Confidentiality - records upon which the participant's name appears will be kept strictly 
confidential within the eye clinic. The information collected throughout the study, which will be 
used for analysis and publication will have the participant’s details removed and replaced by a 
code known only to the investigators so that the participant will not be identifiable from it. 
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Investigators will have completed appropriate training and will be experienced clinicians 
registered with the General Optical Council 
 
For participants in this study there is no direct benefit, however the findings may be of benefit for 
intervention for myopia progression in the future. 
 
5.2 Procedures for Reporting Adverse Events 
 
Adverse clinical events associated with the project will be reported through UREC 
adverse event reporting systems. 
Any adverse events associated with the specific procedures will be reported immediately 






Comparison between data taken with single vision (standard) contact lenses will be 
compared to data taken with MiSight and NaturalVue contact lenses. 
 
7. Direct Access to Source Data and Documents 
 
The investigators will permit UREC review by providing direct access to source data and 
other documents. 
 
8. Ethics and Governance 
 
The study will be conducted in compliance with principles of the Declaration of Helsinki 
(1996), the principles of GCP and in accordance with all applicable requirements. 
 
This protocol and related documents will be submitted for review to Aston University 
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9. Quality Assurance 
  
Monitoring and auditing of this study will be in accordance with the Aston University 
Monitoring and Auditing Policy for Human Participant Research. 
 
10. Data Management 
 
The Chief Investigator will act as custodian of the study data. The data will be shared 
with the other study investigators. 
 
The following guidelines will be strictly adhered to: 
• Participant data will be anonymized 
• All study data will be stored in accordance with University data storage policies for 
research data 
 
Study data will be archived in accordance with Aston University Archive Policies and 




It is intended that the results of the study will be reported in peer reviewed scientific 
journals. 
   
12. Insurance/Indemnity 
 
Insurance/indemnity will not be provided for non-negligent harm. 
Insurance/indemnity for negligent harm will be provided for clinical research procedures 
undertaken by Aston University staff and research students by the University. 
Aston University will provide indemnity/insurance for the design and management of the 
research.  
 
13. Signature of Chief Investigator 
              Nicola Logan 
 ------------------------------------       26/09/2019 
Chief Investigator        Date 
Dr Nicola Logan 
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Appendix 2: Study Participant Information Sheet 
 
PARTICIPANT INFORMATION SHEET 
 
How does the eye respond to blur? 
 
 
You are being invited to take part in a research study. Please take time to read the following 
information carefully and discuss it with others if you wish. Before you decide whether you want to 
take part or not, it is important for you to understand why the research is being done and what it will 
involve.  Our team will be available by phone or in person to go through this information leaflet with 
you, to help you decide whether or not you want to take part and answer any questions you may 
have. If there is anything that you don’t understand, please ask one of the research team to explain 
this further. 
The study is being carried out at Aston University Ophthlamic Research Clinics. We would like 20 
short-sighted young adults to take part in our study. 
This Participant Information Sheet tells you the purpose of the study and an explanation of what will 










Thank you for taking the time to read this Participant Information Sheet. 
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What is the study about? 
Short-sightedness, also called myopia makes objects in the distance, such as the television, look 
blurred. This is caused by the eye growing too long, something that usually happens during 
childhood but can continue into young adulthood. 
We can make people with myopia see better with glasses or contact lenses, but this doesn’t stop 
their eyes continuing to grow longer and become more myopic. 
Children in a study at Aston University have successfully been using a new design of soft contact 
lens (MiSight) to slow the progression of myopia for over 5 years now, however we do not fully 
understand how this lens works. The current study is the first of its kind looking at specifically how 
the eye responds to this type of contact lens. It will allow us to better understand why myopia 
develops and progresses. 
Why have I been chosen? 
You have been given information about this study as you are short-sighted. Whether you decide to 
take part in the study or not, we would like you to continue to go to your own optometrist for regular 
eye tests and glasses and/or contact lens checks. This study does not replace your routine eye 
examination. 
Do I have to take part? 
It is up to you to decide whether you want to take part or not.  If you decide now that you wish to 
take part, you can change your mind in the future and withdraw from the study. You don’t have to 
tell us why and it won’t affect your eye care in the future. 
We will ask you to sign a form (called an informed consent form) to say that you have agreed to be 
part of the study.  At this time, you will be given a copy of this information sheet and a copy of the 
form you have signed. 
Am I suitable for the study? 
If you decide you would like to take part, the first thing we need to do is to check whether you are 
definitely myopic.  We will do this by taking an autorefraction measurement. This takes 
approximately 2 minutes and is a little like having a photograph taken. It measures the strength of 
any spectacles you may require. We need to make sure all particpants who take part are short-
sighted, are not receiving any other treatments for myopia (apart from glasses or contact lenses), 
have healthy eyes and are in good general health too.  
What will happen to me if I take part? 
In this study, we will be comparing how the eye responds when it is corrected with a standard 
contact lens to how it responds when corrected with the MiSight design of contact lens and with 
another lens for myopia control called NaturalVue. Everyone who is able to take part in the study 
will visit the research centre over a period of 2 days. Two visits are required per day. At each visit, 
we will take some measurements of your eyes and test how well you can see. These 
measurements are described below.  
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At the first visit to the research centre, we will: 
• ask you about your spectacle and contact lens wearing history and if you have used any 
myopia control interventions previously 
• assess if you are suitable to participate in the study by measuring your level of myopia using 
an autorefractor. A non-contact instrument where you place your chin on a rest and look at a distant 
target. The measurement takes seconds.  
 
At each visit to the research centre, we will: 
 
• measure how well you see things far away using letters on a letter chart. We will do this while 
you are wearing contact lenses. We will also measure your vision using a black and white grating 
chart 
• measure the shape of the anterior part of your eye and it’s components (lens, anterior chamber 
and ciliary muscle). This is done using an ocular coherence tomographer. Nothing touches your 
eye and you are required to place your chin on a rest and look at a target. 
• the thickness of the light-sensitive tissues at the back of your eye (retina and choroid) using a 
ocular coherence tomographer. Nothing touches your eye and you are required to place your chin 
on a rest and look at a target. 
• measure the length of your  eye. This is done using a machine called an ocular biometer. You 
will place your chin on the machine’s chin rest and look at a spot of light straight ahead and the 
machine will take several quick measurements of the eye length. Nothing touches the eye and all 
you have to do is look at the light and keep your eyes still.  
• assess how well you can focus at near while looking at an image at 33cm. 
• measure the effect of glare on your vision. You will look at a letter target while a bright light is 
near the target 
• measure how well you can see letters of different contrast i.e light grey to dark grey 
• measure the aberrations in the eye – this involves looking at a fixation target while an 
instrument takes some readings. It does not touch your eye. 
 
At the final visit we will also: 
• measure your level of myopia.  To do this accurately, we will put an eye drop into each of your 
eyes. This eye drop relaxes the muscles in the eyes and allows us to accurately measure the level 
of short-sightedness. These drops are used routinely by optometrists.  After 20 minutes, we will 
measure the amount of short-sightedness with a machine called an autorefractor. Again you put 
your chin on the machine’s chin rest and look at a picture or letter placed on the other side of the 
room. Details of the drops are given below. You should not to drive, cycle or operate moving 
machinery until the drop has worn off. 
Eye drop information: Tropicamide 1.0% 
The eye drops used in the study are used to make the pupils larger than normal allowing the 
investigator to view the inside of the eye more easily and to reduce focusing at near. The drops 
take about 15 to 30 minutes to work and around 6 hours to wear off, (in some cases up to 24 
hours.) It is very unlikely, but should you experience any unusual symptoms such as severe 
pain and/ or blood shot around the eye and cloudy vision during this period please contact Dr 
Nicola Logan (n.s.logan@aston.ac.uk 0121 204 4128) and/ or your optometrist/ GP as you may 
be experiencing an adverse reaction to the drops. 
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How long do the visits last? 
The first and last visit to the clinic will last up to one hour.  The other visits will take approximately 
30 minutes. There will be time for you to rest between measurements if you need to.  
What are the possible disadvantages and risks of taking part? 
The following side effects are possible from the use of tropicamide.  
An increase in pupil size (which may make your vision a little uncomfortable when it is really bright 
outside, but you can use sunglasses or a hat to help with this) and a reduction in the ability to focus 
very close up.   
What are the possible benefits of taking part? 
There are no direct benefits to you for participating in the study. 
Your help with the study is valuable because it will help us decide how this new design of contact 
lenses may work to slow myopia progression. 
What happens when the research study stops? 
The information we collect will be kept for six years after the study is concluded and may be 
combined with other research studies. After that, the information we have on computer and on 
paper will be safely deleted or destroyed. 
What if I have a concern about the study? 
If you have any concerns about anything to do with this study, please speak to the research 
team and we will do our best to answer your questions.  Contact details can be found at the end 
of this information sheet. 
If the research team are unable to address your concerns or you wish to make a complaint 
about how it is being conducted then you should contact the Aston University Director of 
Governance, Mr John Walter, at j.g.walter@aston.ac.uk or telephone 0121 204 4869. 
Will my taking part in this study be kept confidential? 
We will take great care to ensure that any information we collect is stored safely.  In computer files 
that contain information about you, we will use an identification number rather than their name or 
any other detail that would allow someone to work out who you are. All information that we collect 
about your eyes will be kept on a password protected computer or in a locked filing cabinet. 
What are the costs and payments for taking part in this study? 
You will be given a £30 voucher to thank you for taking part in this study.  
What will happen to the results of the research study? 
At the end of the study we will tell you what the results of the study were.  We hope to do this quite 
soon after the study ends.  We will tell other researchers and the public about what we have found 
through scientific reports, websites and press releases. Your name won’t appear in any of the 
reports describing the study or its findings. 
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Who is funding the research? 
There is no specific funding for this study. 
Who has reviewed the study? 
This research has been reviewed by an independent group of people, called a Research Ethics 
Committee, to protect your safety, rights, wellbeing and dignity. This study has been reviewed and 
given a favourable opinion by the University Research Ethics Committee.  
Contact for Further Information 
Principal Investigator 
Name:  Dr Nicola Logan       
Address:  Vision Sciences, Aston University, Birmingham, B4 7ET 
 
Investigators 
Dr Raquel Gil Cazorla 
Mr Nikolay Boychev 
Ms Noelia Martinez 












Thank you for taking time to read this information leaflet 
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Transparency statement 
Aston University takes its obligations under data and privacy law seriously and complies 
with the General Data Protection Regulation (“GDPR”) and the Data Protection Act 2018 
(“DPA”).   
Aston University is the data controller and organizer for this study based in the United 
Kingdom. We will be using information from you and your child in order to undertake this study.  
Aston University will process your and your child’s personal data in order to register your child 
as a participant and to manage your child’s participation in the study.  It will process your child’s 
personal data on the grounds that it is necessary for the performance of a task carried out in the 
public interest (GDPR Article 6(1)(e).  Aston University may process special categories of data 
about your child which includes details about your child’s health.  Aston University will process 
this data on the grounds that it is necessary for statistical or research purposes (GDPR Article 
9(2)(j)). Aston University will keep identifiable information about your child for 6 years after the 
study has finished. 
Your rights to access, change or move your child’s information are limited, as we need to 
manage your child’s information in specific ways in order for the research to be reliable and 
accurate. If your child withdraws from the study, we will keep the information about your child 
that we have already obtained. To safeguard your child’s rights, we will use the minimum 
personally identifiable information possible. 
You can find out more about how we use your child’s information at 
www.aston.ac.uk/dataprotection or by contacting our Data Protection Officer at 
dp_officer@aston.ac.uk. 
If you wish to raise a complaint on how we have handled your child’s personal data, you 
can contact our Data Protection Officer who will investigate the matter. If you are not satisfied 
with our response or believe we are processing your child’s personal data in a way that is not 
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Appendix 3: Study Consent Form 
Volunteer Consent Form 
Participant Number:________ 
 
Title of Project:  How does the eye respond to blur? 
 
Name of Researchers: Dr Nicola Logan, Dr Raquel Gil Cazorla, Mr Nikolay Boychev, Ms 
Noelia Martinez, Mr Daniel Lea 
  Initial 
box 
1 I confirm that I have read and understand the information sheet 
(version 3 dated 27/11/19) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had 
these answered satisfactorily.  
 
2 I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my legal rights 
being affected. 
 
3 I agree to take part in the above study.  
 
_________________        ______________         ___________________ 
Name of volunteer        Date                           Signature 
 
________________     _____________      ___________________ 
Investigator taking consent Date                   Signature 
2 copies: 1 for participant 
1 for investigator 
